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The asymmetric dimethylation of histone H3 arginine 2 acts as a repressive 
mark that antagonizes trimethylation of H3 lysine 4. In this study, I report that 
H3R2 is also symmetrically dimethylated (H3R2me2s) by PRMT5 and 
PRMT7, and is present in euchromatic regions. Profiling of H3-tail interactors 
by SILAC-Mass Spectrometry revealed that H3R2me2s excludes binding of 
RBBP7, a central component of co-repressor complexes Sin3a, NURD and 
PRC2. Conversely H3R2me2s enhances binding of WDR5, a common 
component of the MLL/Set1a/b, the NLS1 and the ATAC co-activator 
complexes. The interaction with WDR5 distinguishes H3R2me2s from 
H3R2me2a, which impedes its recruitment to chromatin. The crystallographic 
structure of WDR5 and the H3R2me2s peptide in a stable complex elucidates 
the molecular determinants of this high affinity interaction (collaboration with 
Marina Mapelli IFOM IEO Milan). My findings provide insight into 
H3R2me2s as a novel mark that keeps genes poised in euchromatin for 
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1.1 CHROMATIN AND TRANSCRIPTIONAL REGULATION 
 
Eukaryotic cells compact their genome into condensed chromatin fibers, 
enabling a meter long molecule of DNA to fit within the limited volume of the 
nucleus (Fig.1). The major consequence of this compaction is that condensed 
chromatin is inherently resistant to processes that require access to the DNA 
sequence, such as transcription. 
The basic subunit of chromatin is the nucleosome, which contains 147 base 
pairs (bp) of DNA wrapped around an octamer of core histones, formed by a 
dimer H2A-H2B and a tetramer H3-H4 (Fig.2).  Histones are highly positively 
charged proteins, rich in arginines and lysines, a characteristic that allows 
them to interact strongly with the negatively charged DNA. 
They are defined by two separate functional domains: a “histone-fold” motif 
that is sufficient for both histone- DNA and histone- histone contacts within 
the nucleosome, and NH2-terminal and COOH-terminal “tails” that are 
frequently post-translationally modified on several residues.  
Whereas the histone-fold motif is structured in a globular core, histone tails 
are mostly unstructured and protrude radially from the nucleosome (Kornberg 
and Lorch, 1999; Luger et al., 1997). This allows them to readily associate 
with the “linker” DNA that resides between nucleosomes or with adjacent 
nucleosomes (Hansen, 2002). 
 ! #!
Other than the core histones, chromatin also contains a linker histone, H1. 
Histone H1 is not related in sequence to the core histones but it is still 
characterized by a globular domain flanked by NH2- and COOH-terminal tails 






Fig.1:  The steps involved in the folding of nucleosomes into chromatin fibers 






Only the globular domain is essential for binding the nucleosome, whereas the 
tails have been reported to have a role in chromatin folding (Ramakrishnan, 
1997). In other words, histone H1 seems to be responsible for the formation of 
the compacting of chromatin, thus forming higher order structures. 
Until a decade ago, the above described core histones were considered to be 
conserved as the common components of all nucleosomes (Kornberg and 
Lorch, 1999). However, it has recently been shown that a significant variety of 
histones is present in different species (Kamakaka and Biggins, 2005). Histone 
variants, as they are called, differ from their core counterparts either in the 
way that they are incorporated into chromatin (DNA replication dependent or 





Fig.2: Nucleosome core particle: ribbon traces for the 146-bp DNA 
phosphodiester backbones (brown and turquoise) and eight histone protein 
main chains (blue: H3; green: H4; yellow: H2A; red: H2B. The views are 
down the DNA superhelix axis for the left particle and perpendicular to it for 
the right particle. For both particles, the pseudo-twofold axis is aligned 
vertically with the DNA centre at the top.(Luger et al., 1997) 
 
 
For example, the H2A.Z variant of H2A and the H3.3 variant of H3 are 
deposited throughout the cell cycle in a DNA replication independent manner 
(Mito et al., 2005; Mizuguchi et al., 2004; Park et al., 2005). In contrast to 
most histones that are deposited behind the replication fork, histone variants 
replace resident histones and nucleosomes have to be disrupted to allow their 
incorporation.  
Double variant nuclesomes (H2A.Z and H3.3) reside at promoters or 
regulatory sequences that have been widely accepted as “nucleosome free” 
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and they indeed appear to be far more dispersed than the phased nucleosomes, 
which flank these sites (Jin et al., 2009). 
Since gaining access to a specific site occupied by a nucleosome requires its 
eviction or sliding, these variants, which are continuously being disrupted and 
replaced, could have a key role in destabilizing nucleosomes and therefore in 
modulating DNA accessibility. 
We now have definitive evidence that histones are no longer stable entities but 
are instead highly dynamic and capable of being altered in their structure, 
composition and localization along the DNA (Kamakaka, 2003). 
However, little is known about the processes that link DNA accessibility to 
gene regulation, emphasizing the importance of better understanding the 













1.2 HISTONE MARKS AND HISTONE CODE HYPOTHESIS 
Post-translational modifications (PTMs) are essential for signal transduction. 
By altering the biophysical features of proteins, PTMs can regulate a diverse 
array of phenomena, including protein stability, subcellular localization and 
interactions. 
In the context of histones, whose highly charged nature enable them to interact 
strongly with the DNA, a PTM can directly or indirectly modify chromatin 
structure and contribute to the organization of higher eukaryotic genomes into 
euchromatin and heterochromatin. 
Euchromatic domains are important for regulating transcription, by ensuring 
DNA accessibility, assembly of the transcription machinery, and binding of 
sequence specific transcription factors. Conversely, heterochromatic domains 
maintain the large majority of the genome in a state in which renders it 
inaccessible to the transcriptional machinery, and hence, relatively silent. 
In order to get access to the DNA, the cellular transcription machinery must be 
able to modify chromatin structure. This can be achieved by non-covalently 
altering the DNA structure in an ATP-dependent energy-driven fashion (Strahl 
and Allis, 2000) or by covalently modifying chromatin components 
(Workman and Kingston, 1998). 
The covalent modifying enzymes comprise several groups of proteins, which 
are able to post-translationally modify DNA or histones. 
As previously stated, a striking feature of histones, and particularly of their 
tails, is the large number and type of modified residues they possess (Fig. 3) 
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(Goll and Bestor, 2002). 
According to the histone code hypothesis (Jenuwein and Allis, 2001; Strahl 
and Allis, 2000) histone marks are a critical feature of a genome-wide 
mechanism of information storage and retrieval that may considerably extend 
the information potential of the genetic code. Central to this hypothesis is that 
chromatin structure plays an important regulatory role and that multiple 
signaling pathways converge on histones. Although histone proteins 
themselves come in generic or specialized forms (variants), exquisite variation 
is provided by the covalent modifications (acetylation, phosphorylation, 
methylation, sumoylation, citrullination) of the histone tail domains, enabling 
differential  regulatable contacts with the underlying DNA. 
Histone modifications can: 
- change the charge  
- change the surface 
of one or a combination of specific histone residues. 
For example, attaching an acetyl group to a lysine will neutralize its positive 
charge and reduce the interaction between DNA and histone proteins, 
decompacting chromatin structure. On the other hand, methylation of the same 
amino acid will alter its surface, not its charge. This methylated lysine will 
now be able to interact with chromatin readers or effectors, or displace their 
binding to chromatin. 
While acetylation occurs only on lysine residues, methylation can take place 
on both lysines and arginines. In addition, the situation is more complex since 
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lysines can be monomethylated (me1), dimethylated (me2) or trimethylated 
(me3), while arginines can be dimethylated in a symmetrical or asymmetrical 




Fig.3: Sites of Histone Tail Modifications. The amino-terminal tails of 
histones account for a quarter of the nucleosome mass. They host the vast 
majority of known covalent modification sites as illustrated. In general, marks 
include acetylation (blue AC triangle), arginine methylation (in green and 
pink), phosphorilation (yellow PH triangle), ubiquitination (purple UB 
triangle) and lysine methylation (red ME triangle).  
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Acetylation and methylation of histones have recently emerged as key 
coregulators involved in transcription regulation (Iizuka and Smith, 2003; 
Roth et al., 2001; Santos-Rosa et al., 2002; Zhang and Reinberg, 2001). In 
fact, histone PTMs can directly alter the biophysical and biochemical 
characteristics of chromatin, creating a dynamic platform upon which the 
transcriptional machinery is recruited and assembled. 
Histone tail modifications are very dynamic and the enzymes which transduce 
these covalent modifications are highly specific for particular amino acid 
positions, thereby extending the information content of the genome past the 
genetic code. Histone acetyltransferases (HATs) catalyze the addition of 
acetyl groups to lysine residues of the histone tails. Yeast Hat1, for example, 
catalyzes Lys5- and/or Lys12-specific acetylation of H4, and the NuA4 
complex displays a strong preference for acetylation of H4 and H2A in vitro 
(Roth et al., 2001). Phosphorylation of serines/threonines is carried out by a 
class of enzymes called kinases, such as Ipl1/aurora kinase which is able to 
phosphorylate H3S10 (Hsu et al., 2000). 
Histone methyltransferases (HMTases) covalently link methyl groups to either 
lysines or arginines: examples are the human MLL complexes which are 
capable of methylating H3K4, or the Drosophila Su(var)3-9 which is capable 
of methylating H3K9 (Jenuwein, 2001; Yokoyama et al., 2004). The covalent 
modifications that take place on the histone tails are enzymatically reversible. 
For example, phosphorylation is reversed by phosphatases, and acetylation is 
reversed by histone deacetylases (HDACs). Unlike histone phosphorylation 
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and acetylation, histone methylation was considered static and enzymatically 
irreversible (Kouskouti and Talianidis, 2005) until the identification of the 
H3K4- specific demethylase LSD1, suggesting that histone methylation is 
reversible and dynamically regulated (Shi et al., 2004; Shi and Whetstine, 
2007). This finding was most recently supported by the identification of an 
entire class of enzymes (the JMJ family) that are able to reverse protein 
methylation (Klose et al., 2006; Tsukada et al., 2006; Whetstine et al., 2006). 
But, so far, there is a lot of confusion regarding the existence of arginine 
demethylases (Chang et al., 2007) as will be discussed later.  
The histone code hypothesis predicts that the modification marks on the 
histone tails should provide binding sites for effector proteins. In agreement 
with this notion, the bromodomain was the first protein module shown to 
selectively interact with a covalent mark (acetylated lysine) in the histone 
NH2-terminal tail. 
Chromodomains, on the other hand, appear to be targeting modules for 
methylation marks (Jenuwein and Allis, 2001). Recently, in addition to 
chromodomain, other protein domains have been shown to be capable of 
binding methyl marks on histone tails, including PHD, Tudor, plant Agenet, 
PWWP, SWIRM, and MBT domains (Martin et al., 2006; Maurer-Stroh et al., 
2003; Shi et al., 2006; Taverna et al., 2006; Wysocka et al., 2006). 
Another prediction of the histone code hypothesis is that multiple histone 
modifications act in a combinatorial or sequential fashion on one or multiple 
histone tails, specifying unique downstream functions. For example, H3S10 
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phosphorylation inhibits H3K9 methylation but is synergistically coupled with 
K9 and/or K14 acetylation that marks transcriptional activation. Similarly, 
H3K4 trimethylation promotes acetylation at H3K14, thus stimulating 
transcription (Jenuwein and Allis, 2001; Taverna et al., 2006). On the other 
hand, specific marks seem to be interchangeable while others are strictly 
found in association or exclusion groups rendering the “code” much simpler 
and less combinatorial than expected (Guccione et al., 2006; Kurdistani et al., 
2004). Understanding how these marks are deposited and erased is of central 
importance for understanding how gene transcription is regulated, and for 
elucidating the mechanisms controlling key physiological and pathological 
events such as differentiation, development and cancer.  
 
 
1.3 ARGININE METHYLATION 
1.3.1 THE BIOCHEMISTRY OF PROTEIN ARGININE METHYLATION 
In eukaryotes, from S. cerevisiae to humans, arginine methylation is an 
abundant PTM (Najbauer et al., 1993), occurring on both histones and other 
nuclear and cytoplasmic proteins (Bedford and Clarke, 2009). Arginine side 
chains have two terminal guanidino-groups (NH2), which are often involved 
in hydrogen bonding with protein interaction partners and by directly 
contacting thymine-, adenine-, and guanine- bases and backbone phosphate 
groups on DNA and RNA (Luscombe et al., 2001). The addition of one 
methyl group to either one of the guanidino-groups gives rise to mono methyl 
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arginine (omega-NG-monomethylarginine: MMA), and this reaction can be 
performed by Type I, II and III PRMTs. Subsequently, MMA can be 
dimethylated either asymmetrically (omega-NG,NG-dimethylarginine: 
ADMA) by type I PRMTs or symmetrically (omega-NG,N’G-
dimethylarginine: SDMA) by type II enzymes (Bedford and Clarke, 2009) 
(Fig.4). The direct effect of adding each methyl moiety to an arginine residue 
is a change in its shape, and as a consequence the protein surface is altered and 
the potential hydrogen bond donor is lost. Additionally, the amino acid gets 
bulkier and more hydrophobic (Hughes and Waters, 2006; Stetler et al., 2006). 
PRMTs of type I, II and III make up a family of enzymes conserved from 
yeast to humans (Bachand, 2007), and their exact number is still under 
investigation: in humans and mice, six genes are known to encode enzymes 
with Type I activity (PRMT1, PRMT2, PRMT3, PRMT4 [CARM1], PRMT6, 
and PRMT8) and two genes encode proteins with Type II activity (PRMT5 
and PRMT7). PRMT7 has also been inferred to have Type III activity, while a 
related protein on chromosome 4 (PRMT9-[4q31]), also referred to as 
PRMT10, is predicted, based on sequence similarity, to also be a Type II 
enzyme (Bedford and Clarke, 2009; Krause et al., 2007). All of these PRMTs 
contain the seven-beta strand methyltransferase domain typical of class I 
methyltransferases (Katz et al., 2003), as well as the characteristic “double E” 
and “THWxQ” sequence motifs (Cheng et al., 2005). FBXO11 and FBXO10 
are two other proteins, which, while showing poor sequence similarity to other 
PRMTs, have been proposed to have PRMT type II activity (Cook et al., 2006; 
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Krause et al., 2007). There is, however, little experimental evidence to support 
these predictions, and subsequent reports have described no specific PRMT 















Fig.4: The arginine methylation cycle catalysed by protein arginine N-
methyltransferases. (A) Arginine methylation/demethylation cycle. Type I, II 
and III PRMTs generate monomethylarginine (MMA) on one of the terminal 
guanidino nitrogen atoms. These two nitrogen atoms are equivalent. Next, 
Type I PRMTs are able to generate asymmetric dimethylarginine (ADMA) 
while Type II PRMTs generate symmetric dimethylarginine (SDMA). Type 
III PRMTs can only catalyze the first step to MMA. Two classes of enzymes 
have been described that are able to reverse the methylation reaction. PADI4 
actually converts arginine and methylarginine to citrulline, while releasing 
either an imino or a methylimino group. There is no evidence yet for an 
enzyme catalyzing the remaining step of converting citrulline back to arginine. 
JMJD6, a member of the second class of enzymes, is part of the large Jumonji 
family of demethylases. The demethylase activity of this protein has thus far 
only been characterized in vitro and does not seem to discriminate between the 
demethylation of ADMA or SDMA back to arginine.  (B) PRMT family 
members. The mammalian PRMTs consist of nine members, highly related 
and conserved in amino acid sequence and structure; two classes, PRMT Type 
I and Type II, differ slightly in their catalytic binding pocket, which allows 
MMA to be converted into ADMA or SDMA, respectively. All PRMTs 
contain the conserved methyltransferase signature motifs I, post I, II and III as 
well as the ‘double E loop’ and ‘THW loop’ (in black or colored bars, the 
consensus sequence is indicated). PRMT2 (SH3 domain in purple), PRMT3 
(Zn Finger in yellow) and PRMT9-4q31 (tetratricopeptide repeat domains in 
green) contain additional protein domains that might contribute to substrate 
recognition or mediate protein–protein interactions. PRMTs are ordered based 
on their sequence similarity clustering. Right panel: enzymatic activity on 
histone substrates is indicated to the right of each PRMT (Migliori et al., 
2010). 
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1.3.2 HISTONE ARGININE METHYLATION 
To date, only a few methylated arginines have been described on histones: 
asymmetric and symmetric dimethylation on arginine 3 of histone 4 
(respectively H4/H2AR3me2a catalyzed by PRMT1, and possibly by PRMT8, 
H4/H2AR3me2s catalyzed by PRMT5, and possibly by PRMT7), H3R2me2a 
by PRMT6, H3R17me2a and H3R26me2a by PRMT4/CARM1, and 
H3R8me2s by PRMT5 (Krause et al., 2007). PRMT2 might have weak Type I 
activity, targeting H4, but no specific mapping has been done to identify the 
methylated arginine(s) (Lakowski and Frankel, 2009). In the next chapters, I 
will describe in detail the effect of site-specific methylation of different 
arginines on histones H3, H2A and H4 on transcriptional output. The crosstalk 
with other acetylation or methylation events on histones or with DNA 
methylation will also be addressed. 
 
 
1.3.3 ARGININE METHYLATIONS LINKED TO TRANSCRIPTIONAL  
         ACTIVATION: H4/H2AR3me2a, H3R17me2a, H3R26me2a 
1.3.3.1 H4R3me2a and H2AR3me2a 
Methylation of arginine at position 3 on the histone H4 tail was the first to be 
described (Strahl et al., 2001) and it is of particular interest as H4R3 is the 
only site on which both an asymmetric and a symmetric modification can 
alternatively occur. This means that there are four possible methylation states 
for H4R3: H4R3me0, H4R3me1, H4R3me2a and H4R3me2s. Moreover, the 
 ! "'!
extreme N-terminal tail of histone H4 is identical to that of histone H2A, thus 
both histone tails have the potential to be simultaneously methylated. 
H4/H2AR3 are asymmetrically dimethylated by PRMT1, though there is a 
strong preference towards H4 over H2A (Strahl et al., 2001), and this has been 
described as an essential upstream event for other subsequent histone PTMs 
(Huang et al., 2005). Its loss leads to the deacetylation of both H3 and H4 and 
to an increase in H3K9me3 and H3K27me3 levels. In addition, H4R3me2a-
linked acetylation occurs preferentially on H4K5 and H4K12, which are 
specifically recognized and bound by TAFII250, the major subunit of the 
transcription complex TFIID, through its two tandem bromodomains 
(Jacobson et al., 2000). Although asymmetric dimethylation of H4R3 favors 
histone H4 acetylation, both in vitro and in cells, and thus correlates with gene 
activation, no direct mechanism has been uncovered yet (Huang et al., 2005). 
One hypothesis is that H4R3me2a is directly recognized by a Histone Acetyl 
Transferase (HAT), or by a subunit of one of the H4-specific HAT complexes 
(Doyon et al., 2006). However, there is no experimental data supporting this 
prediction. 
The link between H4R3me2a and activation of gene expression has also been 
established in the case of an aberrant MLL1-EEN-Sam68-PRMT1 complex 
driving leukemogenesis (Cheung et al., 2007), where PRMT1 activity seems 
to cooperate with MLL1-driven H3K4 methylation to activate target genes. 
There is no direct evidence regarding how this may happen mechanistically. 
One possible explanation is that PRMT1-driven H4R3me2a methylation 
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antagonizes PRMT5-driven symmetric dimethylation of the same residue 
(H4R3me2s), which has been linked to deacetylase activity (Pal et al., 2004; 
Pal et al., 2003). In addition, the presence of H4R3me2s at repressed 
promoters strongly correlates with another histone modification on histone 
H3: H3R2me2a (Guccione et al., 2006). H3R2me2a blocks MLL binding and 
subsequent transcriptional activation (Guccione et al., 2007a; Guccione et al., 
2006; Iberg et al., 2008). A recent study links H4R3me2a to other acetylation 
events on both H3 and H4, and the loss of H4R3me2a correlates with poor 
prognosis in breast carcinomas (Elsheikh et al., 2009). Loss of acetylation on 
H4K16 and methylation on H4K20, specifically on repetitive sequences, has 
already been shown to be a hallmark of cancer (Fraga et al., 2005). However, 
it remains to be investigated if the loss of H4R3me2a dimethylation also 




A few years after the identification of PRMT1 as the major type I PRMT, 
CARM1, also known as PRMT4, was shown to methylate histone H3 at 
positions 17 (H3R17me2a) and 26 (H3R26me2a) (Schurter et al., 2001). Soon 
after, the presence of H3R17 asymmetric dimethylation on promoters was 
linked to estrogen-receptor-regulated pS2 gene activation (Bauer et al., 2002) 
and to steroid-hormone-dependent activation (Ma et al., 2001). One year later, 
arginine methylation by CARM1/PRMT4 was linked to lysine acetylation 
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(Daujat et al., 2002): H3K18 and H3K23 acetylations by CBP precede and 
favor the high affinity binding of CARM1/PRMT4 to chromatin. H3R17 is 
subsequently methylated, and this is followed by enhanced gene transcription. 
Once again, the ordered deposition of these modifications was suggested to 
cooperate in transcriptional activation, but many questions remain 
unanswered: which proteins act downstream of H3R17me2a? Are HATs or 
chromatin remodeling complexes recruited by a direct docking mechanism on 
H3R17me2a? Recently, Yang and colleagues reported that TDRD3 is a 
transcriptional coactivator, which interacts directly with H3R17me2a(Yang et 
al.). Other reports have linked CARM1 to co-stimulatory functions: Torres-
Padilla and colleagues have demonstrated a role for PRMT4 in the regulation 
of cell fate and pluripotency (Torres-Padilla et al., 2007). Specifically, the 
degree of methylation of the arginine residues targeted by CARM1 is highest 
in those cells that are destined to contribute to the inner cell mass and the polar 
trophoectoderm. Conversely, the murine trophoectoderm is characterized by 
low arginine methylation on the H3 tail (H3R17 and H3R26). This result 
suggests that epigenetic PTMs might be important in directing blastomeres to 
become part of the ICM, increasing the transcriptional levels of genes 
responsible for the maintenance of pluripotency, such as Oct4, Sox2 and 
Nanog. Further work by the same group characterized the role of PRMT4 in 
mES cells by selectively depleting or overexpressing this enzyme. The results 
suggest that PRMT4 is important in maintaining pluripotency, as cells lacking 
PRMT4 up-regulate endodermal, mesodermal and trophectodermal-specific 
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genes, while cells over-expressing the enzyme have a delay in their 




Much of what is known about H3R17me2a can be applied to H3R26me2a. 
Both arginines are methylated in vitro and in vivo by PRMT4, and have been 
correlated to gene activation. What remains to be explored is whether PRMT4, 
when present in macromolecular complexes within cells, such as the NUMAC 
complex (Xu et al., 2004), can preferentially methylate either H3R17 or 
H3R26. The prediction is that these two PTMs might play different roles, 
since, as compared to their methylated counterparts, the unmethylated 
arginines (H3R17me0 and R26me0) exhibit different hydrogen bonding 
properties and thus, may associate with different histone H3 binders. 
 H3R17me2a could either interfere with or stimulate the binding of 
bromodomains, such as the one contained in PCAF, to the histone H3 tail. The 
PCAF bromodomain has been shown to specifically bind to H3K14 when 
acetylated, and may contact the surrounding amino acids, including H3R17 
(Zeng et al., 2008). Similarly, H3R26 is predicted to affect the binding of 
PC/CBX proteins (Bernstein et al., 2006) or of the mammalian PRC2 complex 
to H3K27me3 (Hansen et al., 2008). Whether H3R26 methylation plays a 
modulating role in Polycomb repressive functions still remains to be explored. 
 
 ! #+!
1.3.4 REPRESSIVE ARGININE METHYLATIONS: H4/H2AR3me2s,   
         H3R8me2s and H3R2me2a 
1.3.4.1 H4/H2AR3me2s 
The symmetric dimethylation of arginine 3 on histone H4 can be catalyzed by 
at least two enzymes: PRMT5 and PRMT7 (Branscombe et al., 2001) 
(Miranda et al., 2004) (Jelinic et al., 2006). Unlike PRMT1, however, both 
PRMT5 and PRMT7 catalyze the formation of SDMA (H4R3me2s). Initial 
reports associated the symmetric dimethylation at H4R3 with transcriptional 
repression, since PRMT5 was co-purified with a high molecular weight E2F4-
containing complex termed CERC (Cyclin E1 repressive Complex). This 
complex, as the name suggests, represses Cyclin E1 transcription, at least in 
part through the catalytic activity of PRMT5 (Fabbrizio et al., 2002). Sif and 
colleagues later described that PRMT5 is linked to hSWI/SNF-mediated 
repression (Pal et al., 2004; Pal et al., 2003). The Brg1 chromatin remodeler, 
in association with mSin3A/HDAC2 and PRMT5, binds to promoters of 
repressed genes, including genes regulated by the Myc-Max-Mad network 
(cad, nuc), and the tumor suppressors NM23 and ST7. These promoters are 
characterized by hypo-acetylated H3 and H4 tails, which are preferentially 
methylated on H4R3me2s and H3R8me2s (Pal et al., 2004; Pal et al., 2003). 
The importance of H4/H2AR3me2s in transcriptional repression was later 
associated with cancer (Eckert et al., 2008; Kim et al., 2005; Pal et al., 2007), 
but it was only recently that a direct mechanism linking the methylation on 
arginine H4/H2AR3me2s to a downstream event was described. Zhao and 
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colleagues showed that H4R3me2s is a direct docking site for the DNA 
methyltransferase DNMT3A, which interacts with the methylated histone H4 
tail through a PHD finger contained in the C-terminal ADD domain (Zhao et 
al., 2009) (See BOX1 for details on DNA Methylation). PRMT5 is the main 
enzyme responsible for this methylation event, and a reduction in PRMT5 
levels leads to diminished DNMT3A binding to chromatin, loss of DNA 
methylation and a subsequent increase in gene expression. Although the 
evidence is limited to a single model of gene regulation during cell 
differentiation (the beta-globin locus), these data are key in expanding our 
knowledge on how arginine methylation can be directly linked to DNA 
methylation and gene silencing. In light of these results, two papers describing 
the link between arginine methylation and its role in germ cells differentiation 
and establishment of imprinting can be reinterpreted. Jelinic and colleagues 
linked the arginine methylation event on H4R3, driven by PRMT7, in 
combination with CTCFL, to DNA methylation at the Igf2/H19 imprinting 
control region (Jelinic et al., 2006). The authors describe the arginine 
methylation event as being upstream of DNA methylation, since the 
expression of DNMT3a/b/L in the absence of PRMT7/CTCF in Xenopus 
oocytes does not lead to efficient methylation of the analyzed sequence. 
Interestingly, in the same assay, DNMT3a/b, in the absence of DNMT3L, did 
not yield a sufficient level of methylation. These data not only reinforce the 
importance of the DNMT3L non-catalytic subunit in establishing DNA 
methylation in germ cells, but suggest the existence of crosstalk between 
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H4R3me2s and the unmethylated histone H3 tail. The PHD finger of 
DNMT3L has been shown to selectively bind histone H3 only in the absence 
of H3K4 methylation, and combination of the two tails 
(H3K4me0/H4R3me2s) could favor the targeting of the methylation to 
imprinted loci (Ruthenburg et al., 2007) (Ooi et al., 2007). Regarding the 
hierarchical order between arginine and DNA methylation, more work needs 
to be done to draw a conclusion.  A recent paper showed that a lack of 
DNMT3L-dependent DNA methylation at imprinted loci leads to the loss of 
H4R3me2s, as well as other repressive histone modifications (Henckel et al., 
2009). The consensus, at present, is that the symmetric methylation events on 
H4R3 and on DNA are interdependent, with the loss of one leading to the loss 
of the other. In a second paper, Ancelin and coworkers describe PRMT5 as a 
crucial partner of Blimp1, a transcriptional repressor essential for primordial 
germ cell (PGC) specification(Ancelin et al., 2006). The authors describe a 
relocalization of PRMT5/Blimp1 from the nucleus to the cytoplasm, with 
consequent loss of H4R3me2s and a de-repression of target genes, such as 
dhx38. These events coincide with the timing of imprint erasure and global 
genome demethylation in germ cells (E11.5). Whether a link between 







The activity of PRMT5 on different substrates such as histone H3 and H4 is 
modulated by various cofactors. COPR5 is a nuclear protein, which binds to 
PRMT5, favoring its H4 specific activity (H4R3me2s) over its H3 activity 
(H3R8me2s) (Lacroix et al., 2008b). Whether there is a different cofactor 
directing methylation on H3R8 is still unknown. H3R8me2s, like H4R3me2s, 
has been associated with transcriptional repression (Pal et al., 2004). 
Hypoacetylated histones are preferentially methylated by PRMT5, and 
specifically, both H3K9ac and H3K14ac block PRMT5 mediated H3R8 
methylation in vitro. This cross-talk was also shown in cell lines, where 
overexpression of PRMT5 leads to a reduction in H3K9ac at the ST7 and 
NM23 promoters, concurrent with H3R8me2s upregulation. This is consistent 
with the recruitment, by the PRMT5 complex, of HDAC activity, though, 
whether H3R8me2 plays a direct role in blocking acetylation by HATs still 
remains to be shown (Pal et al., 2004).  
Two other interactions, which have been described, involve the H3K9 
methyltransferase G9a and the H3K9me3 reader, HP1. In vitro evidence 
suggests that H3R8me2s is capable of blocking G9a-mediated H3K9 
methylation (Rathert et al., 2008). In this context, the methylation of R8 might 
interfere with G9a functions, such as establishment of imprinting and 
maintenance of euchromatic methylation at lysine 9, but direct in vivo 
evidence is still missing (Tachibana et al., 2002). HP1 has been crystallized 
with a histone H3 peptide, and makes essential contacts with unmethylated 
 ! #%!
H3R8. Mutation of the arginine to alanine impairs binding, and it is likely that 
dimethylation would have a very similar effect (Jacobs and Khorasanizadeh, 
2002; Nielsen et al., 2002). In these two latter examples, H3R8 methylation 
acts as a transcriptional activator rather than a repressor, blocking two well-
described mechanisms of transcriptional repression. H3R8me2s has been 
associated with transcriptional activation as well, at least in the context of 
myogenic differentiation (Dacwag et al., 2007). However, it remains to be 




The asymmetric dimethylation on arginine 2 of histone 3 (H3R2me2a), 
catalyzed by PRMT6, has been shown to block the trimethylation on H3K4 
(Guccione et al., 2007a). Although the enzyme catalyzing H3R2me2a in yeast 
has not yet been identified, a similar mechanism of mutual exclusion between 
H3R2me2a and H3K4me3 on chromatin has also been described in S. 
cerevisiae (Kirmizis et al., 2007). In mammalian cells, H3R2me2a prevents 
the MLL-mediated trimethylation of H3K4 by blocking the binding of 
MLL/WDR5 to the histone H3 tail (Couture et al., 2006; Guccione et al., 
2007a; Iberg et al., 2008). Conversely, H3K4me3 impairs the asymmetric 
methylation of H3R2, both in vitro and in vivo, on Myc targets and on genes 
of the HOXA cluster (Guccione et al., 2007a; Hyllus et al., 2007; Iberg et al., 
2008). In yeast, the mechanism regulating the mutually exclusive deposition 
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of these two PTMs is different, as Spp1, the homologue of Ash2L (in contrast 
to the WDR5 homologue), is excluded from binding to histone H3 when R2 is 
asymmetrically dimethylated, and this in turn prevents Set1 methylation on 
H3K4. 
These two marks (H3R2me2a and H3K4me3) are distributed in a mutually 
exclusive fashion on chromatin in both human and yeast cells (Guccione et al., 
2007a; Guccione et al., 2006; Kirmizis et al., 2007). While H3K4me3 is 
mainly present within 2-3Kb around active transcription start sites (TSSs), 
H3R2me2a is distributed outside of these domains and correlates with 
transcriptionally inactive promoters (Guccione et al., 2007a; Kirmizis et al., 
2007). The link between H3R2me2a and transcriptional repression is further 
reinforced by a number of studies in which, at least in vitro, the asymmetric 
dimethylation of arginine 2 reduces, or completely abrogates, the binding of 
key components of the transcriptional machinery. This is the case for the PHD 
fingers of the TAF3 subunit of the TFIID complex (van Ingen et al., 2008), for 
the ING subunits within the HAT and HDAC complexes (Doyon et al., 2006; 
Pena et al., 2006; Ramon-Maiques et al., 2007) and for the BPTF subunit of 
the NURF complex (Li et al., 2006). In each of these cases, the R2 side chain 
is buried within hydrophobic pockets, and the presence of a methyl moiety 
likely causes steric hinderence with the surrounding amino acids that are part 
of the binding cage.  However, this is not the case for all PHD fingers. Two 
examples are the PHD fingers of BHC80 and DNMT3L, which are not 
affected by H3R2me2a. Instead, they are excluded from interacting with the 
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histone H3 tail in the presence of H3K4 trimethylation. The PHD finger of 
BHC80 makes contacts with H3K4me0 and with H3R8 but not with H3R2, 
while the resolution of the DNMT3L crystals is too low to appreciate the 
structure of the bound H3R2 side chain (Lan et al., 2007) (Ooi et al., 2007).   
Other domains, which also bind to histone H3, such as the double chromo 
domain of CHD1, a chromatin remodeling protein (Flanagan et al., 2005), and 
the double Tudor domain of JMJD2A, a histone H3K9 demethylase (Huang et 
al., 2006), are also affected by the presence of the asymmetric dimethylation 
on R2. JMJD2A binds to H3K4me3 and contributes to promote gene 
activation, as has been observed for androgen receptor responsive targets 
(Shin and Janknecht, 2007). Whether H3R2me2a also plays a role in this 
context, needs to be proven. 
 
 
1.3.5 CITRULLINATION AND ARGININE DEMETHYLATION 
As discussed so far, arginine methylation can act in different ways in a 
signaling cascade leading to either transcriptional activation or repression. 
One of the key biochemical events in all signaling cascades is reversibility, 
and thus it is very important to discuss how arginine methylation can be 
removed, restoring the ground state of non-methylated arginine. So far, four 
major mechanisms for the removal of methylated arginines from histones have 
been suggested.  
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HISTONE SUBSTITUTION: in this scenario there is a rapid exchange of a 
methylated histone for a non-methylated one. This can be coupled to 
transcriptional activation, since the -1 nucleosome (relative to the TSS), is 
enriched for H3K4me3 and the histone variant H2A.Z (Schones et al., 2008),  
and can be preferentially evicted upon transcriptional activation in human 
cells. Alternatively, histone chaperones can play a role in substituting 
H2A/H2B or H3/H4 dimers (Park and Luger, 2008). Whether arginine 
methylation plays a role in facilitating any of these processes is not known. 
HISTONE TAIL CLEAVAGE: this mechanism has been recently proposed to 
be conserved in both higher and lower eukaryotes, and is mediated by specific 
serine endopeptidases such as mammalian cathepsyin L (Duncan et al., 2008; 
Santos-Rosa et al., 2009). The consensus in both model systems is that such 
“clipping” mechanisms occur preferentially on histone H3 after 21 amino 
acids, and that modifications associated with gene activation such as 
acetylation at position 23 or methylation at position 4 of histone H3 tend to 
impair this “clipping” process (Duncan et al., 2008; Santos-Rosa et al., 2009). 
The biological significance of these clipping events however remains unclear, 
as they seem to precede histone eviction and gene activation in yeast, 
specifically under nutrient deprivation or sporulation (Santos-Rosa et al., 
2009), while correlating with differentiation in ES cells (Duncan et al., 2008). 
The net result of the clipping event is the elimination of the entire N-terminal 
tail of H3 which contains, depending on the situation and the model system, 
arginine methylation at position 2, 8 and 17. Whether arginine methylation 
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plays a direct role in controlling histone clipping, remains to be explored, 
although in vitro methylation assays suggest that the asymmetric 
dimethylation of H3R2 (H3R2me2a) can be permissive to cleavage (Santos-
Rosa et al., 2009). 
CONVERSION TO CITRULLINE: conversion of arginine to citrulline occurs 
through an enzymatic reaction that releases imine or methylimine, and 
converts the amino acid into citrulline (Cuthbert et al., 2004; Wang et al., 
2004). Cuthbert and colleagues first showed that Peptidyl Arginine Deaminase 
4 (PADI4), a nuclear member of the PADI family, promiscuously deiminates 
arginines on histone H3 (H3R2, H3R8, H3R17, and H3R26) and that 
deimination by PADI4 counteracts arginine methylation by CARM1. The 
authors also concluded that dimethylation of arginines prevents deimination 
by PADI4 (Cuthbert et al., 2004). In a parallel paper, Wang and colleagues 
detected the release of methylamine from CARM1 or PRMT1 asymmetrically 
dimethylated arginines (Wang et al., 2004) on both H3 and H4, suggesting that 
asymmetric dimethylation could be permissive for the deimination reaction 
carried out by PADI4. High levels of citrullinated histones are detected on 
decondensed chromatin in both HL-60 granulocytes and blood neutrophils 
during the formation of neutrophil extracelluar traps (NETs). This seems to be 
a global effect, similar to, but distinct from, that observed for H4K16ac 
(Shogren-Knaak et al., 2006). Citrullinated histones directly impair the 
compaction of in vitro assembled histones, thus defining a biochemical 
mechanism associated with the presence of this unconventional amino acid on 
 ! #*!
histones (Wang et al., 2009). A recent paper strengthens the link between 
PADI4-mediated-citrullination and histone deacetylation, specifically studying 
the pS2 promoter, and the mutually exclusive presence of citrullinated H3 and 
methylated arginine 17 (Denis et al., 2009). The cyclical appearance of 
citrullination and arginine methylation on the estrogen-activated promoter 
suggests that citrullines have to be quickly converted into newly methylatable 
arginines (Denis et al., 2009). Given that several papers have indeed 
questioned whether methylated arginines are a physiological substrate for 
PADI4, as both MMA and ADMA are either poor substrates or completely 
refractory to deimination (Raijmakers et al., 2007) (Hidaka et al., 2005), the 
most likely explanation is that the unmethylated arginine ground-state is 
reestablished either by histone substitution or by yet to be identified enzymes 
able to convert citrullines back to arginines  
DIRECT DEMETHYLATION: demethylation by FAD-dependent 
monoamine oxydases, such as LSD1 and members of the Jumonji family, has 
been extensively studied in the past few years (see (Cloos et al., 2008) for a 
recent review). So far, only one member of the Jumonji family, JMJD6, seems 
to possess an arginine demethylase activity (Chang et al., 2007).This, 
however, has been recently challenged by Webby and coworkers, who claim 
that JMJD6 has a stronger lysine-hydroxylase activity than arginine 
demethylase activity (Webby et al., 2009). The authors link JMJD6 to the 
regulation of gene expression via the posttranslational hydroxylation of the 
splicing factor U2-small-nuclear-ribonucleoprotein-auxiliary-factor-65 
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(U2AF65), which in turn affects the regulation of RNA splicing of a subset of 
genes (Webby et al., 2009). Chang and colleagues had also previously 
reported a similar activity, but as they were enriching for the arginine 
monomethylated pepides in their mass spectrometric analysis, they might have 
overestimated the de-methylase function with respect to the hydroxylase 
function (Chang et al., 2007). Moreover, the fact that JMJD6 shows no 
preference, in vitro, for either asymmetrically or symmetrically dimethylated 
substrates, poses a question regarding the specificity of this reaction. Further 
work on this enzyme is needed to assess which reaction is preferentially 
catalyzed in vivo and whether cofactors can confer substrate specificity.  
 
 
1.3.6 METHYLATED AND UNMETHYLATED ARGININE AS PROTEIN 
DOCKING SITES: ADDING ANOTHER LAYER OF COMPLEXITY TO 
THE “HISTONE CODE” 
A direct effect of PTMs on chromatin is the alteration of its biophysical and 
biochemical characteristics and the creation of a dynamic platform upon 
which the transcriptional machinery is recruited and assembled (Agalioti et al., 
2000) (Metivier et al., 2003). The histone code hypothesis suggests that 
histone PTMs can act as binding sites to be interpreted by chromatin readers 
and effector proteins (Strahl and Allis, 2000). Many nuclear proteins contain 
motifs such as the bromodomain, that selectively interact with acetylated 
histones (Zeng and Zhou, 2002). The “Royal family” domains, which are 
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structurally similar to the prototype chromodomain and bind methylated 
residues, include the Tudor, Plant-Agenet, PWWP, and MBT domains 
(Jenuwein and Allis, 2001; Maurer-Stroh et al., 2003; Schreiber and Bernstein, 
2002). Recently, other domains have been identified as being able to recognize 
methylated arginines or lysines. One example is the large family of PHD 
finger-domains, which are present in several chromatin-associated proteins, 
and have been shown to interact with methylated lysines and arginines on 
histone tails. Examples of PHD domain-containing proteins include the tumor 
suppressor ING2 (inhibitor of growth 2) which binds H3K4me3 (Pena et al., 
2006), and Dnmt3a, which has an ADD domain containing a PHD finger, and 
specifically binds to H4R3me2s (Zhao et al., 2009). As reported in chapter 
1.3.3.2, TDRD3 is a co-activator that is able to directly interact with 
H3R17me2a, promoting transcriptional activation (Yang et al.). One other 
example of a newly identified methyl-binding module is the ankyrin repeat of 
the H3K9 specific methyltransferase G9a, which selectively recognizes 
H3K9me1/2, further extending the repertoire of domains which are able to 
read differentially methylated lysines or arginines (Collins et al., 2008). 
I will now discuss how arginine methylation increases the complexity of the 
histone code. This is achieved via two general mechanisms:  
1) Methylated arginines can act as docking sites for chromatin-binding 
proteins on histone tails (Fig.5A and Table 1). 
2) Methylated arginines can act as exclusion marks, impeding the binding of 










Fig.5: Methylated arginines on histone proteins. (A) Methylated arginines as 
docking sites for protein–histone interactions.  Histone H3/H4: the PHD finger 
of DNMT3a directly binds H4R3me2s, while the PHD finger of RAG2 binds 
H3K4me3/H3R2me2s. The first five residues of histones H2A and H4 are 
identical, and H2A is also methylated at the R3 position. H4R3me2a and 
H3R17me2a are linked to downstream acetylation events and to 
transcriptional activation, but there is no evidence of direct binding of HAT 
complexes to these methylated residues (?). (B) Methylated arginines can 
impede protein–histone interactions. Histone H3: H3R2me2a blocks the 
binding of several proteins/domains to the histone H3 tail: the WD40 domain-
containing protein WDR5, the PHD finger of ING2, of TAF3 and of BPTF, 
the double chromodomain of CHD1 and the double Tudor domain of 
JMJD2A, are all excluded by this asymmetric dimethylated arginine. 
H3R8me2s blocks the binding of HP1 and the catalytic activity of G9a 
towards H3K9me1/2. H3R26me2a could potentially interfere with Polycomb 
(PRC1 and PRC2) binding and repressive functions (?).!






























1.3.6.1 METHYLATED ARGININES AS DOCKING SITES 
The Tudor domain of the Survival of Motor Neuron protein (SMN) was the 
first described example of a binding module able to recognize methylated 
arginines. SMN serves as an assembly factor for small nuclear 
ribonucleoproteins (snRNPs), and is able to specifically recognize the Sm 
proteins SmD1 and SmD3 only when their C-terminal RG-rich domain is 
symmetrically dimethylated (Cote and Richard, 2005; Friesen et al., 2001). 
Tudor domains are found in many organisms and have been implicated in 
allowing protein-protein interactions by direct recognition of methylated 
lysine and arginine residues (Cote and Richard, 2005; Huyen et al., 2004; Kim 
et al., 2006; Sprangers et al., 2003). They were initially identified as common 
protein motifs found in the Drosophila Tud proteins and in other proteins from 
a wide variety of organisms and different kingdoms, including fungi, plants 
and animals (Maurer-Stroh et al., 2003). They are related to PlantAgenet-, 
Chromo-, PWWP- and MBT-domains, and together they form the ‘Royal 
Family’ domains (Maurer-Stroh et al., 2003). Several Tudor domain proteins 
have been shown to interact with modified histones. In particular, 53BP1, a 
protein involved in DNA repair, contains a tandem Tudor domain that was 
originally proposed to bind histone H3 methylated on Lys79 during DNA 
damage response (Huyen et al., 2004). Later, this was shown to be only one of 
several possible interactions between 53BP1 and histones, as both the yeast 
homologue, Crb2, and 53BP1 itself, recognize a histone H4 peptide 
methylated on Lysine 20 (H4K20me2) (Botuyan et al., 2006; Sanders et al., 
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2004). Other examples of Tudor domain structures binding to methylated-
peptides have shown a great variability in their binding pockets and in the 
amino acids involved in the interactions, further increasing our understanding 
of how these domains recognize methylated residues. Specifically, Tudor 
domains can either fold into a single barrel-like structure composed of five ß 
strands (Selenko et al., 2001) or form an intertwined structure consisting of 
two Tudor domains (Arkov et al., 2006; Huang et al., 2006). Additionally, the 
Tudor domains of JMJ2DA, a histone demethylase belonging to the Jumonji 
family of proteins (Cloos et al., 2008), allow the binding of two different 
methylated residues on histone H3 and H4 respectively, by simply changing 
the orientation of the targeted peptide in the binding pocket (Lee et al., 2008). 
Finally, Tudor domains have also been implicated in the recognition of both 
symmetrically and asymmetrically methylated arginines. The Tudor domain of 
the Survival of Motor Neuron (SMN) protein is known to bind both 
symmetrically methylated arginine (Sprangers et al., 2003), likely methylated 
by PRMT5 or PMRT7, and asymmetrically methylated arginines methylated 
by PRMT4 (Cheng et al., 2007). To date, however, no Tudor domain has been 
shown to directly recognize a methyl-arginine on histones. Unfortunately, no 
in silico tools are able to predict whether a given Tudor domain will recognize 
a specific methyl arginine, and thus their binding specificity must be 
determined experimentally on a case-by-case basis.  
Recently, the first interaction of a protein domain with a methylated arginine 
on histone H4 was described (Zhao et al., 2009). As discussed previously, the 
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interaction between the PHD finger–containing DNMT3a ADD domain and 
methylated arginine directly connects arginine methylation to DNA 
methylation, helping to explain how gene repression is initiated and 
maintained. 
Further evidence that a methylated arginine can act as a potential docking site 
came from a report describing a crystal structure in which an H3 peptide 
trimethylated on lysine 4 (H3K4me3) was bound by RAG2, an essential 
protein in the VDJ recombination process. The concomitant presence of a 
symmetric dimethylated arginine at position 2 (H3R2me2s) increased the 
affinity of RAG2 for H3K4me3, at least in vitro (Ramon-Maiques et al., 
2007). Whether H3R2me2s actually exists in vivo, and whether it cooperates 
with H3K4 methylation to control VDJ recombination, however, still remains 
to be investigated (Matthews et al., 2007). 
 
 
1.3.6.2 METHYLATED ARGININES AS EXCLUSION MARKS 
A second, well-characterized mechanism by which PTMs influence protein-
protein interactions is by interfering with binding of other proteins to the 
histone tails. Structures of several PHD fingers, tudor- chromo- and WD40-
domains have been recently co-crystallized with the tail of histone H3. In this 
context, both H3R2 and H3R8 form important hydrogen bonds with the PHD 
domains of several members of the ING family (Pena et al., 2006), BPTF (Li 
et al., 2006), and TAF3 (van Ingen et al., 2008), the chromo-domain of HP1 
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(Jacobs and Khorasanizadeh, 2002; Nielsen et al., 2002), the double chromo-
domain of CHD1 (Flanagan et al., 2005) and the double tudor-domain of 
JMJD2A (Huang et al., 2006). Finally, in the case of the WD40 beta propeller 
of WDR5, the unmethylated H3R2 makes essential contacts with the 
hydrophobic pocket of WDR5 while the asymmetric dimethylation of the 
same arginine disrupts this binding (Couture et al., 2006; Guccione et al., 
2007a). All of these interactions will be described in detail in later sections of 
this chapter, where the effects of arginine dimethylation on each specific 
residue on histone H3, H2A and H4 will also be discussed. 
These mechanisms by which arginine methylation results in the recruitment or 
exclusion of interacting proteins are not only applicable to histones, but are 
also relevant to non histone proteins. For example, the methylation of arginine 
next to a proline-rich motif has been shown to block binding to SH3-, but not 
to WW-domains (Bedford et al., 2000). Similarly, CARM1-mediated 
asymmetric dimethylation of the GRIP1-binding domain of p300 regulates its 
association with the glucocorticoid receptor interacting protein (GRIP1)(Lee 
et al., 2005). 
As such, we speculate that protein might encode “arginine/lysine 
methyl/methyl switches” that are important for regulating and modulating the 
binding affinity of numerous chromatin-binding proteins (Fig.5A and B). This 
is analogous to the concept of “methyl/phospho switches” that has been 
hypothesized by Fischle and colleagues (Fischle et al., 2003). Several such 
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arginine/lysine pairs can be identified on histones. Whether both arginine and 
lysines can be methylated at these sites remains an open question  
During my PhD, I have focused on a specific arginine, H3R2, and investigated 
the role of its symmetric dimethylation with respect to the methylation of the 
neighbour lysine 4 and, as such, its effect on transcription. Moreover, the 
“arginine/lysine methyl/methyl switch” that I have identified, modulates the 
binding of a chromatin binding protein, WDR5, which is part of the complex 
responsible for the methylation of H3K4. 
















Reference PTM Enzyme Associated Function Interactors 
Huang et al, 
2005 H4R3me2a PRMT1 
Transcriptional 
activation ? 
Ma et al, 2001 H3R17me2a PRMT4 
Transcriptional 
activation ? 
Daujat et al, 
2002 H3R17me2a PRMT4 
Transcriptional 
activation ? 
Bauer et al, 




et al, 2007 
H3R17me2a/
H3R26me2a PRMT4 Pluripotency ? 
Wu et al, 2009 
H3R17me2a/
H3R26me2a PRMT4 Pluripotency ? 
Dacwag et al, 




Pal et al, 2004 H3R8me2s PRMT5 
Transcriptional 
repression ? 





Fabbrizio et al, 
2002 H4R3me2s PRMT5 
Transcriptional 
repression ? 
Pal et al, 2003 H4R3me2s ? PRMT5 
Transcriptional 
repression ? 






Zhao et al, 2009 H4R3me2s PRMT5 Transcriptional 
repression 
Dnmt3a directly binds to 
H4R3me2s. 
Jelinic et al, 
2006 
H4R3me2s PRMT7 Paternal Imprinting ? 
Vermeulen et 





Couture, 2006 H3R2me2a - - 
H3R2me2a excludes 
WDR5 binding. 
Huang et al, 
2006 H3R2me2a - - 
H3R2me2a impedes 
JMJD2A binding. 
Kirmizis et al, 





Guccione et al, 





Hyllus et al, 





Iberg et al, 




binding of WDR5, 
JMJD2A, and the PHD 
fingers of ING2, PHF, 
DATF1, and BPTF. 
Ramon-
Maiques et al, 
2007 H3R2me2s ? VDJ recombination 
H3R2me2s, when 
coupled to H3K4me3, 
favors the binding of 




Table1: Methylated arginines on histone proteins. Summary table of the 






































According to the histone code hypothesis, methylated arginines on histones 
can act either as docking sites for methyl-binding proteins, or as exclusion 
marks, preventing their binding. However, only a few methylated arginine 
residues have been characterized so far and the understanding of their 
biochemical function relating to their effect on transcriptional outcome is 
poorly understood. 
As previously reported in chapter 1.3.4.3, work from our lab and others has 
characterized asymmetrically dimethylated histone H3 arginine 2 (H3R2me2a) 
as a repressive mark that is present at the promoter of inactive genes. The 
asymmetric dimethylation of this specific residue impedes the binding of 
Wdr5, a common subunit of the MLL complex, to chromatin. As a result, the 
MLL complex is no longer able to methylate the neighboring lysine 4. The 
lack of H3K4me3 impairs the recruitment of factors that modify chromatin 
structure, such as CHD1. As such, the subsequent recruitment of the 
transcriptional machinery is also impaired.  
On the other hand, methylation of lysine 4 on histone H3 blocks the 
asymmetric dimethylation of arginine 2 on histone H3 by PRMT6. As a 
consequence, the two marks are mutually exclusive.  
The main aim of my PhD thesis is to understand if histone H3 arginine 2 can 
also be symmetrically dimethylated, in addition to being asymmetrically 
dimethyated, and, if so, to shed light on its biological function. 
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The only other residue that has been reported to be symmetrically and 
asymmetrically dimethylated is H4/H2AR3, and the symmetries of the 
methylation seems to play different roles: H4R3me2a is linked to active genes, 
whereas H4R3me2s to repressed ones. 
Based on the data available in literature and previously discussed, I have 
decided to address the following questions: 
- Does H3R2me2s exist in vivo? 
- Is H3R2me2s linked to transcriptional repression similar to 
H3R2me2a? 
- Does H3R2me2s favor or prevent the binding to chromatin of specific 
chromatin readers or effectors?  
- Which is the enzyme responsible for the catalysis of this modification? 
To answer these questions I have:  
1) Raised and validated a specific antibody against this histone mark. 
2) Confirmed the existence of H3R2me2s in vivo and its conservation 
across species. 
3) Used this antibody to perform genome-wide localization studies and to 
associate it with a particular chromatin conformation. 
4) Understanded which enzyme is responsible for H3R2me2s catalysis. 
5) Characterized the downstream transcriptional effects related to 
H3R2me2s loss. 
6) Investigated the chromatin-binding proteins recruited or excluded by 
H3R2me2s to provide insights into its biochemical role. 
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7) Performed correlation studies to contribute to a better understanding of 
possible crosstalks with neighboring modified residues, in particular 
with the methylation of lysine 4 of histone H3. 
In order to achieve the objectives reported above, the methods used in this 





















MATHERIALS AND METHODS 




The antibodies used for ChIP are as follows. PolII (Santa Cruz, sc-899); 
H3K4me2 (Abcam, ab7766); H3K4me1 (Abcam, ab8895); H3K4me3 
(Abcam, ab8580); H3 (Abcam, ab1791); S2 and S5 phosphorylated PolII; 
anti-Flag mouse monoclonal M2 (Sigma); H3K4me3 (Diagenode). For 
H3R2s, antibodies were raised by Millipore (Billerica, MA). Four rabbits were 
immunized with KLH-coupled peptides encompassing the first 10 amino acids 
of histone H3, symmetrically modified on R2 was (Mimotopes, Australia) 




3.2 ANTIBODY PURIFICATION 
The antibody was affinity purified using SulfoLink Coupling Resin (Thermo 
Scientific, 20401) according to manufacturer’s instructions. Before starting, all 
the reagents were equilibrated at room temperature. Briefly, 4ml of slurry 
SulfoLink Coupling resin was added to the column to obtain a 2ml resin bed 
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and column was then equilibrated with 4 resin-bed volumes of Coupling 
buffer (50 mM TrisHCL pH 8.5, 5 mM EDTA-Na, pH 8.5). 5 mg of cysteine-
tagged NH2- ARTKQTARC peptide symmetrically dimethylated on R2 
(Mimotopes, Australia) was re-suspended in coupling buffer and added to the 
column. The column was incubated at room temperature for 2 hours with 
rotation and for an additional 30 minutes without rotation. 
The solution was allowed to drain and the column was washed with at least 3 
resin-bed volumes of coupling buffer. One resin-bed volume of 50 mM L-
Cysteine HCl dissolved in coupling buffer was prepared and added to the 
column, incubated for 20 minutes at room temperature with rotation and for 
additional 30 minutes without rotation. 
The column was then washed with at least six resin-bed volumes of Wash 
solution (1M NaCl) and with 2 resin-bed volumes of Coupling buffer. 
4ml of crude sera against H3R2me2s was added to the column and incubated 
at room temperature for 2 hours with rotation and for additional 30 minutes 
without rotation. The sample was then passed through the column, followed 
by at least 6 washes with resin-bed volumes of degassed PBS. Finally, the 
purified antibody was eluted in 8 ml of Elution buffer (0.2 M Glycine HCL, 
pH 2.5). Fractions of 1 ml were collected and each was neutralized with 50 ul 
of Neutralization buffer (1 M Tris HCl, pH 8.5). For each fraction, the 
absorbance (280nm) was measured and the positive fractions were confirmed 
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to be specific for the symmetric dimethylation of Arginine 2 of Histone H3 by 
western blotting. 
The column was then washed with 16 ml of PBS and kept in PBS 0.05% 
sodium azide at 4°C. 
 
 
3.3 QUANTITATIVE CHROMATIN IMMUNOPRECIPITATION (qChIP)  
Formaldehyde (37%) was added directly to the cell culture medium, to a final 
concentration of 1%. Cells were cross-linked for 10 min at room temperature 
Glycine (0.125 M final concentration) was added and the cells incubated for 
an additional 5 minutes to stop the cross-linking. Fixed cells were washed 
twice with PBS and harvested in SDS buffer (50 mM Tris at pH 8.1, 0,5% 
SDS, 100 mM NaCl, 5 mM EDTA, and protease inhibitors). Cells were 
pelleted by centrifugation, and resuspended in 3 ml of IP buffer (100 mM Tris 
at pH 8.6, 0.3% SDS, 1.7% Triton X-100, and 5 mM EDTA). Cells were 
disrupted by 5-7 pulses (30 sec each one) of sonication with a tapered !-
microtip (6,5 mm) in a Branson digital sonifier 250 D, at a power setting of 
30%, yielding genomic DNA fragments with a bulk size of 300-500 bp. For 
each immunoprecipitation, 1ml of diluted lysate (5x107 cells/ml) was 
precleared by adding 300 µl blocked protein A or G beads (50% slurry protein 
A-Sepharose (Amersham) or Rec-protein G-Sepharose 4B ZYMED 
(Invitrogen); 0.5 mg/ml fatty acid free BSA (Sigma); and 0.2 mg/ml Salmon 
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Sperm SS-DNA in TE). Samples were immunoprecipitated overnight at 4°C 
with the antibodies of interest. Immune complexes were recovered by adding 
50µl of blocked beads and incubated for 2 h at 4°C. Beads were washed and 
the crosslinks were reversed in 1% SDS and 0.1 M NaHCO3. The eluted 
material was purified with QIAquick PCR purification Kit (Qiagen). The 
purified DNA was eluted in 300 microliters of T-buffer (Tris HCl 10 mM pH 
8) and used directly for qPCR. For Solexa analysis the protein A Sepharose 
beads were blocked with BSA only, without SS-DNA. These products were 




3.4 ChIPseq LIBRARY PREPARATION 
The ChIP seq library was prepared using the Illumina Kit (IP-102-1001). 
Briefly, 10 ng of each ChIP DNA sample was diluted in 30 "L and mixed with 
4 "L of T4 DNA ligase buffer with 10mM of ATP, 2"L of mixed dNTP, 1 "L 
of DNA pol, 1 "L of diluted Klenow enzyme and 1 "L of T4 PNK, provided 
in the kit. Samples were then incubated for 30 minutes at 20°C to perform the 
end-repair step. Samples were then purified using QIAquick PCR purification 
kit (Qiagen, 28104) and eluted in 36 "L of EB buffer. To add and “A” base to 
the 3’ end of the DNA fragments obtained, 34 "L of DNA obtained from the 
previous step was incubated with 5"L of Klenow buffer, 10 "L of dATP and 1 
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"L of Klenow fragment (3’ to 5’ exo minus), again provided in the 
ILLUMINA kit, and incubated for 30 minutes at 37 °C on a heat block. 
Samples were then purified using QIAquick MinElute purification kit 
(Qiagen, 28004) and eluted in 12 "L of EB buffer. 
To ligate adapters to the ends of the DNA fragments obtained in the previous 
step, 10 "L of the eluted DNA was incubated with 15 "L of DNA ligase 
buffer, 1 "L of adapter oligos (1:10 dilution in water) and 4 "L of DNA 
ligase. Samples were then incubated for 20 minutes at 25°C, purified using 
QIAquick PCR purification kit and eluted in 45 "L of EB. 
To enrich for adapter-modified DNA fragments, 36 "L of the eluted DNA was 
mixed with 10 "L of 5X Phusion buffer, 1.5 "L of dNTP mix, 1 "L of PCR 
primer 1.1, 1 "L of PCR primer 2.1 and 0.5 "L of Phusion polymerase. 
Samples were then amplified by PCR: 30 sec at 98°C, [10 sec at 98°C, 30 sec 
at 65°C, 30 sec at 72°C] 15 cycles, 5 minutes at 72°C and kept at 4°C. 
Samples were then purified with QIAquick MinElute purification kit and 
eluted in 15 "L of EB. To each sample, 3 "L of 6X loading dye were added. 
Samples were run on a 2% ultra low range agarose gel (Biorad, #161-3107) 
next to a 50 bp DNA ladder (Invitrogen, 10416-014). 
The gel was run for 60 minutes at 120V and stained with SYBR Green 
(Invitrogen, S7585) in a plastic container covered with aluminium foil for 1 
hour, shaking at 50 rpm. 
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The gel was then positioned on a clean dark transilluminator surface. For each 
sample, a band was cut exactly between 200 and 300 bp, the individual pieces 
of gel were purified using Qiagen gel extraction kit (Cat no 28704) and eluted 
in 25 "L of EB. 
Samples were then sent to GIS (Genome Institute of Singapore) for Agilent 
Analysis and Quantification. 
 
 
3.5 DATA PROCESSING 
The Genome Analyzer sequencing output was analyzed by J.Mueller using the 
Genome Analyzer Pipeline provided by Illumina. Sequence tags that aligned 
uniquely to the human genome build HG18 with zero, one, or two 




3.6 QUANTITATIVE PCR  
Real-time PCR was performed with 6 µL of DNA/cDNA per reaction and 200 
nM primers, diluted in a final volume of 20 µL in SYBR Green Reaction Mix 
(Perkin Elmer, Boston, MA). Accumulation of fluorescent products was 
monitored by real-time PCR using a GeneAmp 9700 Sequence Detector 
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(ABI). Each PCR reaction generated only the expected specific amplicon, as 
shown by the melting-temperature profiles of final products (dissociation 
curve, automatically measured by the Taqman 9700). No PCR products were 
observed in the absence of template. PCR primer sequences are given in 
Supplementary data from (Migliori et al., 2012). 
 
 
3.7 PEPTIDE PULL DOWN ASSAY 
Histone H3-tail peptides (95% purity) were purchased from Mimotopes. 
Peptides were re-suspended in PBS at 2mg/ml. The sequence of the 
unmodified peptide was NH2- ARTKQTARKSTGGKAP-GGY-[K(Biotin)]-
OH. 109 cells were used per pull-down. The covalent modifications indicated 
in the text were included during synthesis. For the preparation of nuclear 
lysates from HeLa cells, I used a modified version of the Dignam protocol 
(Dignam et al., 1983). Briefly, cells were collected by centrifugation and 
washed twice in ice cold PBS. The pellet was then re-suspended in 20 ml ice-
cold Homogenization buffer (1ml 1M Tris-Cl, pH7.5, 300 "L 5M NaCl, 6ml 
1M KCl, 7.35ml 1M (34%) sucrose, 250 "L 20%NP40, 100 "L 0.5M EDTA, 
10"L 0.5M EGTA, 0.5 "L 1M DTT in 50 ml) and stratified on a cold Sucrose 
pad (1 ml 1M Tris-Cl, pH7.5, 300 "L 5M NaCl, 6 ml 1M KCl, 0.5 "L 1M 
DTT, 2.94 ml 1M sucrose in 10 ml). Pelleted nuclei were recovered by 
centrifugation at 900 rpm for 10 minutes at 4°C (no brake) and washed in 
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10ml of Wash buffer (1 ml 1M Tris-Cl, pH7.5, 300 "L 5M NaCl, 6 ml 1M 
KCl, 100 "L 0.5M EDTA, 10 "L 0.5M EGTA, 0.5"L 1M DTT in 50 ml). The 
nuclei were then centrifuged at 18000 rpm at 4°C for 30 minutes to remove 
cytoplasmatic residues (Sorvall SS34 rotor). Nuclei were resuspended in 1 
packed nuclei volume of cold Buffer C 0 mM (20mM HEPES, pH 7.9, 25% 
glycerol, 0.2mM EDTA, 1.5mM MgCl2). While stirring 2 packed volume of 
cold Buffer C 840 mM (20 mM HEPES, pH 7.9, 25% glycerol, 0.2 mM 
EDTA, 1.5 mM MgCl2, 840 mM KCl) were added dropwise over 12 hours. 
Nuclei were then lysed by 10 strokes of a Dounce homogenizer (pestle B) and 
the resulting suspension was gently stirred with a magnetic stirring bar for 30 
minutes at 4°C. The suspension was centrifuged at 18000 rpm at 4°C for 30 
minutes (Sorvall SS34 rotor) and the supernatant was diluted in 2 volumes of 
Buffer D (20 mM HEPES, pH 7.9, 20% glycerol, 0.2 mM EDTA, 0.3% Triton 
X-100). For each pull down, 10 mg of nuclear extract was used. 
 
 
3.8 METHYLATION ASSAY 
HeLa cells were transfected with Flag-HA tagged PRMT7, PRMT5 and Ash2. 
For each assay, approximately 107 cells were collected, washed with PBS 
once, and lysed in High-salt lysis buffer (20 mM HEPES [pH 7.4], 10% 
glycerol, 0.35 M NaCl, 1 mM MgCl2, 0.5% Triton X-100, 1 mM 
dithiothreitol) containing proteinase inhibitors (Sigma). 
After incubation at 4°C for 30 min, the lysate was centrifuged thoroughly at 
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14000 rpm at 4°C twice. The balance buffer (20 mM HEPES [pH 7.4], 1 mM 
MgCl2, 10 mM KCl) was added to the resulting supernatant to adjust the final 
NaCl concentration to 300 mM. The lysate was then mixed with anti-HA 
antibodies (Covance) and protein A beads or with anti-Flag agarose (Sigma). 
After incubation at 4°C for 4 h, the beads were spun down and washed three 
times with wash buffer (10 mM HEPES [pH 7.4], 1 mM MgCl2, 300 mM 
NaCl, 10 mM KCl, 0.2% Triton X-100) and once with 1x MAB buffer (50 
mM Tris [pH 8.5], 20 mM KCl, 10 mM MgCl2, 10 mM %- mercaptoethanol, 
250 mM sucrose). The residual buffer was completely removed by aspiration; 
the beads were mixed with 1 µg of recombinant histone H3, or 1 µg of 
synthetic peptides (H3 unmodified, H3R2me2s, H3R2me2a, H3R2me1), 1 µL 
of 2 mM S-adenosyl methionine, and 0.1 µg of bovine serum albumin/µl. 1x 
MAB buffer was added to adjust the total volume to 25 µl. After incubation at 
37°C for 3 h or overnight, sodium dodecyl sulfate loading buffer was added to 
the samples to stop the reactions., The samples were then analyzed by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting to 







3.9 GST-WDR5 PROTEIN PREPARATION 
The N-terminally truncated version of human WDR5 (residues 22-334) was 
cloned as GST-fusion protein in a modified pGEX-6PI vector (GE-Healthcare) 
by PCR from cDNA (ATAATAAGATCTATGGCGACGGAGGAGAAGA 
forward primer, ATAATAGTCGACTTAGCAGTCACTCTTCCACAGT 
reverse primer) using BgL II and SalI as restriction enzymes. The protein was 
expressed in the E. coli strain BL21(DE3)-pLysS (Novagen) for 16 hours at 16 
°C after induction. Cells were lysed by sonication in a Lysis buffer, consisting 
of 50 mM Tris-HCl pH 8, 0.2 M NaCl, 1 mM DTT, 1 mM EDTA and Roche–
Complete protease inhibitor cocktail. After ultracentrifugation, the cleared 
lysate was loaded on a 5-ml GST-Trap column (GE-Healthcare) equilibrated 
with Lysis buffer. The fusion protein was eluted in Lysis buffer supplemented 
with 10 mM reduced Gluthatione, and further dialysed in 20 mM Tris-HCl pH 
7.6, 0.2 M NaCl, 5% glycerol, 1 mM DTT and 1 mM EDTA. To remove the 
GST-tag, the sample was incubated for 16 hours at 4 °C with PreScission 
protease (GE-Healthcare) in a 1:100 weight ratio. The cleaved product was 
separated from the GST tag by loading the sample a second time on a GST-
Trap column equilibrated with cleavage buffer. WDR5-!N21 was collected in 
the flow through, diluted in salt-free buffer to lower the ionic strength, and 
loaded onto a Mono-S 16/60 column (GE-Healthcare) equilibrated with 10 
mM Tris-HCl pH 7.6, 50 mM NaCl, 5% glycerol, 1 mM DTT and 1 mM 
EDTA. The protein was fractionated using a NaCl gradient, concentrated by 
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ultrafiltration, and further separated by size exclusion chromatography on a 
Superdex-200 column (GE-Healthcare) equilibrated in 20 mM Tris-HCl pH 
6.8, 0.15 M NaCl, 1 mM EDTA and 10 mM "-mercaptoethanol. Peak 
fractions were collected, concentrated to 20 mg/ml, and stored at -80°C. 
3.10 CRYSTALIZATION, CRYSTAL STRUCTURE DETERMINATION 
To assemble the WDR5:H3 complex, synthetic H3-R2m2s peptide 
encompassing residues 1 to 16 of H3 was incubated with purified WDR5-
!N21 in a 2-fold molar excess for 1 hour at 20 °C. Crystallization experiments 
were performed with the sitting drop vapor diffusion technique at 20 °C, 
mixing 100 nl of protein solution at 15 mg/ml with 100 nl of reservoir solution 
with a Cartesian Honebeey liquid handler (Genomic Solutions). Tiny crystals 
grew in several conditions, typically consisting of 25-30 %PEG 3350, 50-100 
mM Ammonium Sulphate, at a pH range between 7.5 and 8.5. For data 
collection, crystals grown in 30% PEG 3350, 0.1 M Hepes pH 7.5 and 60 mM 
Ammonium Sulphate were flash-cooled in liquid nitrogen without further 
cryo-protection. The data used for structure solution were collected on the PX 
beamline ID14-1 at ESRF (Grenoble, France). Data were indexed and scaled 
with HKL2000 (Minor, 1997). Crystals belong to the space group P21, and 
contain one copy of the WDR5-H3R2m2s complex per asymmetric unit. 
Molecular replacement was carried out with PHASER (A.J. McCoy, 2004) 
using the apo-WDR5 as a search model (PDB entry 2H13).  Model building of 
the H3 peptide was initiated with manual placement into the difference 
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electron density, and then completed using iterative cycles of manual model 
building in Coot (Emsley and Cowtan, 2004) and restrained refinement in 
CNS (Brunger et al., 1998). The final model contained residues 32-298 of 
WDR5 and the first 6 residues of the H3 peptide. This experiment was 
performed in collaboration with Marina Mapelli. 
3.11 MICROARRAY ANALYSIS 
Gene expression was profiled in quadruplicates on an Illumina Human 6 
version 2 BeadArray. The bead-level microarray data were analysed using the 
R beadarray package, including bead summarization and quantile 
normalization between arrays. Only probes that mapped to a RefSeq gene ID 
were considered. When multiple probes mapped to a single gene, only the 
probe with the maximum expression value was taken. The RefSeq annotation 
was used to define the transcription start site (TSS) and the end site (TES) of 





Gels for the resolution of proteins by SDS PAGE were made from a 30%, 
30:08 mix of acrylamide: bisacrylamide (Fisher Scientific). 10% ammonium 
persulphate (APS) and TEMED were used to catalyze the polymerization of 
the gels. SDS PAGE allows for the  separation of proteins according to their 
relative molecular weight. Because of the negatively charged SDS-molecules, 
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the SDS-peptide complex will migrate in a manner which is inversely 
proportional to the relative size of the polypeptides. 
Cells were trypisinised or scraped off plates, collected, pelleted and washed in 
cold Phosphate Buffered Saline (PBS) then lysed directly in Laemmli sample 
buffer (62.5 mM Tris-HCl pH 6.8 %, 2 % (w/v) SDS, 5 % (v/v) 2-
mercaptoethanol and 10 % (v/v) glycerol), boiled for 5 minutes and lightly 
sonicated to homogenize the sample. 
Equal amount of proteins were loaded in 1mm (or 0.75 mm) thick 
polyacrylamide gels for electrophoresis. The gels were run in a Biorad 
apparatus and the acrylamide concentration was chosen according to the 
molecular weight of the protein analyzed. The gels were run in SDS Running 
Buffer (25mM Tris base pH8.8, 192mM Glycine, 0,1% SDS). The proteins 
were then transferred in semi dry Western tranfer apparatus (Biorad) to 
Protran Nitrocelluose Transfer Membrane (#10-401-196 Schleicher & Schuell 
Whatman) or PVDF (Amersham Hybond™-P # RPN303F) in 1X Transfer 
Buffer (25 mM Tris HCL, 192 mM Glycine, pH 8.3) plus 20% methanol, at 
20V for 1 hour at room temperature. After blotting, the membranes were 
stained with Ponceau S to verify equal loading and transfer. 
Membranes were then blocked for 1 hour at room temperature in 5% milk in 
TBS (20mM Tris HCl pH7.4, 500 mM NaCl) 0,1% Tween (TBS-T). 
After blocking, membranes were incubated with the primary antibodies, 
diluted in TBS-T 5% milk, for 2 hours at RT or overnight at 4°C. After three 
washes, of 10 minutes each in TBS-T, they were incubated with the 
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appropriate horseradish peroxidase conjugated secondary antibody goat anti-
mouse (Santa Cruz, sc-2005), goat anti-rabbit (Santa Cruz, sc-2030), or 
donkey anti-goat (Santa Cruz, sc-2020), diluted in TBS-T 5% milk for 30 
minutes at room temperature. After that, membranes were washed three times 
in TBS-T and the bound secondary antibody was visualized using the ECL 




 3.13 PRODUTION OF LENTIVIRAL PARTICLES  
 HEK 293T (ATCC) cells were seeded at 5x105 cells/ml (15 ml per plate) in 
growth medium (DMEM + 10% FBS + 1x Pen/Strep) in 15 cm tissue culture 
plates and allowed to adhere overnight. Prior to transfection, cells were at 
approximately 70% confluence. Packaging plasmid (pCMV-dR8.9) 12.5 µg, 
Envelope plasmid (VsVg) 10 µg, and Hairpin-pLKO.1 vector 15 µg were 
gently mixed with 1.25 ml of 0.250 M of CaCl2 (dilute with filtered ddH20). 
2x BBS solution (50mM BES, 280mM NaCl, 1.5mM Na2HPO4, pH 6.95 with 
1M NaOH) was added, samples were mixed by vortexing and then incubated 
at RT for 15 min. 
The transfection mixture was then added drop wise to each plate (2.5 ml per 
plate). The plates were gently swirled and incubated at 3% CO2, 37 °C 
overnight (16–20 h). The next day, the media was aspirated and replaced with 
15ml fresh media. Cells were incubated for 24 hours (37 °C, 5% CO2). ~40 
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hours post transfection, the medium containing the lentiviral particles was 
harvested, filtered using a 0.22 um filter unit, and stored at 4 °C for short term 
storage (hours or days), or at -20 °C or -80 °C for long term storage. 15ml of 
fresh media was added to the plate. After 24 hours, the viral supernatant was 
collected and pooled with the supernatant from the first day.  
 Viral particles were then concentrated by ultracentrifugation: the supernatant 
(30 ml) was centrifugated with a Beckman SW28 rotor (capacity for six tubes) 
at 19,400 rpm for 2 h at 20°C. Conical tubes (as opposed to round bottom 
tubes) and swinging bucket rotors (as opposed to fixed angle rotors) were used 
for ease of locating the almost-invisible pellet. After the centrifugation, the 
supernatant was poured out without disturbing the pellet, and the remaining 
liquid was drained by resting the inverted tubes on paper towels. 
 The viral pellets were then re-suspended in 200 µl of 1# HBSS (Invitrogen 
cat. no. 14025-092). 
  
  
 3.14 PRODUCTION OF RETROVIRAL PARTICLES 
Ampho cells were seeded at 5x105 cells/ml (15 ml per plate) in growth 
medium (DMEM + 10% FBS + 1x Pen/Strep) in 15 cm tissue culture plates 
and allowed to adhere overnight. Prior to transfection, cells were at 
approximately 70% confluence Packaging plasmid (VsVg) 10 µg  and 
Hairpin-pLKO.1 vector 15 µg were gently mixed with 1.25 ml of 0.250M of 
CaCl2 (dilute with filtered ddH20). 2x BBS solution (50mM BES, 280mM 
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NaCl, 1.5mM Na2HPO4, pH 6.95 with 1M NaOH) was added, samples were 




3.15 LENTIVIRAL AND RETROVIRAL INFECTION 
Adherent target cells (HeLa and E14) were seeded 1 day prior infection. On 
the day of infection, growth medium was removed and replaced with growth 
medium containing polybrene (Sigma-Aldrich, final concentration 8 µg/ml). 
Suspension cells (P493 and HL60) were split to the appropriate density on the 
day of infection in media containing polybrene (Sigma-Aldrich) (final 
concentration is 8 µg/ml). Polybrene is a small positively charged molecule 
that is capable of neutralizing the charge repulsion between virions and sialic 
acid on the cell surface. Thus, its use increases the efficiency of retroviral 
infection in cell culture. 
Concentrated or fresh virus was added to the cells and the cells were incubated 
overnight at 37 °C, 5% CO2 and the medium was change 24 hours post-
infection. One infection with concentrated virus was used (180 "L for 15 cm 
plates, 60"L for 10cm plated and 10 "L for 6cm plates), or two infections 
(24h apart) with fresh virus were used to infect the target cells. 24 hours after 
the last infection, fresh growth media containing 1 "g/ml of puromycin 
(lentiviral plKO) or 5ug/ml of blasticidin (retroviral pMX) was added.  
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Puromycin/Blasticidin selection requires at least 48 hours. Once the selection 
was deemed to be complete (as determined by the complete death of control, 
non-infected cells treated with similar concentrations of selection agent), cells 
were counted and split to the same confluence. 
For suspension cells, infection was performed by spinoculation. Cells were 
pelleted in PBS and re-suspended in fresh virus media or fresh media 
containing the concentrated virus. A final concentration of 8ug/ml of 
polybrene was added. Cells were then centrifuged at 37 °C at 900 rpm for 4 
hours in a 6 well plate. After centrifugation, media was replaced with fresh 
growth media. This step was repeated 1 to 2 times to improve infection 




3.16 HISTONE ACID EXTRACTION 
5x106 cells were collected, washed in cold PBS twice for 10min at 1200 rpm. 
Cells were then re-suspended in Hypotonic lysis buffer (10mM Tris–Cl pH 
8.0, 1mM KCl, 1.5mM MgCl2 and 1mM DTT, add protease inhibitors before 
use) and transferred to 1.5ml tubes. Samples were incubated for 30 minutes on 
a rotator at 4°C to promote mechanical shearing and hypotonic swelling. !
Nuclei were pelleted by centrifugation at 10000 rpm for 10 min at 4°C. The 
supernatant was discarded and nuclei were re-suspended in 400 "L of 0.4N 
H2SO4. Samples were incubated overnight on rotator at 4°C. Samples were 
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then centrifuged at maximum speed for 10 min at 4°C to remove debris. The 
supernatant, which contains histones, was transferred into a fresh tube (1.5ml) 
and TCA was added to the solution, drop by drop (33% TCA final 
concentration). Tubes were inverted several time to mix and then incubated on 
ice for at least 30 minutes. Precipitated histone were then pelleted at 14000 
rpm for 10 minutes at 4°C and washed in ice acetone twice. Pellets were then 
air dried for at least 30 min at RT and finally dissolved in an appropriate 
volume of ddH2O.  
 
 
3.17 SILAC (Stable Isotopic Labeling using Amino acids in Cell culture) 
1-2 x 105 of HeLa cells were grown in DMEM labeled with either heavy or 
light isotopes. SILAC DMEM: K8R10 (Heavy) contained 444 ml of SILAC 
DMEM, 50 ml of Dialyzed Fetal Bovine Serum, 0.5 ml of K8 stock (146 
mg/ml; final concentration ~0.8mM), 0.5 ml of R10 stock (85 mg/mL, final 
concentration ~0.4mM), and 5 ml of Penicillin Streptomycin). SILAC 
DMEM: K0R0 (Light) contained 444 ml of SILAC DMEM, 50 ml of 
Dialyzed Fetal Bovine Serum, 0.5 ml of K0 stock (146 mg/ml, final 
concentration ~0.8mM), 0.5 ml of R0 stock (85 mg/mL final concentration 
~0.4mM, and 5 ml of Penicillin Streptomycin). Both cell populations were 
passaged for at least five cell doublings by splitting cells in the appropriate 
SILAC media every 2-3 days. Cell density was maintained so that cells were 
actively growing in log phase (between 30-90% confluence).  
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After five cell doublings, incorporation of heavy L-lysine and/or L-arginine is 
around 95%. 106 cells from each sample (light and heavy) were harvested to 
determine incorporation efficiency by mass spectrometry. Once full isotope 
incorporation had been determined, the cell cultures were expanded in their 
respective heavy and light media to obtain the number of cells required for 
subsequent experiments. Note: Light- and heavy-labeled cells can be frozen in 
the appropriate freezing medium (e.g., 10% DMSO in SILAC media). 
Cells were pelleted and washed 5 times in PBS at 1200 rpm at RT and nuclear 
extraction was performed as described previously (3.6). 
After nuclear extracts were prepared, protein concentration from light- and 
heavy-labeled cells was determined by Bradford assay and the same 
concentration was used to perform peptide pull-down assays as described in 
chapter 3.6. In the final step of the peptide pull-down assay, the beads from 
the heavy and light samples were washed separately twice. Then, the samples 
were mixed and washed thrice more. In this way, a 1:1 ratio of the heavy and 
light samples was obtained.  
 
 
3.18 MASS SPECTROMETRY AND DATA ANALYSIS (SILAC)  
After incubation with either H3R2me2a or H3R2me2s modified biotin-
peptides, the bound complexes were pulled down using streptavidin-
conjugated beads. The two pull downs were then pooled, according to the 
standard SILAC procedure (Vermeulen et al., 2007). Eluted protein complexes 
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were separated by 1D SDS-PAGE, and digested with trypsin using published 
procedures. Samples were analysed on an Orbitrap or Orbitrap XL (Thermo 
Fisher) coupled to a Proxeon Easy-nLC. Survey full scan MS spectra (m/z 300 
– 1400) were acquired with a resolution of R=60,000 at m/z 400, an AGC 
target of 1e6 ions, and a maximum injection time of 500ms. The ten most 
intense peptide ions in each survey scan with an ion intensity above 2000 
counts and a charge state $ 2 were sequentially isolated to a target value of 
1e4 and fragmented in the linear ion trap by collisionally induced dissociation 
(CID/CAD) using a normalized collision energy of 35%. A dynamic exclusion 
was applied using a maximum exclusion list of 500 with one repeat count, 
repeat and exclusion duration of 30 seconds. Proteins were searched using 
Mascot version 2.2 (Matrix Science, London, UK) against a concatenated 
target/decoy database, prepared by sequence reversing the human International 
Protein Index (IPI) (version 3.52, 73,928 sequences, www.ebi.ac.uk) and 
adding common contaminants such as human keratins, porcine trypsin and 
proteases to give a total of 148,380 sequences. Cysteine carbamidomethylation 
was searched as a fixed modification, N-acetylation and oxidized methionine 
were searched as variable modifications. Labeled arginine and lysine were 
specified as fixed or variable modifications, depending on the prior knowledge 
about the parent ion. SILAC peptide and protein quantification was performed 
automatically with MaxQuant version 1.0.13.13(Cox and Mann, 2008)  using 
default parameter settings. Maximum false discovery rates (FDR) were set to 
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0.01 for both protein and peptide. This experiment was performed in 
collaboration with Walter Blackstock’s lab in IMCB (Singapore). 
 
 
3.19 ChIP-seq BINDING SITE IDENTIFICATION AND 
CLASSIFICATION 
To identify genome-wide binding-site locations (peaks), sequenced short reads 
from the ChIP-seq experiments were processed using the SISSRs algorithm 
(Jothi et al., 2008). (SISSRs v1.4 was run with the following parameters: 
scanning window size w = 100; p-value p =0.01; false discovery rate D = 
10%1; genome size s = 3,080,000,000 (human hg18). Peak distributions were 
defined using RefSeq annotation. Distances within -5kb/+2kb of a gene TSS 
were defined as promoters. To identify overlapping peaks between datasets, a 
region was first defined as a +/-1kb window from an enriched peak center. 
This region was then compared against the list of similarly defined regions 
from a corresponding dataset. Peaks that fall within the same region were 
considered to be overlapping. ChIP signal density profiles were generated 
using CisGenome v1.2 (Ji et al., 2008) at a 25bp resolution across the genome.  






3.20 De-Novo MOTIV DISCOVERY 
Motif discovery was performed on H3R2me2s enriched sites identified earlier 
by ChIP-Seq. A +/- 100bp window from the location of the peak center were 
taken from each site and their corresponding nucleotide sequences were 
downloaded from the UCSC genome browser with repetitive sequences 
masked. The enriched motifs were then identified using Multiple Em For 
Motif Elicitations (MEME) software suite (http://meme.nbcr.net/). The 
program was run with a minimum and maximum motif width of 6 and 25 
respectively. Reported motifs were ranked according to E-value significance, 
which is the estimated probability of the expected number of motifs with the 
given log-likelihood ratio compared to a random set of sequences of similar 
size and sequence width. This analysis was performed in collaboration with 
Julius Mueller and Diana Low. 
 
 
3.21 CELL LINES 
HeLa, HeLa S3, HEK293T, P493-6 and HL60 cells were provided by Bruno 
Amati. E14 cells were provided by Huck Ng Hui.  
HeLa, HeLaS3 and HEK293T were cultured at 37°C with 5% C02 in 
Dulbecco’s Modified Eagle's Medium (DMEM) containing 10% heat 
inactivated fetal calf serum (FCS), 2 mM L-glutamine, 50 "g/ml penicillin and 
50 "g/ml streptomycin. P493-6 and HL60 were culture in suspension in RPMI 
1640 (Invitrogen), 10% FBS, 2 mM L-glutamine, 50 "g/ml penicillin and 50 
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"g/ml streptomycin. The E14 ES cells were cultured at 37°C with 5% CO2 in 
E14 media (DMEM) with 2mM glutamine, 1mM sodium pyruvate, 1x non-
essential amino acids, 10% FBS, 1x BME, and supplemented with 500 "l 
ESGRO (LIF) per 500 ml of media. The E14 ES line was grown in gelatin– 























4.1 H3R2 IS SYMMETRICALLY DIMETHYLATED IN VIVO 
In order to understand whether H3R2 could be symmetrically dimethylated in 
vivo, our lab first sought to raise an H3R2me2s specific antibody. In 
collaboration with the antibody facility of IMCB, four rabbits were immunized 
with KLH-coupled peptides encompassing the first 10 amino acids of histone 
H3, symmetrically modified on R2. I proceeded to validate 8 sequential 
bleeds, taken from the four rabbits one week after each boost. For each bleed, 
I first performed peptide blots on 7 different synthetic synthesized peptides 
that mimic histone H3 N-terminal tail and which were differentially modified 
on different residues: H3, H3R2me1, H3R2me2a, H3R2me2s, H3K4me3, 
H3R2me2aK4me3 and H3R2me2sK4me3.  
The bleeds that specifically recognized only the H3R2me2s peptide were then 
use for Western blot analysis on HeLa nuclear extracts. Moreover, for every 
tested bleed that gave a clean signal band at the high of histone H3, I 
continued the validation, blocking the chosen antibody with specific or non-
specific peptides (H3, H3R2me2s or H3R2me2a), before using it in Western 
blot experiments (both on peptides and nuclear extracts samples.) 
In Fig.6, I show the complete validation of the antibody that I have decided to 
use for my project.  
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To test if the antibody was working when crosslinked cells were used as 
starting material for immunoprecipitation, I also performed a ChIP-western 
experiment in HeLa cells, in parallel with normal IgG rabbit (negative control) 
and total histone H3 antibody (positive control), and I was able to prove its 
efficiency in ChIP conditions (Fig 6e). 
I then affinity purified the serum, according to the protocol in chapter 3.2, in 










Fig 6: Characterization of the H3R2me2s antibody. a-b. Dot blot analyses: the 
antibody raised against a H3R2me2s peptide specifically recognizes the target 
peptide and fails to recognize the identical but unmodified H3 peptide (H3 
unmodified). Similarly, the H3R2me2s antibody does not recognize other 
arginine methylated peptides, representing sites previously identified on H3 
and H4, and importantly does not recognize either the monomethylated 
(H3R2me1) nor the asymmetrically dimethylated H3R2 peptide (H3R2me2a), 
but does recognize H3R2me2s even when the adjacent lysine at position 4 is 
methylated. c. Peptide competition analyses with the H3R2me2s antibody. 
H3R2me2s peptides were dotted to PVDF membrane. Prior to probing the dot 
blots, the H3R2me2s antibody was pre-incubated with the indicated peptides. 
The data demonstrate that only the H3R2me2s peptide competes binding of 
the H3R2me2s antibody to the H3R2me2s peptide. d. Same as in B, but this 
time HeLa nuclear extract were probed. The immunoblots are representative 
of experiments conducted at least three times and on different bleeds from 
different rabbits. e. ChIP/western: Chromatin Immunoprecipitation was 
performed with IGg, anti-total H3 and anti-H3R2me2s antibody (in duplicate) 









Next, I extended my studies to include samples from various species in order 
to assess the conservation of this newly identified mark. 
In Fig.7, I show by immunoblot analysis that H3R2me2s is present in H. 
sapiens, M. musculus, D. rerio, and D. melanogaster extracts.  
Moreover, staining of D. melanogaster polytene chromosomes, performed in 
our lab using the same antibody, revealed that H3R2me2s was excluded from 
DAPI/histone-rich bands including the chromocenter, whereas the antibody 
specifically raised against the asymmetric dimethylation of the same residue 
(H3R2me2a), was detecting DAPI-histone-rich bands and the chromocenter 
region (Migliori et al, 2012) consistent with its association with 
heterochromatin (Guccione et al., 2007b; Kirmizis et al., 2007). Importantly, 
the two antibodies gave an opposite staining pattern indicating that the 
staining was specific and implying a different function in controlling 
chromatin structure or function. 
 
Fig 7: H3R2me2s conservation across different species. H3R2me2s levels 
were measured in chromatin from different organisms by western blotting. 




4.2 H3R2me2s LOCALISES TO EUCHROMATIC REGIONS IN HUMAN 
CELLS 
In order to assess the distribution of H3R2me2s in mammalian cells, I 
performed genome-wide ChIP-Seq in the human B-cell line P493-6, where our 
lab previously showed a counter correlation between H3K4me3 and 
H3R2me2a (Guccione et al., 2007b). In collaboration with J.Mueller 
(Bioinformatic analysis), we identified 818 H3R2me2s-enriched regions. 32% 
of these H3R2me2s positive sites in the genome were located at promoters, 
within a -5kb/+2Kb window from the Transcription Start Sites (TSS) of 230 
genes (Fig. 8). These H3R2 methylated histones, at promoters, were 
specifically located at the -1 nucleosome, upstream of TSSs (Fig. 9). The 
remaining 68% of the peaks were located outside promoter areas (x<-5kb; 
x>+2Kb) where the enrichment of the signal was broader than a single 
nucleosome.   
 
Fig.8: Distribution of H3R2me2s-enriched peaks identified through genome-
wide ChIP-seq analysis on human B-cell line P493-6 (Bioinformatic analysis 








Fig.9: Distribution frequency along the genome of the H3R2me2s peaks with 
reference to the TSS and transcription end site (TES) of associated genes. 
H3R2me2s sites are specifically enriched at the –1 nucleosome, upstream of 
the TSS (Bioinformatic analysis in collaboration with J.Mueller). 
 
 
Next, I performed genome wide mapping of H3K4me1  (a marker of 
enhancers/insulators (Barski et al., 2007)), of H3K4me3  (a marker of 
proximal promoters) and of Pol II both in the total and phosphorylated active 
form (Pol II-S5).  
We also determined the overlap between these datasets and examples of ChIP-
seq enrichment profiles for the indicated loci are shown in Fig.10. Genome 
wide overlap between H3R2me2s enriched targets and H3K4me1, H3K4me3 




Fig.10: Examples of ChIP-seq results for the indicated loci in P493-6 cells. 
H3R2me2s-enriched sites at promoters (a), and control sites at promoters (b); 
H3R2me2s-enriched sites at distal sites (c) (&5 kb; >2 kb from TSS), and 
control sites at distal sites (d). Binding profiles of ChIP-sequencing results for 
H3R2me2s, H3K4me1, H3K4me3 Pol II and Pol II-S5-P are shown. The y 







Fig.11: Global overlap of H3R2me2s with other histone PTMs and Pol II. 
H3R2me2s marked regions are characterized by high levels of H3K4me3, Pol 
II and Pol II-S5 within promoter regions (a). Outside of promoter regions 
H3R2me2s correlates with H3K4me1 and Pol II-S5 (b). The mean tag density 
of the indicated mark was calculated for each H3R2me2s peak within 500bps. 
All peaks were ranked and split into significant, highly enriched H3R2me2s 
peaks (‘H3R2mes Peaks’) and all H3R2me2s (‘Control Peaks’), which include 
peaks with very low significance. P-values were calculated to test whether the 
two peak fractions are significantly different. Iterative Wilcoxon rank-sum 
statistic for two samples was applied on 1000 randomly drawn equal sized 
subsets of ‘Control peaks’ for this purpose and resulting p-values were 









By de novo motif discovery, we found that two motifs were highly enriched at 
promoters harboring H3R2me2s (Fig.12): the CAAT box, bound potentially 
by multiple transcription factors, including NF-Y, and the GC box (Blake et 













Fig.12: Enriched motifs and the corresponding E-values of H3R2me2s peaks 
at the promoter (a) and outside the promoter (b) (Bioinformatic analysis in 
collaboration with J.Mueller). 
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Accordingly, I observed that NF-Y bound directly to H3R2me2s enriched sites 
as shown in Fig.14a (Ceribelli et al., 2008). Sites with H3R2me2s outside of 
promoters (x<-5kb; x>+2Kb), instead, overlapped with a repeated motif 
(CA/TGGGG)2 reminiscent of the STRE (Stress Response) Element 
(Martinez-Pastor et al., 1996; Singh et al., 2001) and consistently showed no 
binding of NFY (Fig.12b). To further validate this hypothesis, I attempted to 
check for the presence of LEDGF on these promoters  (a transcription factor 
known to bind and activate stress-related genes (Singh et al., 2001)). 
Unfortunately, I could not ChIP LEDGF with the antibody I had available. 
To better understand the correlation between H3R2me2s deposition and NF-Y 
recruitment, I decided to take advantage of the dominant negative form of NF-
Y (m29) (Mantovani et al., 1994), which harbors mutation in a key DNA-
contacting residue. I transfected HeLa cells with wt NF-YA or m29 and 
performed ChIP 2 days after transfection. 
Whenever the mutant, m29, was transfected, NF-Y was no longer able to bind 
to DNA (as expected) and H3R2me2s levels were dramatically reduced too 
(Fig.13), suggesting an active role of the transcription factor in the 




Fig.13: ChIP analysis for NF-Y and H3R2me2s in wild type and m29 
transfected cells. ChIP analysis for NF-Y (a), normalized against the input, 
and H3R2me2s (b), normalized against the input and histone H3. Red bars 
indicate cells transfected with WT NF-Y and green bars indicate cells 
transfected with the dominant negative mutant, m29. Both NF-Y and 




Moreover, I validated the ChIP seq dataset by quantitative Real-Time-PCR, 
and sampled many genomic locations for the enrichment of several Post 
Translational Modifications on histone H3 and H4. As negative controls, I 
designed primers respectively on promoter or distal regions that were negative 
for H3R2me2s binding from the ChIP seq dataset (Migliori et al, 2012). 
Representative values from 5 independent quantitative ChIP experiments are 
shown in Fig.14.  As previously mentioned, H3R2me2s was present on the -1 
nucleosome relative to the TSS of transcribed genes (Fig.14c and k). These 
promoters had relative low histone density in the region surrounding the TSS, 
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if compared to other equally active genes. (Fig.14b: compare Sector i to sector 
ii). H3R2me2s marked promoters were enriched for H3K4me2/3 (Fig.14e-f), 
H3 and H4 acetylation (Fig.14g-h), and high levels of RNA Polymerase II 
(Pol II) (Fig.14i).  
PolII was phosphorylated at slightly lower levels on those genes (Pol II-S5-P), 
when compared to highly expressed genes (Fig.14j: compare sector-i to the 
first 5 genes on sector-ii). Nonetheless H3R2me2s marked the promoters of a 
specific subset of poised or moderately active genes (Fig.14k).  
Indeed when we compiled the occupancy of elongating Pol II along the gene 
bodies, the genes whose TSS were marked by H3R2me2s (black) showed a 
relatively high traveling Pol II ratio, lower than highly expressed genes (red), 
but significantly higher than repressed ones (light green) (Fig.15). As controls, 
we also analyzed genes whose TSS were marked by H3K4me3 (positive 
control for highly expressed genes), the phosphorylated form of PolII (positive 







Fig.14: Validation of the genome-wide mapping of H3R2me2s in B cells. a. 
NFYA binds to H3R2me2s enriched promoters. NFY-A levels normalized for 
the input at target and control sites in P493-6 cells. b. H3R2me2s levels at 
target and control sites at promoters (Sector i and ii) and at sites distant from 
any annotated TSS (Sector iii and iv). (b-j) As in a, with the 
immunoprecipitation performed with the antibody indicated on the right side 
of each panel. The qChIP values are expressed as % of input or as % of 
input/H3 (for histone modifications). k. Steady state mRNA levels of the 




Fig.15: The Pol II occupancy within the gene body of genes with a significant 
H3R2me2s peak at promoters, corresponds to the one of moderately active 
genes. To each intragenic region of the human genome (hg18), the mean, Pol 
II occupancy was assigned. All intragenic regions were ranked and clustered 
in 3 groups according to their steady state expression levels from high (red 
color) to low (light green). Finally, each cluster was plotted with increasing 
Pol II occupancy together with the increasing Pol II occupancy of genes with a 
significant H3R2me2s (a), H3K4me1 (b), Pol II-S5 (c) and H3K4me3 (d), at 
the respective promoter. In black is reported the occupancy for each of them. 





H3R2me2s was also enriched at sites that were distant from TSSs (Fig.14c; 
sector iii), and these were characterized by high level of H3K4me1/2 (Fig.14d-
e), H3 and H4 acetylation (Fig.14g-h), and by the presence of S5 phospho-Pol 
II (Fig.14j), reminiscent of the chromatin signature present at enhancers 




4.3 H3R2me2s IMPEDES CO-REPRESSORS BINDING 
Since H3R2me2a prevents histone H3 binding by several chromatin “readers” 
such as the WD40 domain of WDR5, and the PHD fingers of Spp1, ING2, 
PHF2, DATF1, BPTF, and TAF3 (Guccione et al., 2007b; Kirmizis et al., 
2007) (Iberg et al., 2008; Vermeulen et al., 2007), I addressed whether this 
was also the case for H3R2me2s.  
I used a Stable Isotope Labeling by Amino acids in Cell culture (SILAC)-
based quantitative screen to identify proteins interacting with the H3R2me2s 





Fig.16: Schematic representation of the SILAC-based histone peptide pull-
down approach. HeLa nuclear extracts were used for peptide pull-down assays 
with either unmodified or H3R2me2s-modified peptides; unmodified versus 
H3R2me2a-modified peptides or H3R2me2a-modified versus H3R2me2s-
modified peptides. The reverse-swap light-heavy experiments were also 
conducted in biological duplicates (gray arrows). 
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Most bound proteins did not discriminate between unmethylated H3, 
H3R2me2a or H3R2me2s peptides. These proteins represented those that 
either interacted non-specifically with the peptides/beads, or interacted with 
the histone H3-tail regardless of the H3R2 methylation status. Two categories 
of proteins were identified here: H3 interactors, blocked by the presence of 
H3R2me2s, and proteins that selectively recognized H3R2me2s.  
Five complexes belonged to the former, and shared two common subunits: 
RBBP4 and RBBP7. 
 
 
Fig.17: Functional protein association network of the interactome specifically 
binding to the histone H3 tail and excluded by H3R2me2s. Different protein 





Both RBBP4 and RBBP7 are WD40 domain-containing proteins part of the 
NURD and Sin3a complexes (Zhang et al., 1999), promoting transcriptional 
repression by nucleosome remodeling and deacetylation. RBBP4/7 are also 
part of the PRC2 complex (Kuzmichev et al., 2002), responsible for histone 
H3 lysine 27 methylation and of the hSNF2h complex, responsible for loading 
cohesin (Hakimi et al., 2002). Moreover, RBBP4 and RBBP7 are also 
subunits of the chromatin assembly factor 1 (CAF-1) complex, which is 
required to assemble chromatin, following DNA repair and DNA replication 
(Verreault et al., 1996). A schematic representation of all the interacting 
partners identified in our pull down experiments is shown in Fig.17, where all 
the protein-protein interactions experimentally described in literature are also 
highlighted.  
In particular, RBBP7 has been described to bind histone H4 (Saade et al., 
2009); (Murzina et al., 2008). In Fig.18, I showed for the first time that 
RBBP7 also bound the tail of histone H3, as it co-immunoprecipitated with a 
H3 peptide from nuclear extracts.  Additionally, the purified GST-RBBP7 
fusion protein associated with the same H3 peptide in an in vitro binding 
assay, confirming that the association was direct. Importantly, the presence of 
the symmetric dimethylation on arginine 2, and of the trimethylation, but not 
of the mono- or dimethylation on lysine 4, prevented the binding of RBBP7 to 





Fig.18: RBBP7 is excluded by H3R2me2s from binding to chromatin. Top: 
RBBP7 exclusion by H3R2me2s was assessed by western blotting (WB), 
following pulldowns from nuclear extracts with negative control beads (–) or 
histone peptides: H3 unmodified, H4 unmodified, H3K4me3 and H3R2me2s. 
Bottom: direct interaction of purified RBBP7 to histones H3 and H4 was 
confirmed by pull-down assay; bound RBBP7 was visualized by Coomassie 




Fig.19: ChIP-re-ChIP: H3R2me2s and H3K4me3 are present on the same 
nucleosome. a. The first ChIP was performed in growing P493cells with the 
indicated antibodies. The recovered DNA from the H3R2me2s 
immunoprecipitation was eluted (DTT) and re-ChIPped a second time (b) with 
the indicated antibodies. Two H3R2me2s enriched sites and two control 
promoters are shown. 
 
 
Nucleosomes methylated on H3R2me2s were also methylated on H3K4, as 
demonstrated by a ChIP-ReChIP experiment (Fig.19), and occupied the -1 
position relative to TSS of active promoters. These promoters were 
hyperacetylated and not methylated on H3K27, the major target site for the 
PRC2 repressor complex (Fig.20). This was consistent with the exclusion of 
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multiple co-repressor complexes and directly linked the presence of 
H3R2me2s with an open chromatin state. 
 
 
Fig.20: H3K27me3 does not correlate with H3R2me2s. H3K27me3 levels at 
target (i) and control (ii) sites at promoters and at sites (iii and iv) distant from 
















4.4 H3R2me2s FAVORS THE BINDING OF THE CO-ACTIVATOR WDR5 
In the second category of proteins specifically bound to H3R2me2s, I 
identified the four core components of the human MLL/Set1a/b complexes 
(Yokoyama et al., 2004); (Dou et al., 2006): WDR5, Ash2L, RBBP5 and 
Dpy30 (Fig.21), consistent with the hypothesis that H3R2me2s might supports 
euchromatin maintenance. These four proteins were the only proteins that 
showed a high binding ratio to H3R2me2s peptide, a weak binding to the H3 




Fig.21: Functional protein association network of the interactome specifically 





Next, using an in vitro methylation assay, I tested whether an H3R2me2s 
methylated peptide would be a good substrate for the K4 SET-
methyltransferase. H3R2me2s greatly favored the methylation on H3K4 
(Fig.22), explaining the mechanistic basis for the co-localization of these two 
modifications at the same chromatin sites (Fig.19). The in vitro assay 
generated H3K4me1 and H3K4me2, while we failed to detect H3K4me3, in 
line with previous reports (Fig.22) (Song and Kingston, 2008; Patel et al., 




Fig.22: Immunoprecipitated MLL complex preferentially monomethylates and 
dimethylates H3R2me2s in vitro. Flag-Ash2 immunoprecipitates were 
incubated with the indicated peptides in the presence of an S-adenosyl-l-
methionine (SAM) methyl donor. The status of methylation was detected 




To understand the functional significance of the specific association of WDR5 
with H3R2me2s, I validated this interaction by alternative methods. First, I 
performed H3 peptide pull down assays from nuclear extracts, followed by 
immuno-blotting. As shown in Fig.23, WDR5 preferentially precipitated with 
the H3R2me2s peptide. I could also detect binding to the H3 unmodified 
peptide and to the H3K4me2/3 peptides, although with lower affinity, while 
H3R2me2a completely blocked binding, as previously reported (Guccione et 
al., 2007a; Schuetz et al., 2006; Ruthenburg et al., 2006). 
 
 
Fig.23: WDR5 binds specifically to H3R2me2s. WDR5 binding to H3R2me2s 
was assessed by western blotting (WB) following pulldowns from nuclear 
extracts with histone H3 peptides: unmodified, H3R2me2a, H3R2me2s, 
H3K4me2 and H3K4me3. 
 
 
Secondly, in order to assess the efficiency of direct binding, in collaboration 
with the BIACORE facility in IFOM IEO in Milan, we measured the affinity 
of WDR5 towards differentially modified H3 peptides. Real time bio-
interaction showed that WDR5 binds H3R2me2s with an affinity one order of 
magnitude higher than that displayed for the unmodified H3 peptide (with 
KD= 0.1 "M and KD= 5.6 "M respectively) (Migliori et al, 2012). Lastly, I 
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performed a genome wide mapping of WDR5 in P493-6 cells and found that it 
was enriched on genomic locations marked by H3R2me2s, both at promoters 
and enhancer sites (Fig.24).  
 
 
Fig.24: H3R2me2s-marked regions are bound by WDR5. The mean tag 
density of the indicated mark was calculated for each H3R2me2s peak within 
500 base pairs (bp). All peaks were first divided on the basis of their proximity 
to TSS. Next, they were ranked and split into significant, highly enriched 
H3R2me2s peaks (H3R2me2s peaks); and control peaks, which include peaks 
with very low significance. P values were calculated to test whether the two 
peak fractions were significantly different. Iterative Wilcoxon rank-sum 
statistical analysis for two samples was applied on 1,000 randomly drawn 
equally sized subsets of control peaks for this purpose, and resulting P values 
are indicated above each individual plot (Bioinformatic analysis in 








4.5 THE WD40 DOMAIN OF WDR5 IS A NOVEL METHYL ARGININE 
“READER”  
To gain better insight into the preferential binding of H3R2me2s to WDR5, I 
next purified WDR5 protein and, in collaboration with Marina Mapelli 
(IFOM-IEO, Milan), we determined the crystallographic structure of the 
complex at 1.9Å resolution. As previously reported (Couture et al., 
2006;(Schuetz et al., 2006);(Han et al., 2006), WDR5 folds into a seven-blade 
"-propeller arranged around a central narrow channel where the side chain of 
R2 is accommodated (Fig. 25). An omit-map computed from the high-
resolution dataset revealed clear electron density for the two R2 methyl 
groups, and illustrated how the water molecule network was reorganized to 
account for the increased hydrophobicity of the modified side chain. The 
structure superposition showed that the overall binding mode of H3 to WDR5 
was mostly unaffected by the symmetric R2 dimethylation and that the main 
differences were confined to the bottom of the inner cavity where the R2 side 
chain was inserted (Fig. 25c-e). Of the two water-mediated hydrogen bonds to 
the carbonyls of Ser-175 and Ser-218, in which the guanidinium moiety of the 
unmodified R2 was engaged, only the first one was maintained in the 
H3R2me2s structure, while the other was replaced by hydrophobic interaction 
mostly contributed by the side chain of Phe-219, toward which the methylated 
R2 nitrogen projects. As observed for the other WDR5:H3 complexes(Couture 
et al., 2006);(Schuetz et al., 2006);(Han et al., 2006), the structural 
determinants of the histone recognition resided in the N-terminal Ala-1, Arg-2 
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and Thr-3 residues, while the side chain of Lys-4 pointed away from the 
surface. This could be important in the context of K4 methylation, or could 
simply be a mutually exclusive situation to the MLL-SET bound conformation 
(Southall et al., 2009). These results demonstrated that WDR5, while binding 











Fig.25: Crystal structure of WDR5 bound to the N terminus of histone H3 
symmetrically dimethylated on arginine 2. (a,b) Cartoon representation of 
WDR5 in complex with (a) R2me2s- and (b) unmodified (PDB 2H13 (ref. 
39)) histone H3 peptides. Histone H3 peptides, in yellow ball-and-stick 
representation, bound the narrower top surface of the WDR5 '-propeller and 
inserted the Arg2 side chain into its central channel. (c,d) Enlarged view of the 
Arg2 interaction network. The hydrophobic part of the arginyl side chain was 
stabilized by the phenylalanine clamp formed by Phe133 and Phe263 (purple 
sticks), while the guanidinium group participated in direct and water-mediated 
bonding to hydrogen (dashed lines). Two hydrogen bonds to structurally 
conserved water molecules anchored the unmodified Arg2 to the bottom of the 
WDR5 channel. The dimethylated side chain displaced one of the waters and 
protruded toward the Phe219 aromatic ring to make tighter hydrophobic 
interactions. (e) Superposition of the two structures (in collaboration with 
M.Mapelli). 
 
I proceeded to mutate Phe219 to show that this residue was the one mainly 
affecting the interaction with H3R2me2s. I have substituted Phe219 with a 
histidine in the same position and observed a severe impaired interaction with 
H3R2me2s, as shown in Fig. 26. 
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The positively charge histidine was probably interfering with the hydrophobic 
interaction that F219 was engaging with H3R2me2s. 
 
Fig.26: F219 is the main residue that affects WDR5 binding to H3R2me2s. 
WDR5 wt and WDR5 F219H binding to H3R2me2s was assessed by western 
blotting (WB) following pulldowns from nuclear extracts with histone H3 
peptides: unmodified, H3R2me2a, H3R2me2s, H3K4me2 and H3K4me3. The 
interaction between WDR5 and H3R2me2s is impaired when F219 is mutated 
to H. 
In 2008, Song and colleagues crystallized WDR5 binding to a MLL peptide, 
called win motif (WDR5 interacting). In this structure, WDR5 used the pocket 
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that was previously identified for the binding of histone H3, also for the 
interaction with MLL(Song and Kingston, 2008). The authors demonstrated 
the existence of a molecular competition between the MLL and histone H3 
(when mono or dimethylated on K4) for WDR5 binding. Moreover, according 
to the authors, this binding site was only conserved in MLL1 and not in MLL2 
or MLL3, suggesting a differential regulation of the interaction between 
WDR5, histone H3 and the different MLL proteins.  
Since H3R2me2s bound specifically WDR5, stronger than unmodified histone 
H3, or H3 methylated on K4, I wanted to understand whether histone H3 
symmetrically dimethylated on R2 could better compete for the binding to 
WDR5 in presence of the win motif, used in the paper reported above. 
I first incubated H3R2me2s (Fig.27b) or unmodified H3 (Fig.27a) as a control 
with streptavidin beads, followed with purified GST-WDR5, to allow the 
binding of WDR5 to the peptide and thus the beads. Increasing concentrations 
of win motif were added to the bound complex, and the presence of WDR5 
bound to the beads (to H3 or H3R2me2s) or in solution (bound to the win 
motif) was assessed. 
As shown in Fig.27, at increasing levels of win motif, H3R2me2s was better 
able to compete for the binding of WDR5 compared to H3, suggesting that 
this modification can play a role too in the differential regulation of the 
interaction between WDR5, histone H3 and the different MLL proteins.  
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   BOUND          UNBOUND      BOUND    UNBOUND    BOUND     UNBOUND    BOUND       UNBOUND 
 
Fig.27: Competition assay. Level of WDR5 bound to beads or unbound in the 
supernatant fraction. Since H3 (a) or H3R2me2s (b) were bound to the beads, 
WDR5 in the beads fraction indicated its interaction with the respectively H3 
(a) and H3R2me2s (b) whereas its presence in the soluble fraction (unbound) 
indicated its binding to the win motif, which had been added at increase 
concentration. H3R2me2s better competed, compared to H3, with the win 
motif for the binding of WDR5. 
 
 
4.6 H3R2me2s RECRUITS WDR5 IN VIVO UPON CELL CYCLE EXIT  
To gain an understanding of the biological pathways that might be regulated 
by H3R2me2s, in collaboration with J.Mueller, we performed gene set 
enrichment analyses on the genes enriched for H3R2me2s at their promoters 
(Fig.28). These genes belonged to fundamental pathways of transcription 
regulation and protein posttranslational modification, including acetylation, 
lysine demethylation and Phosphorylation (Migliori et al, 2012). A second 
category that was highly enriched in the GO analysis was vesicle-mediated 
transport. I focused on those genes belonging to the category of transcriptional 
co-regulators, and asked whether I could modulate H3R2me2s levels and 
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correlate it with the status of chromatin. I addressed this point in two cellular 
systems: the first system was the same P493-6 human B cells that I have used 
thus far. The progression through the cell cycle of these cells depended on the 
sustained expression of c-Myc (Schuhmacher et al., 1999). Upon Myc 
depletion (Fig. 28a), cells arrested in G0/G1 and target genes preferentially 
accumulated H3R2me2s (Fig. 28b). This event correlated with increased 
acetylation and recruitment of Pol II (Fig.28b), consistent with the 
NURD/Sin3a complexes exclusion (Fig.17). Interestingly, when I checked for 
the levels of WDR5 in the same cells, I noticed a marked decrease of bulk 
WDR5 levels, consistent with the fact that WDR5 levels were regulated by 
Myc (Fig.28a). As expected, I observed a reduction in WDR5 binding to 
chromatin, and reduced H3K4me3 levels at most control sites (Fig. 28b, right 
panels). However, I detected an increased binding of WDR5 at H3R2me2s 
enriched sites. This was most likely due to the high affinity interaction 
between WDR5 and the symmetric dimethylated H3R2, which became 
extremely important in situation when WDR5 nuclear molarity was reduced. 
For this reason, I could speculate that the increased affinity for H3R2me2s, in 
conditions of reduced nuclear concentration of WDR5, played a key role in 
maintaining the “ON” state, for this set of genes, which indeed were not 
transcriptionally downregulated upon cell cycle exit, but rather upregulated 









Fig.28: WDR5 is recruited by H3R2me2s on H3R2me2s target genes. P493-6 
cells were treated for 3 d with tetracycline. HL60 cells were differentiated for 
3 d with DMSO. (a) Levels of WDR5 in growing and tet-treated P493-6 cells 
(+tet). Western blotting (WB) was used to detect endogenous Myc, WDR5, 
actin, histone H3 and H3R2me2s levels in growing and arrested cells. (b) 
H3R2me2s levels normalized for total histone H3 at target and control sites 
under the two conditions: proliferating (blue bars) or quiescent (red bars) 
P493-6 cells. Similar ChIP experiments were conducted; the antibody is 
indicated on the side of each panel. The quantitative ChIP (qChIP) values 
were expressed as percent of input or normalized for total histone H3, in the 
case of histone modifications. (c) Expression levels of target and control 
genes. Values were represented as fold change between the two experimental 
conditions (proliferating or quiescent). (d) Levels of WDR5 in growing and 
differentiating HL60 cells. Western blotting was used to detect endogenous 
Myc, WDR5, actin, H3 and H3R2me2s levels. (e) H3R2me2s levels 
normalized for total histone H3 at target and control sites for the two 
conditions: proliferating cells (blue bars) or differentiated HL60 cells (red 
bars). Similar ChIP experiments were conducted; the antibody was indicated 
on the left side of each panel. The qChIP values were expressed as in b. (f) 
Expression levels of target and control genes. Values were represented as fold 















4.7 H3R2me2s RECRUITS WDR5 IN VIVO UPON HL60 
DIFFERENTIATION 
Next, I explored the functional role of H3R2me2s in human promyelocytic 
HL60 cells, which can be differentiated to granulocytes upon treatment with 
DMSO (Collins and Foster, 1983). Upon differentiation, cells were forced out 
of the cell cycle, and concomitantly, Myc and WDR5 levels were reduced 
(Fig.28d). I performed a genome wide mapping of H3R2me2s in both 
undifferentiated and differentiated HL60 cells. I noticed that overall, 
H3R2me2s tended to accumulate at target sites (Fig.28e), concomitant with 
WDR5 recruitment and increased H3K4me3 methylation. This was similar to 
what I observed in P493-6 cells (Fig.28b). Once again, I noticed that 
H3R2me2s enriched promoters were kept in an “open” conformation, and 












4.8 H3R2me2s DISTRIBUTION IN GROWING AND RETINOIC ACID 
DIFFERENTIATED MOUSE EMBRYONIC STEM CELLS  
In order to study the H3R2me2s changes in an alternative differentiation 
system, I performed ChIP seq of H3R2me2s in growing mouse embryonic 
stem cells (ES) or treated with Retinoic Acid (RA) for 6 days. 
In collaboration with D. Low (Bioinformatic analysis), we identified 598 
H3R2me2s-enriched regions in ES. 74% of these H3R2me2s positive sites in 
the genome were located at promoters, within a -5kb/+2Kb window from the 
Transcription Start Sites (TSS) of 441 genes. The remaining 26% of the peaks 
were located outside promoter areas (x<-5kb; x>+2Kb), where the enrichment 
of the signal was broader than a single nucleosome (Fig.29). 
 
Fig.29: Distribution of H3R2me2s-enriched peaks identified through genome-
wide ChIP-seq analysis on mouse embryonic stem cell (ES) (Bioinformatic 
analysis in collaboration with D.Low).  
 
 
Upon treatment with Retinoic Acid for 6 days, we identified 644 H3R2me2s-
enriched regions. 65% of these H3R2me2s positive sites in the genome were 
located at promoters, within a -5kb/+2Kb window from the Transcription Start 
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Sites (TSS) of 418 genes. The remaining 35% of the peaks were located 
outside promoter areas (x<-5kb; x>+2Kb) and enrichment of the signal was 
broader than a single nucleosome (Fig.30). 
 
Fig.30: Distribution of H3R2me2s-enriched peaks identified through genome-
wide ChIP-seq analysis on mouse embryonic stem cell upon 6 days of 
RetinoicAcid treatment (RA) (Bioinformatic analysisnalysis in collaboration 
with D.Low).  
 
Since the mark was mainly located at promoter regions (~70%) in both 
conditions, I decided to focus on promoters for further analysis. 
When I compared the H3R2me2s positive sites in ES versus RA, I observed 
that H3R2me2s stably marked only 192 sites in both conditions, whereas 245 
and 216 sites were respectively specific to ES- or RA- only (Fig.31). This 






Fig.31: Overlap between H3R2me2s peaks in ES and RA.Venn diagram 
showing the overlap between H3R2me2s peaks in ES (growing mouse 
embryonic stem cells) and RA (differentiated mouse embryonic stem cells 
upon 6 days of Retinoic Acid treatment). 
 
Moreover, by de novo motif discovery, we found that the CAAT box, bound 
potentially by multiple transcription factors, including NF-Y, was highly 
enriched at both promoters and distal regions harboring H3R2me2s (Fig. 32) 




Fig.32: Enriched motifs and the corresponding E-values of H3R2me2s peaks 






Next, I performed NF-Y ChIP seq both in growing and retinoic acid-treated 
mouse embryonic stem cells, to better understand the correlation between the 
transcription factor NF-Y and H3R2me2s. 
We identified 10323 NFY-enriched regions: in the genome, 55% of these NF-
Y positive sites were located at promoters, within a -5kb/+2Kb window from 
the Transcription Start Sites (TSS) of 5706 genes. The remaining 45% of the 
peaks were located outside promoter areas (x<-5kb; x>+2Kb). 
Upon treatment with Retinoic Acid for 6 days, we identified 6607 NFY-
enriched regions: 64% of these NF-Y positive sites were located at promoters, 
within a -5kb/+2Kb window from the Transcription Start Sites (TSS) of 4242 
genes. The remaining 36% of the peaks were located outside promoter areas 
(x<-5kb; x>+2Kb). 
Again, considering the distribution of NF-Y predominantly at promoters, I 
decided to focus on promoters and I compared NF-Y with H3R2me2s peaks in 
ES versus RA. 
The peaks showed a ~90% overlap with a strong positive correlation between 








a                                                               b 
 
Fig 33: Overlap between NF-Y and H3R2me2s in ES and RA. Venn diagram 




This data confirmed, at a genome-wide level, the results obtained in P493-6 
(Fig.14a). 
I then divided mouse promoters in 16 categories (A-P) based on whether they 























Fig.34:  Mouse promoters divided in 16 categories (A-P) according to the 
presence of NF-Y and/or H3R2me2s in ES and RA conditions. The data are 
shown with a diagram Venn (upper part) and snapshots of peaks for one 
representative gene for each category is presented (bottom part). P is the 




The most interesting categories were H, I and J: H represented the H3R2me2s 
ES specific sites which retained NF-Y binding in ES and RA conditions, I the 
sites with stable H3R2me2s and NF-Y binding in both conditions and J the 
H3R2me2s RA specific sites with constant NF-Y binding in ES and RA 
conditions. 
It will be useful to understand what happens to the genes in these categories at 
the chromatin state, and also at the transcription level. In particular, further 
work needs to be done to score for changes in H3K4me3, H3 acetylation, 
K27me3, PolII and WDR5 presence at these sites in the different categories 
upon RA treatment. 
Transcription is a complex mechanism that needs to be controlled by different 
stimuli. The hypothesis is that the genes characterized by H3R2me2s prepare 












4.9 PRMT5/WDR77 AND PRMT7 METHYLATE H3R2me2s  
Lastly, I sought to identify the enzyme catalyzing H3R2me2s. The human 
genome encodes 2 characterized, type II PRMTs, PRMT5 and PRMT7. When 
immunoprecipitated from transfected cells and incubated with recombinant 
histone H4, both these PRMTs could catalyze the symmetric dimethylation of 
H4R3 (Fig.35a). 
  
Fig.35: PRMT7 and PRMT5–WDR77 methylate H3R2me2s. (a,b) PRMT5 
and PRMT7 immunoprecipitates from transfected cells were incubated with 
recombinant histone H4 (a) or H3 (b) and SAM. H4R3me2s and H3R2me2s 
levels were visualized by western blotting (WB). (c) Cells were infected with 
short hairpin RNA (shRNA) viruses, targeting the indicated PRMTs. Two 
shRNA were used for each PRMT and the relative knockdown (KD) was 
quantified by RT-PCR. (d) Western blot analysis of the level of different 
histone modification (H3, H3R2me2s, H3K4me3, H3K9me3, H3K27me3) 
from total extract of HeLa cells. HeLa cells were infected with scramble, 
shPRMT5, shPRMT7 and double shPRMT5 and PRMT7. (e) H3R2me2s 
levels at target and control sites in scramble control cells, or cells knocked 
down for PRMT5 or PRMT7. ChIP experiments were conducted with the 
antibody indicated on the left side of each panel. The qChIP values are 
expressed as percent of input or normalized for total histone H3, in the case of 
histone modifications. (f) Expression levels of target and control genes. 
Values are represented as fold change compared to scramble.  
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The experiment was repeated immuno-precipitating FlagHA tagged PRMT5 
and PRMT7 from cells using both Flag and HA antibodies. Although PRMT5 
has been reported to be a potential contaminant in Flag immunoprecipitates 
(Nishioka and Reinberg, 2003), I actually did not detect PRMT5 as a 
contaminant and observed a stronger methylation catalyzed by PRMT7 
(Fig.35b). When the experiment was performed immunoprecipitating with HA 
beads instead, I consistently observed a stronger methylation with PRMT5 
(Fig.36). I can as such conclude that both enzymes are able to catalyze the 




Fig.36: PRMT7 and PRMT5–WDR77 methylate H3R2me2s. HA-PRMT5 and 
HA-PRMT7 immunoprecipitates from transfected cells were incubated with 
recombinant H3, in the presence SAM. H3R2me2s levels were subsequently 




Finally, I decided to knockdown the levels of PRMT5 and PRMT7 (Fig.35c) 
in cells, to observe the effects on H3R2me2s levels in bulk or at specific target 
sites. By reducing the levels of PRMT5 or PRMT7, I observed a reduction in 
bulk of H3R2me2s levels (Fig.35d). Depletion of both PRMT5 and PRMT7 
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produced the strongest effect on the reduction of the mark and this also 
resulted in reduced H3K4me3 levels. The levels of heterochromatic marks 
such as H3K9me3 and H3K27me3 remained stable, demonstrating specificity. 
At target sites, I also observed a reduction of H3R2me2s, which resulted in 
reduced WDR5 recruitment, reduced H3K4me3 and H3 acetylation (Fig.35e) 
and transcription downregulation (Fig.35f). Similar results were also obtained 







Fig.37: WDR77 KD reduces H3R2me2s levels in cells. a. Cells were 
transfected with PSuper vector, targeting WDR77. The relative KD was 
quantified by RT-PCR. b. H3R2me2s levels normalized for total histone H3 at 
target and control sites in scramble control cells, or cells KD for WDR77. 
Similar ChIP experiments were performed with the antibody indicated on the 
right side of each panel. The qChIP values are expressed as % of input or 
normalized for total histone H3, in the case of histone modifications. c. 
Expression levels of target and control genes. Values are represented as fold 




Since both PRMT5 and PRMT7 were able to catalyze the symmetric 
dimethylation of H3R2, I wanted to investigate whether the two protein were 
interacting with each other. 
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I transfected PRMT5 and PRMT7 in HeLa and tested for interaction by co-
immunoprecipitation. While I detected PRMT5 and PRMT7, when I 
immunoprecipitated them with the respective antibody, I was not able to show 
an interaction between them (Fig.38). 
 
 
Fig.38: PRMT5 and PRMT7 do not interact. Immunoprecipitated PRMT5 and 
PRMT7 from FlagHA-PRMT5 and PRMT7 co-transfected HeLa cells were 
blotted against PRMT5 (a) and PRMT7 (b). PRMT5 and PRMT7 do not 
interact. 
 
Moreover, I performed pull-down for PRMT5 and PRMT7 from Flag-HA 
stable HeLa cell line from nuclear and cytoplasmic fraction, followed by 
SILAC/MS (data not shown), and I did not observe the interaction. 
This does not exclude that the two enzymes might work together. PRMT7 is 
indeed a strong monomethylase and PRMTs activity is enhanced on substrate 





4.10 PRMT5 IS NUCLEAR AND BINDS TO H3R2ME2S TARGETS IN 
CANCER CELL LINE HST746. 
PRMT5 and PRMT7 were mainly localized in the cytoplasm of the cell lines 
that I have studied. This could probably be one of the reasons why the ChIP of 
these two enzymes did not work and I failed to assess whether they were 
binding to H3R2me2s target genes. 
We performed an immunohistochemistry screening (collaboration with the 
histopathology facility in IMCB, Singapore), scoring for the localization of the 
different PRMTs. The stomach cancer cell line p53 mutant, HST746, was 
identified to have nuclear PRMT5, as shown in Fig.39, while PRMT7 was still 
present both in the nucleus and cytoplasm. PRMT6 has a constitutively 
nuclear localization. 




Fig.39: Immunohistochemistry of PRMT5 and PRMT7 in HST746 cells in 
collaboration with the histopatology facility of IMCB. PRMT5 gives a nuclear 
staining (brown), PRMT7 both a nuclear and cytoplasmic staining, while 




In HST746, I succeeded to ChIP PRMT5 but not PRMT7, probably due to 
PRMT7 low levels in the nucleus. 
I tested 3 positive and 3 negative control genes for H3R2me2s and found that 
PRMT5 was enriched at H3R2me2s target genes only (Fig.40d).  
Moreover, H3R2me2s showed a significant reduction at its targets upon 
PRMT5 knockdown, whereas no change was observed upon PRMT7 
knockdown, suggesting that in HST746, PRMT5 is the main enzyme 
responsible for H3R2me2s deposition (Fig 40a).  H3acetylation (Fig 40c) 
levels were reduced specifically upon PRMT5 knockdown, suggesting a 
correlation between H3 acetylation and H3R2me2s, while the level of lysine 4 
methylation (Fig 40b) at these sites was reduced upon PRMT5 and PRMT7 






Fig.40: PRMT5 methylates H3R2me2s in HST746 cells. H3R2me2s levels at 
target and control sites in scramble (blue) control HST746 cells, or HST746 
cells knocked down for PRMT5 (black) or PRMT7 (green). ChIP experiments 
were conducted with the antibody indicated on the right side of each panel. 
The qChIP values are expressed as percent of input or normalized for total 
histone H3, in the case of histone modifications. 
 
To further confirm that PRMT5 is, in these cells, the enzyme responsible for 
H3R2me2s methylation, I performed Western blot for the mark upon PRMT5 
and PRMT7 knockdown and observed that H3R2me2s bulk levels were 
significantly reduced just upon PRMT5 knockdown, or when both PRMT5 
and PRMT7 were knocked down (Fig.41). This data highlighted the 
importance of PRMT5 and PRMT7 localization, since I did not observed any 
reduction upon PRMT7 knockdown, which was cytoplasmic in these cells, 
and I did observe reduction upon PRMT5 knockdown, which was mainly 
nuclear. 
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Understanding the signaling that in physiological conditions triggers 
PRMT5/7 re-localization to the nucleus, will be critical to understand how to 
regulate their catalytic activity towards some of their targets.  
 
 
Fig.41: H3R2me2s in bulk reduction upon PRMT5 knockdown in HST746 
cells. Western blot analysis of the level of H3 and H3R2me2s from total 
extract of HST746 cells. HST746 cells were infected with scramble, 


























Methylation of histones has been linked to both transcriptional activation and 
repression. Here I show, for the first time, that opposite symmetries of 
methylation of the same arginine side chain play opposite roles in either 
excluding or recruiting the same co-activator, WDR5, to chromatin. Fig.42 




Fig.42: Schematic representation of the role of H3R2me2s. At promoters, it 
prevents heterochromatinization upon differentiation or cell-cycle exit, by 
recruiting WDR5, despite its reduced molarity in the nucleus, and by 
excluding co-repressor complexes such as PRC2, NURD and Sin3a, by 
impeding RBBP7 binding. PRMT6, in contrast, catalyzes the asymmetric 
dimethylation of H3R2, which leads to the exclusion of WDR5 from binding 
to histone H3. At distal regulatory elements (right), H3R2me2s favors the 







5.1 H3R2me2s ON THE -1 NUCLEOSOME  
The genomic distribution of this newly identified histone modification, 
symmetric dimethylation of arginine 2 on histone H3, is extremely intriguing. 
Firstly, it is present on the -1 nucleosome relative to the TSS, where it seems 
to play an important role in preventing other nucleosomes from assembling in 
the surrounding region. In support of this, the presence of H3R2me2s inhibits 
CAF1 binding by impeding the interaction of RBBP7 with H3 (Fig.18). This 
functions as a de facto fail-safe mechanism to prevent unwanted 
heterochromatinization.  
The exclusion of RBBP7 is a key mechanism to simultaneously exclude not 
only CAF1, but several other co-repressor complexes (Fig.17), preventing 
H3K27 methylation by PRC2 and deacetylation by NURD and Sin3a. My 
genome-wide mapping studies of H3R2me2s reveal the presence of this mark 
at specific promoters that need to be expressed upon cell cycle exit, 
differentiation and are induced by other extracellular signaling stimuli or 
stress signals.  
I have been able to validate this in two cell lines, P493-6 and HL60, where I 
demonstrated that the stronger affinity of H3R2me2s for WDR5 is the reason 
why gene promoters, enriched for this histone PTM, are kept in a euchromatic 
state. When the levels of WDR5 are reduced, such as upon cell cycle exit or 
differentiation, WDR5 recruitment to H3R2me2s target genes is either 
unchanged or increased. On the other hand, it is released from binding to 
several promoters that are not enriched in H3R2me2s, leading to their 
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repression. 
Another important feature of the H3R2me2s at the promoter region is its 
correlation with the transcription factor NF-Y (Fig.14a, Fig.33). By de novo 
motif discovery, I found that the CAAT box is a common motif present at 
H3R2me2s target genes (Fig.12a, Fig.32). The CAAT box is potentially bound 
by multiple transcription factors, including NF-Y, which is indeed enriched at 
the promoters of most H3R2me2s target genes. 
The transcription factor NF-Y is a complex of 3 subunits: NF-YA, NF-YB and 
NF-YC, which are all required for DNA-binding, even if most of the 
sequence-specific interactions are provided by NF-YA (McNabb et al., 1995; 
Sinha et al., 1995). NF-YB and NF-YC are characterized by a histone-like 
motif: NF-YB belongs to the H2B and NF-YC to the H2A family (Baxevanis 
et al., 1995). NF-YB and NF-YC first associate to form a tight dimer, thus 
allowing the subsequent association of NF-YA, the regulatory subunit of the 
trimer, whose levels vary depending on cell type and/or cell cycle. 
Notably, the disruption of the DNA-binding ability of NF-Y, by transfecting 
cells with a dominant negative form of NF-YA, causes a drastic decrease of 
the symmetric methylation of arginine 2 (Fig.13). 
This suggests that NF-Y plays an active role in H3R2me2s deposition. Since 
PRMT5 and PRMT7, which I have identified as the enzymes responsible for 
the catalysis of the mark, do not possess a DNA binding motif, NF-Y could 
possibly target H3R2me2s to specific DNA loci. Understanding whether NF-
Y is able to interact with PRMT5 and/or PRMT7 could be of extreme 
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importance to shed light on the mechanism by which the deposition of the 
H3R2me2s is regulated. 
Another interesting experiment would be to understand whether modulation of 
H3R2me2s could regulate NF-Y binding, by assessing NF-Y binding to its 
targets in cells in which PRMT5 or PRMT7 levels have been reduced by 
knockdown or completely removed by genetic knockout. 
NF-YB and NF-YC have the ability to substitute for H2B and H2A 
respectively, and can form a hybrid octamer with H3-H4 (Gatta and 
Mantovani, 2008). This is fascinating, especially considering my findings that 
H3R2me2s is linked to regions with low histone occupancy. A hypothesis 
could be that NF-Y binds to DNA and substitutes for histone H2A and H2B in 
nucleosomes where H3R2me2s is present. As such, the regions flanking the 
sites characterized by this novel mark become depleted of nucleosomes and 
are thus available for the transcription machinery to bind, favoring the 




5.2 H3R2me2s AT DISTAL SITES IN P493-6 
H3R2me2s not only localizes at promoters, but also at sites distal from 
annotated TSS (Fig.8, Fig.29, Fig.30). This is, to my knowledge, the first 
evidence of the targeted recruitment of WDR5, a key subunit of co-activator 
complexes, to specific euchromatic sites outside of promoter regions that are 
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enriched for H3K4me1 and H3/H4 acetylation. This particular chromatin 
signature has been associated with enhancers, and so far there have been no 
reports as to how H3K4me1 and H3/H4 acetylation were deposited at these 
regions. H3R2me2s is not present at all “enhancers”, but could be involved in 
recruiting methyltransferases and acetylatransferases at specific sites in the 
genome. 
Work by other groups (Patel et al., 2008a; Patel et al., 2008b; Song and 
Kingston, 2008) showed that the binding pocket of WDR5, which interacts 
with H3R2me2s, can also interact with the SET domain of MLL1 with 
comparable affinity (Migliori et al., 2012; Patel et al., 2008a; Patel et al., 
2008b; Song and Kingston, 2008). Moreover, the WDR5 peptide-binding cleft 
has recently been shown to bind MLL2-4 and SET1A and SET1B via a 
conserved win motif (Zhang et al., 2012), which does not exclusively interact 
with MLL1, as previously claimed (Song and Kingston, 2008).  
My data demonstrates competitive binding of WDR5 to both H3R2me2s and 
the SET catalytic subunit of the MLL complex, and this competition might 
have a regulatory function for the diverse enzymatic activities of the MLL 
complex at different genomic sites.  
At distal sites, the WDR5/Ash2/Rbbp5/DPY30 sub-complex could be 
recruited to chromatin via the high affinity interaction between WDR5 and 
H3R2me2s. This sub complex has been proposed to have direct H3K4 
monomethylation capability (Cao et al., 2010; Patel et al., 2009), which would 
fit with the observed co-localization of H3R2me2s and H3K4me1 at all 
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enhancer sites distant from TSSs (Fig.11). At promoters, the situation might 
be slightly different as the topology of the interactions among subunits of the 
WDR5/Ash2/Rbbp5/DPY30 sub complex could be rearranged by the direct 
binding of MLL or SET1a/b to WDR5, via the win motif, allowing the SET-
containing enzyme to further trimethylate histone H3.  
On the other hand, Takahashi and colleagues have recently shown that the 
reconstituted yeast WRAD (WDR5/Rbbp5/Ash2/DPY30) complex does not 
have a substantial HMT activity. Indeed, less than 1% of H3K4me1 and no 
H3K4me2-3 were detected in their methylation assays, when they use the 
WRAD complex compared to the wild type Set1/COMPASS or 
MLL/COMPASS-like complexes (Takahashi et al., 2011). 
In vivo, the situation could be completely different and other proteins could 
play a role in promoting the activity of the WRAD complex. 
The presence of H3K4me1 at distal regions could also be linked to the 
presence of NF-Y. Tabach and colleagues have demonstrated that NF-Y 
promotes H3K4me1, by recruiting the Co-REST associated KDM1-
H3K4me2-demethylase complex (Tabach et al., 2005). Considering that NF-
YB has been recently shown to interact with Ash2L and WDR5, though with 
low affinity, (Fossati et al., 2011), a regulation loop between H3R2me2s-
WDR5/Ash2L-NF-Y and H3K4me1 could be proposed. 
An alternate explanation is that the function of H3R2me2s is linked to WDR5 
recruitment, but not necessarily in the context of any SET-domain-containing 
complex. WDR5 is present in many other complexes, for example the ATAC 
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complex (Wang et al., 2008) and the MOF complex (Cai et al., 2010), which 
possess acetyltransferase activity. These complexes could serve as a scaffold 
that regulates chromatin recruitment in a manner that is dependent on the state 
of H3R2-methylation.  
It is important to note that binding of WDR5 to H3R2me2s, while specific, is 
not likely to be the sole mechanism by which it is recruited to chromatin. 
WDR5 is indeed present at many other promoters, where it is recruited by 
alternative methods, and where, in the absence of H3R2me2s, is unlikely to 
interact directly with histone H3. 
In 2011, Wang and colleagues identified HOTTIP, a long non-coding RNA 
transcribed from the 5’ of the HOXA locus, as a direct interactor of WDR5. In 
vivo, HOTTIP has been shown to coordinate the activation of several HOXA 
genes and its binding to WDR5 targets the MLL complex activity to all genes 
in the HOXA cluster (Wang et al., 2011).  
From my data, I did not detect any H3R2me2s in the HOX loci, supporting an 
alternative mechanism of WDR5 recruitment at these regions.  
WDR5 is also the first member of the Trithorax complex to be shown to 
interact directly with Oct4 and to be able to regulate self-renewal in mouse 
embryonic stem cells (Ang et al., 2011). The authors observed a strong 
correlation between WDR5 and Oct4 binding to chromatin on a genome-wide 
scale.  Moreover, they proved that WDR5 is required in the initial phase of 
somatic cell reprogramming to iPS cells. As such, they proposed a model by 
which Oct4 first binds to and promotes WDR5 expression in somatic cells. 
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Next, Oct4 interacts with WDR5 and confers DNA specificity to the 
WDR5/MLL complex, which re-establishes H3K4me3 on self-renewal genes 
such as Nanog or Pou5f1. This increase in H3K4 methylation efficiently 
recruits Oct4 to these promoters and robustly activating transcription of 
pluripotency-associated genes (Ang et al., 2011).  
These examples, together with my data, shed light on the different possible 
mechanisms by which the WDR5/MLL complex is recruited to various 
subsets of genes and the mechanism that is operative is dependent on the cell 
type and extracellular stimuli. 
 
 
5.3 WDR5 AS A METHYL-ARGININE “READER” 
WD-40 repeats (also known as WD repeats) are short 40-60 amino acid motifs 
that preferentially end with a Tryptophan and an Aspartic Acid (WD). They 
are highly conserved from bacteria to mammals and are often found as part of 
multi-subunit complexes, where they play a key role in mediating protein-
protein interactions. As highlighted by the crystal structures solved to date, 
WD40 domain proteins have several surfaces for the interaction with multiple 
binding partners and it is no surprise that they are crucial for maintaining the 
integrity of the complexes that they are part of. They serve as interaction hubs 
and are associated with a wide variety of physiological pathways such as 
vesicle biogenesis (Pryer et al., 1993), cytokinesis  (de Hostos et al., 1993), 
control of protein stability (Hatakeyama et al., 1999), RNA processing (Vagin 
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et al., 2009), control of replication (Chakraborty et al., 2011; Shen et al., 2010) 
and transcriptional regulation (Guccione et al., 2007b; Hoey et al., 1993; 
Mersman et al., 2012; Migliori et al., 2012). 
In terms of transcriptional regulation, proteins containing WD-domains, such 
as EED, LRWD1, WDR77, RbBP4/7 and the homologue drosophila 
NURF55, have been shown to mediate localization of chromatin modifiers to 
specific sites on the genome by directly binding histones and their methylated 
tails.  
From my data, WDR5 can also be considered part of this group, by its 
interaction with H3R2me2s. 
The crystal structure of the complex containing WDR5 and a symmetric 
dimethylated H3R2 peptide has helped me to gain mechanistic insights into 
the interaction between WDR5 and this newly identified mark. WDR5 is a 
seven-bladed "-propeller fold channel, where every blade is composed of 
four-stranded antiparallel "-sheet. The main difference between the structure 
of WDR5 bound to unmodified H3 (Couture et al., 2006) and to H3R2me2s is 
the re-organization of the water-mediated interaction network at the bottom of 
the beta-propeller pore in which the Arg-2 side chain is inserted. While the 
unmodified H3R2 side chain is hydrogen-bonded to two water molecules, 
mediating the interaction with the carbonyl group of Ser-175 and Ser-218, the 
dimethylated Arg-2 is H-bonded only to one water molecule, bridging to Ser-
175.  Superposition of the methylated and unmodified Arg-2 side chain shows 
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a marginal shift of the guanidinium group away from the water molecule in 
the direction of a hydrophobic pocket contributed by Phe-219.  
Phe-219 is thus a critical determinant of the high affinity interaction between 
WDR5 and H3R2me2s. Following this line of reasoning, mutating Phe-219 
into a more hydrophilic residue (WDR5F219H) reduces the binding affinity 
between H3R2me2s and WDR5, without severely affecting WDR5 binding to 
the unmodified H3 (Fig.26). As previously discussed in the introduction 
(Chapter 1.3.6.1), few proteins have been shown to interact specifically with 
methylated arginines on histones. Additionally, to my knowledge, this is the 
first time where opposite symmetries of methylation of the same arginine side 
chain have been reported to play opposite roles in either excluding or 
recruiting a single protein to chromatin. This is even more interesting 
considering that the protein in question is WDR5, a common core subunit of 
the MLL complex, which is essential for MLL complex recruitment, assembly 
and activity. Lysine 4 of histone H3, the main target of this methyltransferase, 
is located next to R2. This emphasizes the importance of the regulation of 
WDR5 binding to histone H3, since this ultimately results in regulation of 
transcription. I have been able to demonstrate that H3R2me2s promotes H3K4 
methylation by the MLL complex, whereas H3R2me2a, which excludes the 
binding of WDR5, prevents H3K4 methylation (Fig.22). 
The interplay between WDR5, H3 (either unmodified or symmetrically 
dimethylated on R2) and the other components of the SET complexes, is 
reminiscent of another important WD40 domain protein: EED. EED, together 
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with EZH2 and SUZ12, form the PCR2 complex, a transcriptional co-
repressor complex whose activity depends on its ability to trimethylate 
H3K27. While EZH2 is the catalytic subunit of the PRC2 complex, EED binds 
directly to H3K27me3 through its C-terminal domain, leading to the allosteric 
activation of the methyltransferase activity of PRC2 and, as such, to the 
propagation of the repressive mark (Margueron et al., 2009). Similarly, 
H3R2me2s may favor H3K4 methylation by its interaction with WDR5. This 
interaction displaces the win motif from WDR5 binding cleft and could cause 
an allosteric change in the complex, leading to its activation, or favoring its 
processivity. WDR5, and MLL itself, might in fact become available to 
interact with different proteins on chromatin, due to the binding of H3R2me2s 
to the pocket where the win motif of MLL was binding before, inducing an 
overall conformational change. 
Margueron and colleagues were able to co-crystalize EED in complex with 
H3K27me3, through one of its hydrophobic/aromatic cavity formed mainly by 
3 residues: F97, Y148 and Y365. EED is characterized by two different 
binding sites, one on either end. The peculiarity of this cage is that it is able to 
prevent the binding of large or charged amino acids, specifically at position -2, 
that typically flank activation marks. This is probably the reason why EED 
binds to H3K27me3 and H3K9me3 (ARKS) and not to H3K4me3 (RTKQ). 
While the function of EED in vivo has only been linked to H3K27me3, in 
vitro studies have shown that it binds to most of the repressive marks, such as 
H3K9me3 or H4K20me3, and this binding decreased with the degree of 
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methylation (for example, H3K27me3>me2>me1). This poor specificity 
observed in vitro could be explained by interactions that occur only on the 
surface between EED and the histone marks, and not inside the pocket of the 
"-propeller. However, in the case of WDR5, the binding occurs deep inside 
the central cavity, where the presence of two phenylalanines favor the 
formation of a specific hydrophobic interactions with H3R2me2s. Conversely, 
both the mono-methylation and the asymmetric dimethylation of arginine 2 of 
histone H3 disrupts this binding. As such, the interaction between WDR5 and 
H3R2me2s appears to be extremely specific. In sharp contrast with EED can 
bind to several different methylated residues on histone H3 in vitro, WDR5 
has not been observed to interact with any other symmetric dimethylated 
arginines on histones. 
Besides EED, the PRC2 complex contains a second WD40 protein, NURF55 
in drosophila and RBBP4/7 in human. This 7-blade beta-propeller was 
originally identified as an interacting partner of the retinoblastoma protein 
(Huang et al., 1991). Subsequently, it was co-purified with the HAT1 
acetyltransferase complex (Parthun et al., 1996) and several corepressor 
complexes, including PRC2 (Muller et al., 2002), NuRD (Le Guezennec et al., 
2006) and CAF1 (Tyler et al., 1996). NURF55 has been described to bind both 
H3 and H4 (Verreault et al., 1996) (Beisel et al., 2002), but it was not until 
recently that a series of papers unraveled the complex crosstalk among histone 
modifications on their tails that modulate the binding of this multifunctional 
chromatin reader. 
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The crystal structure of NURF55 bound to histone H4 revealed that the 
binding occurs with the first helix of the histone fold, a region normally buried 
in the nucleosome structure (Song and Kingston, 2008). Consistently, 
mutations that disrupted such interactions resulted specifically in the loss of 
HAT1 acetyltransferase activity, which is directed towards newly synthetized 
and non-nucleosomal H4. Unlike the binding between WDR5 and histone H3, 
which occurs deep in the central cavity of the WD40 propeller, NURF55 
interacts with H4 on the side surface of the protein. The two sides of the 
surface are hydrophobic on one side, and negatively charged on the other, 
perfectly matching the H4-helix with alternating hydrophobic and positively-
charged amino acids. The resulting hydrogen bond network is extensive, and 
contributes to stable binding. This property is unique to the surface of this 
beta-propeller, and is absent from WDR5 and other members of the family. 
RBBP4/7 is also part of the NURF complex, and whether the interaction 
surface on H4 is made accessible during the remodeling process by the ISWI-
containing ATP-dependent chromatin-remodeling complex still remains to be 
addressed. A more recent publication reconciled the binding data and the 
activity of NURF55 containing complexes directly on chromatin, by solving 
the crystal structure of NURF55 bound to H3 (Schmitges et al., 2011). The 
authors showed that in the context of the PRC2 complex, NURF55 is able to 
bind to both Su(z)12, which binds to the same binding pocket as the H4 
peptide, and to H3, which binds instead to the top-flat surface of the beta-
propeller. Unlike WDR5, the arginine at position 2 does not interact with 
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residues in the central cavity Nonetheless, H3R2, together with H3K4, are 
very important in recognizing NURF55. An important observation is that the 
methylation on H3K4 impairs NURF55/Su(z)12 binding (Nowak et al., 2011; 
Schmitges et al., 2011). More specifically, H3K4me3 methylation on 
nucleosomes reduces the catalytic turnover of PRC2, resulting in an overall 
reduction in H3K27 methylation. Interestingly, the authors show that despite 
an involvement of H3R2 in binding to the surface of NURF, the presence of 
the asymmetric dimethylation (H3R2me2a) of this residue does not impair 
binding (Schmitges et al., 2011). This is in line with more recent data showing 
that the opposite symmetricity (H3R2me2s) has instead a negative effect on 
this interaction (Migliori et al., 2012).  
As previously discussed, the cofactor WDR77, also called Mep50, is another 
WD40 protein, which associates with histones. WDR77 binds specifically to 
histone H2A, most likely favoring the specific methylation of H2AR3 by 
PRMT5 (Furuno et al., 2006). The exact surface of interaction and how 
WDR77 stimulates this methylation event is however, still unknown. Solving 
the crystal structure of PRMT5/WDR77 in combination with H2A will prove 
extremely interesting and enable further understanding of the role of this 
WD40 protein in aiding PRMT5 activity. 
Additionally, LRWD1, another WD40 repeat domain-containing protein, was 
recently identified in two large proteomic screens as interacting with 
repressive tri-methyl marks (H3K9me3, H3K27me3 an H4K20me3) and with 
the ORC complex (Bartke et al., 2011; Vermeulen et al., 2010). Further 
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studies have shown that ORC binding to chromatin, and specifically to 
heterochromatin, is stabilized by LRWD1 (Shen et al., 2010). The ability of 
LRWD1 to bind heterochromatin was thus described accurately by multiple 
groups, but none addressed if this interaction was direct. A more recent study 
proves that LRWD1 is recruited to pericentric heterochromatin by binding 
directly to H3K9me3. The localization of the WD40 protein is not altered in 
cells lacking H4K20me3 (Suv420h1h2-/-), while it is compromised in cells 
lacking H3K9me3 (Suv39h1h2-/-). Functionally this interaction helps to 
maintain heterochromatin silencing, as Lrwd1 knockdown results in failure to 
silence the major satellite repeats. However, the authors fail to mechanistically 
explain how the WD40 motifs simultaneously interact with H3K9me3, ORC 
and possibly other co-repressors to stabilize heterochromatin in cis (Chan and 
Zhang, 2012). This will be an interesting question to address with both 
biochemical and structural biology studies. 
 
 
5.4 PRMT5/WDR77 AND PRMT7 METHYLATE H3R2me2s 
Finally, I have presented evidence that PRMT7 and PRMT5/WDR77 can 
symmetrically dimethylate histone H3 arginine 2 both in vitro (methylation 
assays) and in vivo (in bulk reduction of H3R2me2s upon knock down of 
PRMT5 and PRMT7, alone and in combination). 
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One aspect that is still unclear is how these two enzymes are regulated in order 
to direct methylation of H3R2, as compared to their other histone targets, such 
as H2A/H4R3 and H3R8.  
As previously discussed in chapter 5.1, PRMT5 and PRMT7 do not have any 
DNA binding motif so their recruitment has to be mediated by transcription 
factors or cofactors that specifically target their activity to arginines on 
specific subset of genes. 
For example, COPR5 (cooperator of Prmt5), binds specifically to PRMT5 
over the other PRMTs. This cofactor strongly binds to histone H4, directing 
the activity of PRMT5 to H4 arginine 3, as opposed to other PRMT5 targets, 
such as H3R8me2s. In addition, COPR5 also directs the substrate specificity 
of the PRMT5-containing complexes to particular subsets of genes (Lacroix et 
al., 2008a). 
A recent paper linked COPR5, PRMT5 and the transcription factor RUNX1 
(Runt-related transcription factor 1) - CBF" (core binding factor -") complex 
(Paul et al., 2011) in the context of myogenic differentiation. It was previously 
known that PRMT5 played a role in the activation of the MYOG promoter 
during MYOD-induced muscle differentiation (Dacwag et al., 2007). Sardet 
and Fabbrizio showed that downregulation of COPR5 interferes with 
myogenic differentiation, as PRMT5, because the cells were not able to exit 
the cell cycle in the absence of the cofactor. They also observed a significant 
decrease in p21 and p27, cell cycle regulators involved in the control of the 
permanent G1 arrest (which is required for differentiation). They also 
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observed, decreased expression of the main myogenic inducer, MYOG, 
suggesting that only a subset of genes was regulated by COPR5. Moreover, 
COPR5 levels increased during muscle differentiation, supporting the 
hypothesis of COPR5 playing a role in this process. In addition, by ChIP, they 
found an enrichment of COPR5, PRMT5 and H4R3me2s on the promoters of 
these genes. As RUNX1 interacts with COPR5, and is known to regulate p21 
and MYOG, it may hence target PRMT5 to these particular loci. This work is 
additional evidence supporting the role of cofactors and adaptors in the 
targeting of PRMTs. 
In a similar manner, the transcription factor NF-Y could possibly target 
PRMT5 and PRMT7 to chromatin, thus directing H3R2me2s. In my studies, I 
observed a significant correlation between the presence of the H3R2me2s and 
the binding of NF-Y, as previously discussed. Further work will be however 
required to assess whether PRMT5 or PRMT7 are directly interacting with 
NF-Y or if they require an adaptor, such as COPR5.  
In my studies, I tested the role of WDR77, a known cofactor of PRMT5, but 
not that of COPR5 in H3R2me2s deposition. It would be interesting to follow 
this up in the future and validate whether is specifically the knockdown of 
WDR77, or also COPR5, that causes a bulk reduction of H3R2me2s. 
WDR77 is able to bind histone H2A, directing PRMT5 activity (Furuno et al., 
2006) and further work to understand whether it is able to direct PRMT5 to 
H3 too to methylate R2 is required. 
 ! "$$!
Another mechanism of symmetric histone arginine regulation could be related 
to the shuttling of PRMT5 and PRMT7 from the cytoplasm to the nucleus and 
vice versa. 
While PRMT6 has a clear nuclear localization signal (NLS), these enzymes 
have been described to be mostly cytoplasmic even if localization can be cell 
type specific and can also dynamically change upon different stimuli or during 
the cell cycle (Herrmann et al., 2009). For example in some cancer cell lines, 
such as HST746 (as reported in chapter 4.10), PRMT5 is nuclear, even if the 
specific signal that is deregulated in these cells is not clear. In a study recently 
published by Teng and colleagues, the treatment of human pancreatic cells 
with AS1411, a drug currently under clinical trials, caused the re-localization 
of PRMT5 to the cytoplasm and as consequence, the de-repression of a subset 
of PRMT5 target genes (Teng et al., 2007). Specifically, AS1411 functions as 
a nucleolin-binding aptamer with a strong growth-inhibitory effect on highly 
proliferative cells, such as cancer cells, but minimal consequences on 
quiescent or non-malignant cells (Girvan et al., 2006).  
To address the mechanisms behind the antiproliferative activity of AS1411, 
Teng and colleagues focused their attention on nucleolin-containing 
complexes that could be altered in AS1411-treated cancer cells, and at the 
biological consequences of these changes. They identified PRMT5 as a novel 
interactor of nucleolin and showed that AS1411 shuttles PRMT5, from the 
nucleus to the cytoplasm, thus altering PRMT5 activity. No changes were 
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observed when cells were pre-treated with nucleolin specific siRNA. 
Moreover, nucleolin itself was shown to be a target of PRMT5 methylation. 
The change of localization of PRMT5 to the cytoplasm, after treatment with 
AS1411, caused transcriptional de-repression of the tumor suppressor gene 
ST7 and cell cycle regulator cyclin E2 gene. As a result, the authors observed 
a significant increase in the proportion of cells in S phase, and a decrease the 
proportion of cells in G2-M phase (Teng et al., 2007). 
These findings not only shed light on the precise mechanism by which 
AS1411 exerts its anti-proliferative activity, but they are also an example of 
PRMT5 activity can be altered depending on its sub-cellular localization. 
Based on this work, the shuttling could be dependent on the interaction with 
specific proteins, which possess a nuclear localization/export signal. 
Additionally, the regulation of such interactions could depend on the activity 
of PRMT5 and PRMT7 themselves. Understanding which signaling cues 
control H3R2me2s deposition is essential to better investigate its biological 
function. I tried to predict some of these possible stimuli based on the GO 
analysis of the target genes of H3R2me2s. However, since the mark is 
predominantly present at promoters of transcription factors and chromatin 
remodelers, most of the likely changes in H3R2me2s levels are associated 
with widespread chromatin remodeling events. 
To address which genes may cause the nuclear/cytoplasmic shuttling of 
PRMT5 and PRMT7 and/or an increase/decrease of H3R2me2s levels, a 
genome-wide siRNA screen could be performed, and the sub-cellular 
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localization of fluorescently-labeled PRMT5 and PRMT7 monitored. As the 
regulation of H3R2me2s is highly cell type specific, choosing the right system 
will be of extreme importance. 
Another important feature of PRMTs is their ability to methylate histones in 
the nucleus, as well as in the cytoplasm. In particular, PRMT5, together with 
WDR77, has been described to symmetrically dimethyate R3 of cytosolic 
H2A and thus to repress differentiation genes in embryonic stem cells (Tee et 
al., 2010).  
The cofactor WDR77, also called Mep50, had previously been shown to direct 
PRMT5 activity on non-nucleosomal H2A, but not H4 (Furuno et al., 2006). 
As with PRMT5 localization, Mep50 is also mainly cytoplasmic in ES cells 
and its level of expression significantly decreases during differentiation, 
reinforcing its role in maintaining ES pluripotency via PRMT5/Mep50-
mediated H2AR3me2 symmetric dimethylation. 
A further experiment to better understand the mechanism of deposition of 
H3R2me2s would be to check the presence of the mark in the cytoplasm, since 
I observed a similar decrease of H3R2me2s upon PRMT5 or PRMT7 and 
WDR77 knock down.  
WDR77, on the other hand, is not only present in the cytoplasm but can also 
be in complex with PRMT5 in the nuclear fraction too, as discussed in chapter 
4.9. The exact subcellular compartment in which of H3R2 gets symmetrically 
dimethylated thus still remains to be assessed. 
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To conclude, additional experiments are required to better characterize the 
specific interactors of PRMT5 and PRMT7, the mechanisms by which they 
are shuttled between the nucleus and the cytoplasm, as well as the signaling 
cascades that control H3R2me2s deposition.  
 
To conclude, Histone H3-Arginine 2 has emerged as a key amino acid residue, 
mediating protein-protein interaction between histones and various chromatin 
regulators.  I have identified the symmetric dimethylation of this residue 
(H3R2me2s), which occurs at specific sites in the genome correlating with 
euchromatic regions. I have also shown that this modification plays a very 
different role in comparison to asymmetric dimethylation (H3R2me2a), 
revealing that subtle steric changes at this site can dictate dramatically 
different molecular and functional consequences for transcriptional regulation. 
I propose that this newly described positive crosstalk between H3R2me2s, 
H3K4 methylation and H3/H4 acetylation acts to preserve the euchromatic 
context at promoters or distal regulatory sites that need to be poised for 
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chr17 43328351 43328551 200 66 13.69 NM_003110 
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chr10 126376551 126376751 200 25 6.48 NM_014661 
chr22 41846551 41846751 200 25 25.92 NM_001197 
chr11 47371751 47371951 200 25 8.64 NM_152264 
chr12 50721651 50721851 200 24 6.22 NM_173157 
chr7 75382251 75382451 200 24 12.44 NM_000941 
chr5 142094451 142094651 200 24 6.22 NM_015071 
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chr14 99202851 99203051 200 24 6.22 NM_006668 
chr14 102436651 102436851 200 24 12.44 NM_030943 
chr15 23608051 23608251 200 24 8.29 NM_024490 
chr15 38177251 38177451 200 24 6.22 NM_001003943 
chr15 72871651 72871851 200 24 8.29 NM_001127190 
chr15 97835551 97835851 300 24 24.88 NM_001130926 
chr9 94542851 94543051 200 24 12.44 NM_015250 
chr9 94921951 94922151 200 24 6.22 NM_004148 
chr17 159251 159451 200 24 8.29 NM_001190413 
chr17 17510251 17510451 200 24 8.29 NM_030665 
chr6 37126251 37126451 200 24 8.29 NM_173558 
chr19 47592951 47593151 200 24 12.44 NM_032488 
chr6 52279951 52280251 300 24 12.44 NM_002388 
chr2 96887351 96887651 300 24 12.44 NM_016466 
chr1 23107151 23107351 200 24 6.22 NR_036214 
chr1 25219151 25219351 200 24 6.22 NM_001031680 
chr2 238089351 238089551 200 24 12.44 NM_024101 
chr1 46370951 46371151 200 24 24.88 NM_003629 
chr1 151804751 151804951 200 24 6.22 NM_005978 
chr21 18113651 18113851 200 24 24.88 NM_017447 
chr22 21602351 21602551 200 24 24.88 NM_001178126 
chr22 21602851 21603051 200 24 6.22 NM_001178126 
chr10 112610551 112610751 200 24 8.29 NR_026932 
chr10 133424851 133425051 200 24 6.22 - 
chr10 134086851 134087051 200 24 12.44 NM_173541 
chr3 13101051 13101251 200 24 24.88 NM_001134382 
chr20 60611051 60611251 200 24 24.88 NR_029676 
chr11 57071651 57071851 200 24 8.29 NM_001105565 
chr3 142998751 142998951 200 23 5.96 NM_139209 
chr4 37832951 37833151 200 23 5.96 - 
chr21 42248251 42248551 300 23 7.95 NM_015500 
chr12 6928551 6928851 300 23 11.92 NM_002831 
chr5 32348951 32349151 200 23 11.92 NM_001040446 
chr12 51759451 51759651 200 23 7.95 NM_032840 
chr12 110697351 110697651 300 23 23.85 NM_000690 
chr7 44854351 44854551 200 23 7.95 NM_012412 
chr14 74475651 74475851 200 23 7.95 NM_002632 
chr8 18986151 18986351 200 23 7.95 NM_015310 
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chr15 19931551 19931751 200 23 5.96 NR_028067 
chr9 127043551 127043751 200 23 11.92 NM_005347 
chr8 134107851 134108051 200 23 5.96 NM_006748 
chr8 144560351 144560551 200 23 5.96 NM_201589 
chr9 91259751 91259951 200 23 5.96 NM_006378 
chr16 3063751 3063951 200 23 23.85 NM_001012636 
chr16 11674551 11674751 200 23 7.95 NM_003498 
chr16 84163451 84163651 200 23 7.95 NM_001134473 
chr9 130980351 130980551 200 23 7.95 NM_203434 
chr9 133396651 133396851 200 23 5.96 NM_001135954 
chr17 21154951 21155151 200 23 11.92 NM_002756 
chr17 24092051 24092251 200 23 11.92 NM_004295 
chr9 135834951 135835151 200 23 7.95 NM_001134398 
chr9 136438351 136438551 200 23 5.96 NM_002957 
chr9 136439251 136439451 200 23 5.96 NM_002957 
chr17 35121751 35121951 200 23 7.95 NM_004448 
chr17 35361951 35362151 200 23 7.95 NM_178171 
chr9 138863451 138863651 200 23 7.95 NM_001135861 
chr17 53950251 53950451 200 23 11.92 NM_004687 
chr17 76827451 76827651 200 23 5.96 NM_144679 
chr18 10468251 10468551 300 23 5.96 NM_153000 
chr18 44600851 44601051 200 23 5.96 - 
chr9 4782651 4782851 200 23 7.95 NM_005772 
chr19 9806851 9807051 200 23 23.85 NM_006221 
chr9 138271251 138271451 200 23 5.96 NM_181701 
chr22 21028751 21028951 200 23 7.95 NR_027293 
chr19 33774951 33775151 200 23 11.92 - 
chr19 43187751 43187951 200 23 7.95 NM_015073 
chr9 138139051 138139351 300 23 5.96 NM_152833 
chr19 47312551 47312751 200 23 5.96 NM_002698 
chr2 25453651 25453851 200 23 7.95 NM_175630 
chr2 26422251 26422451 200 23 7.95 NM_033505 
chr2 43250251 43250551 300 23 5.96 NM_006887 
chr1 4383051 4383251 200 23 7.95 NR_027088 
chr2 96192551 96192751 200 23 7.95 NM_004418 
chr2 128115351 128115551 200 23 11.92 NM_001161416 
chr9 138547851 138548051 200 23 7.95 NM_017617 
chr20 35866851 35867151 300 23 5.96 NM_080607 
chr21 42691051 42691251 200 23 5.96 NM_032405 
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chr11 44920551 44920751 200 23 5.96 NM_006034 
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chr11 66802751 66802951 200 22 22.81 NM_207354 
chr3 196178151 196178351 200 22 5.7 - 
chr11 67790151 67790351 200 22 5.7 NM_022338 
chr4 1683951 1684151 200 22 7.6 NM_006527 
chr4 7015951 7016251 300 22 5.7 NM_001113363 
chr11 124967851 124968051 200 22 5.7 NM_152713 
chr12 1821651 1821851 200 22 5.7 NM_001163926 
chr3 128965051 128965251 200 22 11.41 NM_007283 
chr12 48343651 48343851 200 22 5.7 NM_001031698 
chr3 134693051 134693251 200 22 5.7 NM_001134422 
chr12 122136351 122136551 200 22 7.6 NM_020845 
chr6 33390851 33391051 200 22 22.81 NM_003190 
chr12 131519951 131520151 200 22 5.7 NM_001142641 
chr9 123069851 123070051 200 22 5.7 NM_001127662 
chr14 67805751 67805951 200 22 11.41 - 
chr7 77265851 77266051 200 22 7.6 NM_001127358 
chr7 150270651 150270851 200 22 5.7 NM_172057 
chr14 99172251 99172451 200 22 22.81 NM_032425 
chr14 102311951 102312251 300 22 7.6 NM_145726 
chr14 104219051 104219251 200 22 7.6 NM_001031714 
chr8 30068651 30068851 200 22 7.6 NM_015344 
chr15 29379851 29380051 200 22 22.81 NM_015995 
chr9 99907751 99907951 200 22 7.6 NM_014788 
chr8 145567651 145567851 200 22 5.7 NM_174922 
chr15 79391751 79391951 200 22 7.6 NM_181900 
chr9 73599451 73599751 300 22 5.7 NM_001135820 
chr15 88403451 88403651 200 22 7.6 NM_002168 
chr9 91207551 91207751 200 22 7.6 NM_006378 
chr9 91246151 91246351 200 22 5.7 NM_006378 
chr9 100860451 100860651 200 22 7.6 NM_004612 
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chr16 66973651 66973851 200 22 5.7 NM_018667 
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chr17 59053251 59053451 200 22 22.81 NM_203351 
chr17 68799651 68799851 200 22 5.7 NM_012121 
chr17 72037351 72037551 200 22 5.7 NR_033357 
chr18 72902851 72903051 200 22 7.6 NM_001025092 
chr18 75322151 75322351 200 22 5.7 NM_172389 
chr19 2239451 2239651 200 22 7.6 NM_198532 
chr19 13767051 13767251 200 22 5.7 NM_023072 
chr19 16344951 16345151 200 22 5.7 NM_016270 
chr19 17831551 17831751 200 22 11.41 NR_001593 
chr19 48836151 48836451 300 22 22.81 NM_145296 
chr19 50311651 50311851 200 22 22.81 NM_001007269 
chr19 55612251 55612451 200 22 11.41 NM_003121 
chr19 63758651 63758851 200 22 5.7 NM_014453 
chr2 20641851 20642051 200 22 11.41 NM_022460 
chr1 999851 1000051 200 22 5.7 NM_017891 
chr2 86098751 86098951 200 22 5.7 NR_026984 
chr2 128106951 128107151 200 22 5.7 NM_001161416 
chr1 22014251 22014451 200 22 5.7 NM_001013693 
chr1 24894851 24895051 200 22 11.41 NM_013943 
chr20 24971251 24971451 200 22 11.41 NM_032501 
chr9 91238051 91238251 200 22 5.7 NM_006378 
chr1 153256751 153256951 200 22 5.7 NM_015872 
chr1 154334151 154334351 200 22 7.6 NM_001093725 
chr1 179377351 179377551 200 22 5.7 NM_016545 
chr21 33679351 33679651 300 22 7.6 NM_005534 
chr1 201558951 201559151 200 22 5.7 NM_006763 
chr9 139325051 139325251 200 22 5.7 NM_001004354 
chr1 224977251 224977451 200 22 11.41 NM_002221 
chr21 42529351 42529551 200 22 7.6 NM_207174 
chr1 233078451 233078651 200 22 22.81 - 
chr1 234163451 234163651 200 22 5.7 NM_000081 
chr10 12324151 12324351 200 22 5.7 NM_014142 
chr22 18615051 18615251 200 22 22.81 NR_031618 
chr10 63538751 63538951 200 22 5.7 - 
chr10 70881151 70881351 200 22 22.81 NM_012339 
chr22 20850051 20850251 200 22 7.6 NM_007128 
chr22 21613651 21613851 200 22 22.81 NM_001178126 
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chr22 21825551 21825751 200 22 5.7 NM_004914 
chr10 82251351 82251551 200 22 5.7 NM_207372 
chr9 122726951 122727151 200 22 5.7 NM_005658 
chr10 135117151 135117351 200 22 7.6 NR_002934 
chr11 47372451 47372651 200 22 7.6 NM_152264 
chr3 130777551 130777751 200 21 5.44 NM_015103 
chr11 72210751 72210951 200 21 21.77 NM_033388 
chr11 73399351 73399651 300 21 7.26 NM_022803 
chr11 117306951 117307151 200 21 7.26 NM_001077263 
chr11 118753451 118753651 200 21 21.77 NM_004205 
chr5 1188451 1188651 200 21 21.77 NM_006598 
chr12 6675851 6676051 200 21 5.44 NM_153685 
chr12 47494751 47494951 200 21 5.44 NM_000725 
chr3 130780551 130780751 200 21 10.89 NM_015103 
chr5 176716851 176717051 200 21 7.26 NM_006480 
chr12 119151151 119151351 200 21 7.26 NM_025157 
chr13 31371051 31371251 200 21 10.89 NR_027062 
chr13 113149951 113150251 300 21 5.44 NM_199162 
chr14 68890551 68890751 200 21 5.44 NM_004450 
chr14 103251651 103251851 200 21 10.89 NM_024071 
chr14 104193451 104193651 200 21 5.44 NM_001031714 
chr22 18396251 18396451 200 21 21.77 NR_029706 
chr14 105018551 105018851 300 21 5.44 NM_001311 
chr8 41691551 41691851 300 21 10.89 NM_020478 
chr15 63416951 63417151 200 21 5.44 NM_004884 
chr9 6879451 6879651 200 21 21.77 - 
chr9 19398351 19398551 200 21 10.89 NM_001010887 
chr9 70926451 70926651 200 21 7.26 NM_001170414 
chr9 78378751 78378951 200 21 5.44 NM_001097636 
chr9 86475351 86475551 200 21 5.44 NM_001007097 
chr9 92643351 92643551 200 21 10.89 NM_001174167 
chr16 2887651 2887851 200 21 10.89 NM_020912 
chr9 94915951 94916151 200 21 5.44 NM_032310 
chr9 95069851 95070051 200 21 10.89 NM_001098808 
chr9 98287451 98287651 200 21 10.89 NM_014282 
chr2 64993651 64993851 200 21 7.26 NR_036586 
chr9 106866651 106866851 200 21 7.26 - 
chr9 111721951 111722251 300 21 10.89 - 
chr9 112754851 112755051 200 21 7.26 NM_057159 
chr9 115326151 115326551 400 21 21.77 NM_130795 
chr9 122695451 122695651 200 21 5.44 NM_015651 
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chr9 123548851 123549051 200 21 5.44 NM_138709 
chr16 83647351 83647651 300 21 10.89 NM_014732 
chr9 128272551 128272751 200 21 7.26 - 
chr9 128925151 128925351 200 21 5.44 NM_012098 
chr9 128970451 128970651 200 21 7.26 NM_012098 
chr9 130705251 130705451 200 21 7.26 NM_174933 
chr16 87952051 87952251 200 21 21.77 - 
chr9 129388251 129388451 200 21 10.89 NM_001035534 
chr17 9870551 9870751 200 21 5.44 NM_001130831 
chr9 131641651 131641851 200 21 7.26 NM_001008563 
chr9 133104151 133104351 200 21 10.89 NM_033387 
chr9 134977851 134978051 200 21 5.44 NM_006266 
chr9 135392451 135392651 200 21 5.44 NM_014694 
chr2 98444551 98444851 300 21 21.77 NM_004027 
chr9 135758151 135758351 200 21 7.26 NM_001134398 
chr9 135812551 135812751 200 21 21.77 NM_001134398 
chr17 35082251 35082451 200 21 5.44 NM_002686 
chr9 138535651 138535851 200 21 7.26 NM_017617 
chr9 138777651 138777851 200 21 7.26 NM_203347 
chr9 138779251 138779451 200 21 5.44 NM_203347 
chr9 138989051 138989451 400 21 10.89 NM_000954 
chr17 40844251 40844451 200 21 21.77 NM_001159330 
chr9 139295751 139295951 200 21 10.89 NM_017723 
chr17 44820251 44820451 200 21 10.89 NM_014897 
chr17 59885251 59885551 300 21 7.26 NM_001085423 
chr2 128051151 128051351 200 21 10.89 NM_001080527 
chr17 77908651 77908851 200 21 7.26 NM_207459 
chr18 52896251 52896451 200 21 21.77 NR_033372 
chr9 135558151 135558351 200 21 7.26 NM_001134707 
chr19 1884451 1884651 200 21 7.26 NM_001319 
chr19 2114751 2114951 200 21 21.77 NM_032482 
chr19 4422951 4423151 200 21 10.89 NM_001001520 
chr19 16340451 16340651 200 21 5.44 NM_016270 
chr19 16344451 16344651 200 21 5.44 NM_016270 
chr19 16346851 16347051 200 21 5.44 NM_016270 
chr9 137920051 137920251 200 21 5.44 NM_015447 
chr19 47319751 47319951 200 21 5.44 NM_002698 
chr2 238205351 238205551 200 21 5.44 NM_001137550 
chr9 138273351 138273551 200 21 10.89 NM_181701 
chr5 176857751 176857951 200 21 10.89 NM_213636 
chr19 54872051 54872351 300 21 10.89 NM_198318 
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chr19 56567151 56567451 300 21 7.26 NM_005601 
chr19 60369751 60370051 300 21 5.44 NM_178837 
chr2 43211251 43211451 200 21 7.26 NM_006887 
chr1 11767651 11767851 200 21 5.44 NM_005957 
chr1 19514351 19514551 200 21 7.26 NM_001040126 
chr2 128108451 128108651 200 21 5.44 NM_001161416 
chr1 23833751 23833951 200 21 7.26 NR_027042 
chr1 24110751 24110951 200 21 7.26 NM_001841 
chr1 26489151 26489451 300 21 7.26 NM_031286 
chr2 219823451 219823651 200 21 5.44 NR_003063 
chr6 33668751 33668951 200 21 5.44 NR_027908 
chr20 2768651 2768851 200 21 7.26 NM_022760 
chr20 33658751 33658951 200 21 10.89 NR_024377 
chr1 111860151 111860351 200 21 21.77 NM_020683 
chr1 154341451 154341651 200 21 7.26 NM_170707 
chr20 55625551 55625851 300 21 5.44 NM_001160418 
chr1 158863151 158863351 200 21 5.44 NM_003037 
chr20 60246751 60246951 200 21 10.89 NM_144498 
chr20 61738851 61739051 200 21 7.26 NM_012384 
chr20 62168651 62168951 300 21 7.26 NM_003195 
chr21 42226851 42227051 200 21 5.44 NM_199050 
chr1 224102151 224102351 200 21 21.77 NM_000120 
chr3 39270251 39270451 200 21 7.26 NM_001337 
chr21 44048851 44049051 200 21 7.26 NR_026961 
chr10 51173451 51173651 200 21 21.77 NM_001077685 
chr2 128114751 128114951 200 21 21.77 NM_001161416 
chr10 73220851 73221051 200 21 5.44 NM_001171934 
chr10 76255951 76256151 200 21 5.44 NM_012330 
chr10 101770651 101770851 200 21 5.44 NM_015221 
chr10 112475751 112475951 200 21 21.77 NM_001134363 
chr10 121058351 121058551 200 21 10.89 - 
chr22 40805851 40806051 200 21 5.44 NM_033318 
chr22 41491151 41491351 200 21 21.77 NM_017436 
chr22 46873451 46873751 300 21 10.89 - 
chr11 260651 260851 200 21 5.44 NM_138329 
chr11 2503751 2503951 200 21 21.77 NM_181798 
chr3 42193051 42193251 200 21 7.26 NM_014965 
chr11 47373851 47374051 200 21 7.26 NM_152264 
chr11 60382451 60382651 200 21 10.89 NM_004778 
chr11 60596351 60596551 200 21 21.77 NM_014207 
chr3 53184051 53184251 200 21 5.44 NM_212539 
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chr11 64179751 64179951 200 20 20.74 NM_138734 
chr3 88190851 88191051 200 20 5.18 NM_001008390 
chr3 128939951 128940251 300 20 6.91 NR_033428 
chr3 130761851 130762051 200 20 5.18 NM_153833 
chr11 66797351 66797551 200 20 5.18 NM_001619 
chr11 66898651 66898851 200 20 6.91 NM_001166212 
chr11 67528451 67528651 200 20 10.37 NM_030930 
chr11 72566451 72566651 200 20 6.91 NM_014824 
chr4 1230051 1230251 200 20 6.91 NM_001328 
chr4 2233651 2233851 200 20 6.91 NM_006454 
chr11 118887351 118887651 300 20 5.18 NM_006288 
chr4 186584151 186584351 200 20 5.18 NM_018359 
chr12 6617651 6617851 200 20 20.74 NM_020400 
chr12 6674151 6674351 200 20 10.37 NM_001135734 
chr12 6939151 6939351 200 20 10.37 NR_029779 
chr12 13145751 13145951 200 20 5.18 NM_001080555 
chr5 66537751 66537951 200 20 10.37 NM_005582 
chr5 131464151 131464351 200 20 6.91 NM_000758 
chr12 50753651 50753851 200 20 5.18 NM_021934 
chr12 56158551 56158751 200 20 5.18 NM_001080156 
chr5 156844251 156844451 200 20 5.18 NM_001099287 
chr5 156861051 156861251 200 20 6.91 NM_001099287 
chr12 112155751 112155951 200 20 10.37 NM_017901 
chr6 31812651 31812951 300 20 10.37 NM_001288 
chr21 43647551 43647751 200 20 5.18 NM_173354 
chr13 98762051 98762251 200 20 5.18 NM_004951 
chr7 822651 822851 200 20 20.74 NM_001171945 
chr13 102480151 102480451 300 20 5.18 NM_000452 
chr7 2561551 2561751 200 20 6.91 NM_152743 
chr7 5539851 5540151 300 20 10.37 NM_001101 
chr7 43653851 43654051 200 20 20.74 NM_004760 
chr7 50223351 50223551 200 20 5.18 NM_006060 
chr14 68891851 68892051 200 20 6.91 NM_004450 
chr7 105492651 105492851 200 20 5.18 NM_182715 
chr14 93562351 93562551 200 20 20.74 NM_023112 
chr8 21825751 21825951 200 20 10.37 NM_003974 
chr14 104604851 104605051 200 20 5.18 NM_013345 
chr8 37802951 37803151 200 20 5.18 NM_018310 
chr22 18611751 18611951 200 20 6.91 NR_031618 
chr8 123883951 123884151 200 20 10.37 NM_014943 
chr15 38629351 38629551 200 20 6.91 NM_001080791 
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chr7 22871351 22871551 200 20 6.91 NR_003075 
chr8 144553951 144554151 200 20 20.74 NM_201589 
chr8 145703751 145703951 200 20 10.37 NM_138431 
chr9 15501051 15501251 200 20 10.37 NM_001128217 
chr15 72841851 72842051 200 20 6.91 NM_000761 
chr15 78057651 78057951 300 20 10.37 NM_004049 
chr15 81311751 81311951 200 20 5.18 NM_001080435 
chr15 86970551 86970751 200 20 5.18 NM_022767 
chr9 91178951 91179151 200 20 6.91 NM_024077 
chr9 129641351 129641551 200 20 6.91 NM_000118 
chr9 91253151 91253351 200 20 20.74 NM_006378 
chr9 92979751 92979951 200 20 6.91 - 
chr9 94893351 94893551 200 20 6.91 NM_032310 
chr16 10595951 10596151 200 20 6.91 NM_001424 
chr16 23954151 23954351 200 20 10.37 - 
chr9 111220351 111220551 200 20 6.91 NR_026918 
chr9 115324951 115325151 200 20 6.91 NM_130795 
chr16 65108651 65108851 200 20 6.91 NM_001172643 
chr9 116167951 116168151 200 20 20.74 NM_030767 
chr9 122671751 122671951 200 20 5.18 NM_015651 
chr16 66849251 66849451 200 20 6.91 NM_003983 
chr16 67082251 67082451 200 20 20.74 NM_018667 
chr9 123585851 123586151 300 20 6.91 NM_138709 
chr16 79598051 79598251 200 20 10.37 NM_020188 
chr9 123744951 123745151 200 20 5.18 NR_030382 
chr16 84325451 84325651 200 20 5.18 NR_031731 
chr16 86293251 86293551 300 20 5.18 NR_024488 
chr16 86662151 86662351 200 20 5.18 - 
chr22 21585851 21586051 200 20 6.91 NM_001178126 
chr16 87561251 87561451 200 20 6.91 NM_005187 
chr9 129000251 129000451 200 20 6.91 NM_032293 
chr17 1566351 1566551 200 20 10.37 NM_001163673 
chr17 1602751 1602951 200 20 10.37 NM_002615 
chr9 129732851 129733051 200 20 5.18 NM_001135219 
chr17 3760551 3760751 200 20 5.18 NM_002558 
chr9 126056751 126056951 200 20 5.18 NM_001166167 
chr17 9878751 9878951 200 20 5.18 NM_201432 
chr17 16261951 16262151 200 20 10.37 NM_016113 
chr9 133214851 133215051 200 20 5.18 NM_032728 
chr9 134275651 134275851 200 20 10.37 NM_207417 
chr9 135284851 135285051 200 20 6.91 NM_139027 
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chr17 24163651 24163851 200 20 6.91 NM_001077498 
chr9 135639951 135640151 200 20 5.18 NM_007101 
chr17 27636551 27636751 200 20 6.91 NM_138328 
chr9 131845951 131846151 200 20 6.91 NM_015033 
chr17 35038251 35038451 200 20 6.91 NM_181505 
chr17 35156551 35156751 200 20 5.18 NM_001030002 
chr9 138806051 138806251 200 20 6.91 NM_032928 
chr17 37517451 37517651 200 20 10.37 NM_024119 
chr9 132910751 132911051 300 20 5.18 NM_006059 
chr9 139475251 139475451 200 20 5.18 NM_015537 
chr17 45617151 45617351 200 20 6.91 NR_024192 
chrX 11722051 11722251 200 20 6.91 NM_006800 
chr17 55594251 55594451 200 20 10.37 NM_000717 
chr17 61856751 61856951 200 20 20.74 - 
chr17 72036851 72037051 200 20 20.74 NR_033357 
chr2 128051751 128051951 200 20 10.37 NM_001080527 
chr17 73746651 73746851 200 20 6.91 NM_001145529 
chr2 128107551 128107751 200 20 6.91 NM_001161416 
chr9 134635751 134635951 200 20 5.18 - 
chr17 77919051 77919251 200 20 5.18 NM_018949 
chr5 133295251 133295451 200 20 10.37 NM_020199 
chr17 78144651 78144851 200 20 20.74 NM_019613 
chr17 78413951 78414151 200 20 20.74 NM_024702 
chr9 139466751 139466951 200 20 5.18 NM_015537 
chr9 135296151 135296351 200 20 5.18 NM_001135775 
chr18 44772551 44772751 200 20 10.37 NM_001190821 
chr18 75667151 75667451 300 20 5.18 NM_012283 
chr18 75680451 75680651 200 20 10.37 NM_012283 
chr2 201918151 201918351 200 20 6.91 NM_139163 
chr19 3508651 3508851 200 20 5.18 NM_174983 
chr19 10064151 10064451 300 20 5.18 NM_018381 
chr9 34575851 34576051 200 20 5.18 NM_147164 
chr19 43162251 43162451 200 20 5.18 NM_015073 
chr19 51642951 51643251 300 20 6.91 NM_001103149 
chr2 24199651 24199851 200 20 6.91 NM_199346 
chr9 138551251 138551451 200 20 5.18 NM_017617 
chr2 29086851 29087051 200 20 6.91 NM_199280 
chr2 42834151 42834351 200 20 10.37 NM_148962 
chr2 47060451 47060651 200 20 10.37 NM_001171508 
chr2 47352751 47352951 200 20 5.18 NM_001743 
chr1 846851 847051 200 20 5.18 NR_026874 
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chr3 10374351 10374551 200 20 6.91 NR_024272 
chr1 2422551 2422751 200 20 10.37 NM_014638 
chr3 12775951 12776151 200 20 6.91 NM_018306 
chr1 9608451 9608651 200 20 5.18 NM_005026 
chr1 9806951 9807151 200 20 6.91 NM_014944 
chr1 10923151 10923351 200 20 10.37 NM_001170754 
chr2 109200651 109200851 200 20 5.18 NR_036223 
chr2 112749451 112749651 200 20 10.37 NM_198581 
chr1 20370351 20370651 300 20 10.37 NM_001105572 
chr9 138992251 138992451 200 20 20.74 NM_000954 
chr1 33592951 33593151 200 20 6.91 NM_004427 
chr20 17787551 17787751 200 20 6.91 - 
chr20 23569051 23569251 200 20 20.74 NM_000099 
chr20 25211151 25211451 300 20 6.91 NM_002862 
chr20 25246251 25246451 200 20 6.91 NM_002862 
chr1 148805751 148805951 200 20 10.37 NM_021960 
chr20 42763651 42763851 200 20 6.91 NM_003881 
chr1 153925251 153925451 200 20 6.91 NM_139118 
chr1 158725551 158725751 200 20 5.18 NM_001184716 
chr6 37039851 37040051 200 20 5.18 NM_153370 
chr1 179364251 179364451 200 20 20.74 NM_016545 
chr20 61832051 61832251 200 20 20.74 NM_017806 
chr21 42158051 42158251 200 20 10.37 NM_001040424 
chr1 224898851 224899051 200 20 20.74 NM_002221 
chr21 42757451 42757651 200 20 5.18 NM_080860 
chr22 18209951 18210251 300 20 6.91 NM_024627 
chr10 44782651 44782851 200 20 5.18 NM_032023 
chr20 43943051 43943251 200 20 10.37 NM_080603 
chr9 129684851 129685051 200 20 10.37 NM_000476 
chr10 82214851 82215051 200 20 10.37 NM_001128309 
chr22 35181851 35182051 200 20 5.18 NM_012473 
chr10 101370251 101370451 200 20 5.18 NM_031212 
chr22 35745451 35745651 200 20 5.18 NR_024038 
chr10 105445651 105445851 200 20 5.18 - 
chr22 38195451 38195751 300 20 6.91 NM_002409 
chr22 40660951 40661151 200 20 6.91 NM_001110215 
chr7 2518551 2518751 200 20 6.91 NM_001166355 
chr10 126378651 126378851 200 20 5.18 NM_014661 
chr22 42911051 42911251 200 20 5.18 NM_001137606 
chr10 134088751 134088951 200 20 10.37 NM_173541 
chr22 49314451 49314651 200 20 20.74 NM_001113756 
 ! "'*!
chr11 606651 606851 200 20 20.74 NM_004029 
chr11 2367151 2367351 200 20 6.91 NM_004356 
chr3 13349951 13350151 200 20 10.37 NM_024923 
chr11 44585051 44585251 200 20 10.37 NM_001024844 
chr3 46112851 46113151 300 20 10.37 NM_005283 
chr3 53188451 53188751 300 20 10.37 NM_212539 
chr11 60616251 60616451 200 20 10.37 NM_014207 
chr11 62137251 62137451 200 20 5.18 NM_153265 
chr11 64972651 64972851 200 19 6.57 NR_030343 
chr11 65077951 65078151 200 19 19.7 NM_001164266 
chr11 65805851 65806051 200 19 9.85 NM_182553 
chr3 171146551 171146751 200 19 6.57 NR_027622 
chr11 85633251 85633451 200 19 19.7 NM_003797 
chr11 94653351 94653551 200 19 6.57 NM_144665 
chr11 120840451 120840651 200 19 9.85 NM_003105 
chr12 6673851 6674051 200 19 19.7 NM_001135734 
chr5 10654451 10654651 200 19 19.7 NM_001164440 
chr5 14263051 14263251 200 19 6.57 NM_007118 
chr5 131567951 131568151 200 19 6.57 NM_001017973 
chr12 46562851 46563051 200 19 9.85 NM_000376 
chr5 134415251 134415451 200 19 6.57 NM_002653 
chr12 110357851 110358051 200 19 6.57 NM_005475 
chr12 110682251 110682451 200 19 6.57 NM_000690 
chr12 130032651 130032851 200 19 6.57 NM_198827 
chr12 131122551 131122751 200 19 6.57 NR_003290 
chr12 131520451 131520651 200 19 6.57 NM_001142641 
chr13 39599451 39599651 200 19 19.7 NR_033877 
chr13 50068451 50068751 300 19 6.57 - 
chr13 113831251 113831451 200 19 19.7 NM_007368 
chr14 49539051 49539251 200 19 19.7 NM_001012706 
chr9 123700651 123700951 300 19 6.57 NR_030382 
chr7 44064351 44064551 200 19 9.85 NM_000290 
chr14 68087651 68087951 300 19 19.7 - 
chr7 50276051 50276351 300 19 9.85 NM_006060 
chr7 68794351 68794551 200 19 9.85 NM_015570 
chr7 99656451 99656651 200 19 9.85 NM_024070 
chr14 92582051 92582251 200 19 19.7 NR_002808 
chr8 8597951 8598251 300 19 6.57 NM_194284 
chr8 27862951 27863151 200 19 6.57 NM_173833 
chr8 37336551 37336751 200 19 19.7 - 
chr15 29352151 29352351 200 19 19.7 NM_015995 
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chr8 96313051 96313251 200 19 9.85 NM_177965 
chr15 39592151 39592451 300 19 6.57 NM_001135685 
chr15 41595851 41596051 200 19 6.57 NM_002373 
chr15 56539151 56539351 200 19 19.7 NM_000236 
chr15 65882251 65882451 200 19 9.85 NM_001031807 
chr15 68069451 68069651 200 19 19.7 NR_030714 
chr15 72398351 72398551 200 19 9.85 NM_182791 
chr15 72479051 72479251 200 19 6.57 NM_000781 
chr15 73127051 73127251 200 19 6.57 NM_021823 
chr15 88941251 88941451 200 19 9.85 NM_001042574 
chr8 25371851 25372051 200 19 6.57 NM_017634 
chr16 2998451 2998751 300 19 19.7 NM_020982 
chr9 94857151 94857451 300 19 9.85 NM_145006 
chr9 95046651 95046851 200 19 9.85 NM_006648 
chr9 95091251 95091451 200 19 6.57 NM_001098808 
chr16 11184251 11184451 200 19 9.85 NM_003745 
chr16 15637351 15637551 200 19 9.85 NM_001184998 
chr16 29730251 29730451 200 19 6.57 NM_145239 
chr16 56122251 56122551 300 19 9.85 NM_033212 
chr16 65833851 65834051 200 19 19.7 NM_013241 
chr16 66140551 66140751 200 19 9.85 NM_001193524 
chr16 66876951 66877151 200 19 9.85 NM_003983 
chr16 80071851 80072051 200 19 9.85 NM_030629 
chr9 123788351 123788551 200 19 6.57 NR_030382 
chr9 126025751 126025951 200 19 6.57 NM_001166167 
chr5 597851 598051 200 19 6.57 NM_004174 
chr17 1495151 1495351 200 19 6.57 NM_145352 
chr9 130704051 130704251 200 19 9.85 NM_174933 
chr17 19214151 19214351 200 19 9.85 NM_139032 
chr17 22894351 22894551 200 19 6.57 NM_014238 
chr17 26859451 26859651 200 19 6.57 NR_029710 
chr17 35507651 35507851 200 19 6.57 NM_021724 
chr17 35601051 35601251 200 19 6.57 NM_016339 
chr17 39603751 39604051 300 19 19.7 NM_080863 
chr9 139035751 139035951 200 19 6.57 NM_207511 
chr22 35955151 35955351 200 19 6.57 NM_002872 
chr17 43403251 43403451 200 19 6.57 NM_176096 
chr17 44648851 44649051 200 19 6.57 NM_001135186 
chr17 44650151 44650351 200 19 6.57 NM_001135186 
chr17 52517651 52517951 300 19 9.85 NM_003488 
chrX 152644451 152644651 200 19 19.7 NM_000033 
 ! "("!
chr17 58974851 58975051 200 19 19.7 NM_005828 
chr17 70349451 70349651 200 19 19.7 NM_000835 
chr17 70662251 70662451 200 19 9.85 NM_001002032 
chr17 76326551 76326751 200 19 9.85 - 
chr18 19247351 19247551 200 19 6.57 NM_032933 
chr18 19802651 19802851 200 19 19.7 NM_153211 
chr18 44564151 44564351 200 19 9.85 - 
chr19 1211951 1212151 200 19 6.57 NM_001280 
chr19 1215551 1215751 200 19 19.7 NM_001280 
chr9 139468751 139468951 200 19 6.57 NM_015537 
chr19 4293751 4293951 200 19 6.57 NM_032868 
chr19 4767051 4767251 200 19 6.57 NM_182919 
chr19 5080951 5081151 200 19 19.7 - 
chr19 6690051 6690351 300 19 6.57 NM_004240 
chr9 27357551 27357751 200 19 6.57 NM_020641 
chr19 8384051 8384251 200 19 9.85 NM_016496 
chr19 13959251 13959651 400 19 9.85 NM_002918 
chr19 16860851 16861151 300 19 6.57 NM_003950 
chr19 17047251 17047451 200 19 6.57 NM_033417 
chr19 17281151 17281451 300 19 9.85 NM_024050 
chr19 38556251 38556451 200 19 19.7 NM_001806 
chr19 40501651 40501951 300 19 6.57 NM_001185101 
chr19 45701551 45701751 200 19 9.85 NM_025213 
chr19 47193051 47193251 200 19 6.57 NM_152296 
chr19 49946351 49946551 200 19 19.7 NM_005178 
chr19 50601451 50601651 200 19 19.7 NM_001142502 
chr19 54113551 54113751 200 19 19.7 NM_014475 
chr19 55630951 55631151 200 19 6.57 NM_004533 
chr9 138377751 138377951 200 19 6.57 NM_001080849 
chr2 705351 705551 200 19 6.57 NM_152834 
chr2 20487551 20487751 200 19 6.57 NM_004040 
chr9 138545951 138546151 200 19 6.57 NM_017617 
chr2 25370351 25370651 300 19 9.85 NR_031570 
chr2 25391451 25391651 200 19 19.7 NR_031570 
chr2 30359251 30359451 200 19 19.7 NM_030915 
chr2 43215251 43215451 200 19 6.57 NM_006887 
chr9 138632851 138633051 200 19 9.85 NM_201446 
chr1 3585251 3585451 200 19 9.85 NM_001126241 
chr1 8989951 8990151 200 19 6.57 NM_207420 
chr1 9831051 9831251 200 19 6.57 NM_014944 
chr1 17406551 17406751 200 19 9.85 NM_013358 
 ! "(#!
chr2 177063151 177063351 200 19 9.85 - 
chr2 219827351 219827651 300 19 6.57 NM_006000 
chr1 27762651 27762851 200 19 19.7 NM_001029882 
chr2 238103351 238103551 200 19 6.57 NM_015893 
chr1 45046551 45046751 200 19 6.57 NM_001136537 
chr1 54647051 54647251 200 19 9.85 NM_001009955 
chr20 34904851 34905051 200 19 19.7 NM_199181 
chr1 112740251 112740451 200 19 19.7 NM_018704 
chr1 148868751 148868951 200 19 19.7 NM_207044 
chr1 151775351 151775551 200 19 6.57 NM_014624 
chr1 151805451 151805651 200 19 19.7 NM_005978 
chr1 153084751 153084951 200 19 9.85 NM_170782 
chr1 153100951 153101151 200 19 9.85 NM_170782 
chr20 60607451 60607651 200 19 6.57 NR_029676 
chr1 179172051 179172251 200 19 9.85 NM_020950 
chr1 233166651 233166851 200 19 9.85 - 
chr1 243928751 243928951 200 19 19.7 - 
chr21 44416851 44417051 200 19 9.85 NM_198155 
chr10 18679351 18679551 200 19 9.85 NM_201590 
chr10 71938251 71938451 200 19 6.57 NM_014431 
chr22 20885151 20885351 200 19 6.57 NM_007128 
chr9 139680651 139680851 200 19 6.57 NM_024757 
chr10 73078251 73078451 200 19 6.57 NM_001164375 
chr22 21606551 21606751 200 19 6.57 NM_001178126 
chr22 21731751 21731951 200 19 9.85 NM_002073 
chr22 21748051 21748251 200 19 6.57 NM_002073 
chr22 23159851 23160051 200 19 6.57 NM_000675 
chr22 34136751 34136951 200 19 6.57 NM_006739 
chr10 105208151 105208351 200 19 6.57 NM_001001412 
chr10 105295151 105295351 200 19 9.85 NM_004210 
chr3 49429251 49429451 200 19 9.85 NM_022171 
chr10 121190751 121190951 200 19 6.57 NM_002925 
chr11 525551 525751 200 19 9.85 NM_005343 
chr11 2364351 2364551 200 19 19.7 NM_004356 
chr11 6382351 6382551 200 19 6.57 NM_000543 
chr3 13496551 13496751 200 19 6.57 NM_024827 
chr3 37923151 37923351 200 19 19.7 NM_001008392 
chr3 43923551 43923751 200 19 9.85 - 
chr3 45583351 45583551 200 19 9.85 NM_014240 
chr9 78564051 78564251 200 19 9.85 NR_015342 
chr11 58787751 58788051 300 19 9.85 NM_001039396 
 ! "($!
chr11 62231451 62231751 300 19 6.57 NM_012202 
chr3 53189351 53189551 200 19 9.85 NM_212539 
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Post-translational modifications (PTMs) such as methylation, acetyla-
tion, phosphorylation and ubiquitination occur on nucleosomal his-
tones and regulate transcriptional responses to control higher order 
chromatin structure and transmit epigenetic information1. The 
positively charged amino acids arginine and lysine are enriched in 
histones. Methylation of these residues at specific sites is evolution-
ary conserved from yeast to humans and has the specific effect of 
rendering the amino acid residue bulkier and more hydrophobic2–5, 
changing the interaction potential of the whole protein6.
Lysines can be mono-, di- or trimethylated in a processive man-
ner by several SET-domain–containing complexes7, and different 
degrees of methylation are recognized by different ‘reader’ and effec-
tor proteins8. One example of a highly conserved methylation event 
occurring on histone H3 is the trimethylation of lysine 4 (H3K4me3). 
H3K4me3 was first described as a PTM present at active sites in 
yeast4. Subsequently, it has been mapped genome-wide in a variety 
of cellular systems5,9–12, where it has been shown to associate with 
active promoters, while being depleted from both facultative and 
constitutive heterochromatin5. Histone H3 lysine 4 is modified by 
several enzymes that contain a SET domain, including the human 
proteins SET1, SET7, SET9, SMYD3 and MLL1 to MLL4. These 
enzymes are components of macromolecular complexes that despite 
sharing several common elements, have different and only partially 
redundant specificity13,14.
Arginines, on the other hand, can be methylated by two classes of 
protein-arginine methyltransferases (PRMTs): type I PRMTs catalyze 
the formation of asymmetrical dimethylarginine (W-NG,NG-dimethyl-
arginine or ADMA), whereas type II PRMTs catalyze formation of 
symmetrical dimethylarginine (W-NG,N`G-dimethylarginine or 
SDMA)(Fig. 1a). For example, H3R2 can be asymmetrically dimeth-
ylated by the type-I PRMT6, antagonizing the binding of several chro-
matin cofactors to histone H3 (refs. 15–17). H4R3, by contrast, can be 
symmetrically dimethylated by the type-II enzyme PRMT5, possibly 
leading to an interaction with the plant homeodomain (PHD) finger 
of DNMT3A, although contradictory findings about this interaction 
have been reported18,19.
We and others have previously described a negative correlation 
between the presence of two PTMs on adjacent amino acid residues on 
histone H3: H3K4me3 and H3R2me2a2,15–17. H3R2me2a prevents the 
binding of WDR5, a core component of the H3K4 methyltransferase 
complex MLL, and inhibits MLL methyltransferase activity2,15–17,20. 
Conversely, H3K4me3 prevents methylation of H3R2 by PRMT6. 
Here we set out to investigate whether H3R2 could also be symmetri-
cally dimethylated and whether this modification would have effects 
similar or opposite to those of H3R2me2a. We show that this PTM 
exists in vivo and is conserved in higher eukaryotes. To gain insights 
into the downstream effects of this methylation event, we character-
ized the set of proteins specifically interacting with histone H3 when 
symmetrically dimethylated at arginine at position 2 (H3R2me2s). 
We found that several proteins, including RBBP7, are excluded from 
binding histone H3 by the presence of this methyl mark. We also 
show that WDR5 is strongly binding to H3R2me2s, and by solving 
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Symmetric dimethylation of H3R2 is a newly identified 
histone mark that supports euchromatin maintenance
Valentina Migliori1,2, Julius Mu¨ller1, Sameer Phalke1, Diana Low1,3, Marco Bezzi1,2, Wei Chuen Mok1,  
Sanjeeb Kumar Sahu1, Jayantha Gunaratne1, Paola Capasso4, Christian Bassi5,7, Valentina Cecatiello5, Ario De Marco4, 
Walter Blackstock1, Vladimir Kuznetsov3, Bruno Amati5,6, Marina Mapelli5 & Ernesto Guccione1,2
The asymmetric dimethylation of histone H3 arginine 2 (H3R2me2a) acts as a repressive mark that antagonizes trimethylation 
of H3 lysine 4. Here we report that H3R2 is also symmetrically dimethylated (H3R2me2s) by PRMT5 and PRMT7 and present in 
euchromatic regions. Profiling of H3-tail interactors by SILAC MS revealed that H3R2me2s excludes binding of RBBP7, a central 
component of co-repressor complexes Sin3a, NURD and PRC2. Conversely H3R2me2s enhances binding of WDR5, a common 
component of the coactivator complexes MLL, SET1A, SET1B, NLS1 and ATAC. The interaction of histone H3 with WDR5 
distinguishes H3R2me2s from H3R2me2a, which impedes the recruitment of WDR5 to chromatin. The crystallographic structure 
of WDR5 and the H3R2me2s peptide elucidates the molecular determinants of this high affinity interaction. Our findings identify 
H3R2me2s as a previously unknown mark that keeps genes poised in euchromatin for transcriptional activation upon cell-cycle 
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its crystal structure bound to an H3R2me2s peptide, we establish that 
the WD40 domain of WDR5 is a strong symmetric arginine methyl 
reader. Finally, we show how modulation of this modification, cata-
lyzed by both PRMT7 and the PRMT5–WDR77 complex, correlates 
with changes in other chromatin marks and gene expression, specifi-
cally, upon cell-cycle exit and cell differentiation.
RESULTS
H3R2 is symmetrically dimethylated in vivo
In order to understand whether H3R2 could be symmetri-
cally dimethylated in vivo, we first raised an H3R2me2s-specific 
 antibody (Supplementary Fig. 1). Immunoblot analysis revealed 
that H3R2me2s is present in human, Mus musculus, Danio rerio 
and Drosophila melanogaster protein extracts (Fig. 1b). We next 
explored the distribution of H3R2me2s in the genome. Staining of 
D. melanogaster polytene chromosomes showed that H3R2me2s 
is excluded from 4`,6-diamidino-2-phenylindole (DAPI)-stained 
histone-rich bands, including the chromocenter (Fig. 1c, top). As a 
control, we also raised an antibody specifically recognizing the asym-
metric dimethylation of the same residue (H3R2me2a), which was, 
conversely, detected in DAPI-stained histone-rich bands and at the 
























































































5 µm 5 µm 5 µm 


















































h i iviii ControlsH3R2me2s-enriched
≤5 kb; >2 kb from TSS














































































1 2 3 4 5 6 7 8 9 10 11 1 2 3 4 5 6 7 8 9 10 111213141516171819 20 2122 23






1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Figure 1 H3R2me2s is a newly discovered histone modification associated with euchromatic sites. (a) Type I and II PRMTs generate monomethylarginine 
(MMA). Type I PRMTs are able to generate asymmetric dimethylarginine (ADMA), by adding a second methyl moiety to the same nitrogen atom, whereas 
type II PRMTs generate symmetric dimethylarginine (SDMA). (b) H3R2me2s levels were measured in chromatin from different organisms by western 
blotting. Total histone H3 level is shown as a reference for loading. h.p.f., hours post fertilization. (c) Top: H3R2me2s staining in Drosophila polytene 
chromosomes (green); DAPI is used to stain DNA and is shown in red. Bottom: same as top, staining for H3R2me2a. (d) Distribution of H3R2me2s-
enriched peaks identified through genome-wide ChIP-seq analysis on human B-cell line P493-6. (e) Distribution frequency along the genome of the 
H3R2me2s peaks with reference to the TSS and transcription end site (TES) of associated genes. H3R2me2s sites are specifically enriched at the –1 
nucleosome, upstream of the TSS. (f–i) Examples of ChIP-seq results for the indicated loci in P493-6 cells. H3R2me2s-enriched sites at promoters (f), 
and control sites at promoters (g); H3R2me2s-enriched sites at distal sites (h) (a5 kb; >2 kb from TSS), and control sites at distal sites (i). Binding 
profiles of ChIP-sequencing results for H3R2me2s, H3K4me1, H3K4me3 Pol II and Pol II-S5-P are shown. The y axis denotes sequence tags reads.  
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 heterochromatin2,15–17. Notably, the two antibodies had opposite stain-
ing patterns, indicating that the staining is specific and implying that they 
have different roles in controlling chromatin structure and function.
H3R2me2s localizes to euchromatic regions in human cells
In order to assess the distribution of H3R2me2s in mammalian 
cells, we conducted genome-wide chromatin immunoprecipitation 
sequencing (ChIP-seq) analysis in the human B-cell line P493-6, 
for which we had previously shown a counter correlation between 
H3K4me3 and H3R2me2a15. We identified 818 H3R2me2s-enriched 
regions (Supplementary Data 1), and 32% of these were located 
at promoters, within a window of –5 o 2 kilobase (kb) from the 
transcription start site (TSS) of 230 genes (Fig. 1d). At promoters, 
these H3R2, symmetrically dimethylated histones were specifically 
located at the −1 nucleosome, upstream of the TSS (Fig. 1e). The 
remaining 68% of the peaks were located outside promoter areas 
(x a 5 kb; x q 2 kb) and enrichment of the signal was broader than 
for a single nucleosome. In the same cell line, we next analyzed the 
genome-wide mapping of H3K4me1, a marker of enhancers and insu-
lators5; H3K4me3, a marker of proximal promoters; and polymerase II 
(Pol II), in both the total and phosphorylated active form (Pol II-S5). 
We determined the overlap between these datasets, and examples 
of ChIP-seq enrichment profiles for the indicated loci are shown in 
Figure 1f–i. Genome-wide overlap between H3R2me2s-enriched tar-
gets and those of H3K4me1, H3K4me3 and Pol II are summarized in 
Supplementary Figure 2.
We then conducted de novo motif discovery and found that two motifs 
were highly enriched at promoters harboring H3R2me2s (Fig. 1j). 
These motifs, which are typically present at several CpG island 
promoters, are the CAAT box and the GC box21. CAAT boxes are 
potentially bound by multiple transcription factors, including NF-Y. 
We tested for the presence of NF-Y at H3R2me2s-enriched sites 
and indeed detected a strong binding (Supplementary Fig. 3a)22. 
However, sites with H3R2me2s outside of promoters (x a 5 kb; x q 2 kb) 
overlapped with a repeated motif (5`-CA(or T)GGGG-3`)2, remi-
niscent of the stress response element (STRE)23,24, and consistently 
showed no binding of NFY (Fig. 1k and Supplementary Fig. 3a).
The solexa genomic dataset was validated by quantitative real-time 
PCR, and several genomic locations were sampled for the enrichment 
of different post-translational modifications on histones H3 and H4. 
Representative values from five independent quantitative ChIP exper-
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Figure 2 H3R2me2s impedes co-repressor binding. (a) Schematic representation of the SILAC-based histone peptide pull-down approach. HeLa 
nuclear extracts were used for peptide pull-down assays with either unmodified or H3R2me2s-modified peptides; unmodified versus H3R2me2a-
modified peptides or H3R2me2a-modified versus H3R2me2s-modified peptides. The reverse-swap light-heavy experiments were also conducted in 
biological duplicates (gray arrows). (b) Representative MS spectrum for RBBP7. The peptides enriched after pulldown with H3R2me2s (from the 
heavy extract in this case) show a lower intensity, indicating specific binding of these proteins to histone H3, which is blocked by the presence of the 
symmetric dimethylation at H3R2. (c) Functional protein association network of the interactome specifically binding to the histone H3 tail and excluded 
by H3R2me2s. Different protein complexes are highlighted. RBBP4/7 are common components of all the complexes. (d) Top: RBBP7 exclusion by 
H3R2me2s was assessed by western blotting (WB), following pulldowns from nuclear extracts with negative control beads (–) or histone peptides: H3 
unmodified, H4 unmodified, H3K4me3 and H3R2me2s. Bottom: direct interaction of purified RBBP7 to histones H3 and H4 was confirmed by pull-
down assay; bound RBBP7 was visualized by Coomassie blue staining. RBBP7 is excluded by both H3R2me2s and H3K4me3. (e) H3K27me3 levels at 
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H3R2me2s was preferentially located on the –1 nucleosome rela-
tive to the TSS of transcribed genes (Supplementary Fig. 3). These 
promoters have low histone density in the region surrounding the 
TSS in comparison to other equally active genes. (Supplementary 
Fig. 3b; compare sector i to sector ii). H3R2me2s-marked promoters 
(Supplementary Fig. 3c) were enriched for H3K4me2 and H3K4me3 
(H3K4me2/3) (Supplementary Fig. 3e,f), histones H3 and H4 
acetylation (Supplementary Fig. 3g,h), and for high levels of RNA 
polymerase II (Pol II) (Supplementary Fig. 3i).
Pol II was phosphorylated at lower levels on H3R2me2s-marked 
promoters (Pol II-S5-P) when compared to the TSS of highly expressed 
genes (Supplementary Fig. 3j; compare sector i to the first five genes 
on sector ii). Nonetheless, H3R2me2s marked the promoter of a spe-
cific subset of poised or moderately active genes (Supplementary 
Fig. 3k). If we compare the levels of occupancy of elongating Pol II 
along the gene bodies, H3R2me2s targets show a substantially higher 
traveling Pol II ratio compared to repressed genes but show a lower 
ratio than highly expressed genes do (Supplementary Fig. 4).
H3R2me2s was also enriched at sites that are distant from TSSs 
(Supplementary Fig. 3c, sector iii). These sites were characterized by 
high levels of H3K4me1 and H3K4me2 (Supplementary Fig. 3d,e), 
H3 and H4 acetylation (Supplementary Fig. 3g,h), and by the pres-
ence of Ser5-phosphorylated Pol II (Supplementary Fig. 3j), reminis-
cent of the chromatin signature present at enhancers5. Control sites 
far from annotated TSS are analyzed in Supplementary Figure 3, 
sector iv, and show no substantial enrichment of H3K4 methylation 
or Pol II accumulation, compared to targets.
H3R2me2s impedes co-repressor binding
Because H3R2me2a prevents histone H3 binding by several chroma-
tin readers, such as the WD40 domain of WDR5 and the PHD fingers 
of spp1, ING2, PHF2, DATF1, BPTF and TAF3 (refs. 2,15,17,25), we 
addressed whether this was also the case for H3R2me2s. We used a 
stable isotope labeling by amino acids in cell culture (SILAC)-based 
quantitative screen to identify proteins interacting with the H3R2me2s 
peptide25. The experimental strategy is illustrated in Figure 2a. 
Most bound proteins could not discriminate between unmethylated 
histone H3, H3R2me2a or H3R2me2s peptides. These proteins were 
those that either interacted nonspecifically with the bead-bound 
peptides, or interacted with the histone H3 tail regardless of the 
H3R2 methylation status. Two categories of proteins were identified: 
(i) histone H3 interactors, which were blocked by the presence of 
H3R2me2s, and (ii) proteins selectively recognizing H3R2me2S.
Five complexes belonged to the former category and shared two 
common subunits: RBBP4 and RBBP7 (RBBP4/7) (Fig. 2b and 
Supplementary Fig. 5). Both RBBP4 and RBBP7 are WD40 domain–
containing proteins that are part of the NURD and Sin3a complexes26, 
promoting transcriptional repression by nucleosome remodeling and 
deacetylation. RBBP4/7 are also part of the PRC2 complex27, responsi-
ble for histone H3 lysine 27 methylation, and of the human SNF2h com-
plex, responsible for loading cohesin28. Moreover, RBBP4/7 are also 
subunits of the chromatin assembly factor 1 (CAF-1) complex, which 
is required to assemble chromatin following DNA repair and DNA 
replication29. A schematic representation of all the interacting part-
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Figure 3 H3R2me2s is bound at high affinity by WDR5. (a) Functional protein association network of the interactome specifically binding to the 
H3R2me2s-modified peptide. (b) Representative MS spectrum for WDR5. Independent SILAC experiments were conducted. The peptides enriched after 
pulldown with H3R2me2s (from the heavy extract in this case) show a higher intensity, indicating specific binding of these proteins to H3R2me2s.  
(c) Immunoprecipitated MLL complex preferentially monomethylates and dimethylates H3R2me2s in vitro. Flag-Ash2 immunoprecipitates were 
incubated with the indicated peptides in the presence of an S-adenosyl-L-methionine (SAM) methyl donor. The status of methylation was detected using 
specific antibodies to H3K4me1, H3K4me2 or H3K4me3. (d) WDR5 binding to H3R2me2s was assessed by western blotting (WB) following pulldowns 
from nuclear extracts with histone H3 peptides: unmodified, H3R2me2a, H3R2me2s, H3K4me2 and H3K4me3. (e) Surface plasmon resonance 
binding kinetics of WDR5 to unmodified histone H3 (left graph) or H3R2me2s (right graph) peptides. (f) H3R2me2s-marked regions are bound by 
WDR5. The mean tag density of the indicated mark was calculated for each H3R2me2s peak within 500 base pairs (bp). All peaks were first divided on 
the basis of their proximity to TSS. Next, they were ranked and split into significant, highly enriched H3R2me2s peaks (H3R2me2s peaks); and control 
peaks, which include peaks with very low significance. P values were calculated to test whether the two peak fractions were significantly different. 
Iterative Wilcoxon rank-sum statistical analysis for two samples was applied on 1,000 randomly drawn equally sized subsets of control peaks for this 


























140 VOLUME 19 NUMBER 2 FEBRUARY 2012 NATURE STRUCTURAL & MOLECULAR BIOLOGY
A R T I C L E S
where all the protein-protein interactions experimentally described 
in the literature are also highlighted. RBBP7, in particular, binds his-
tone H4 (refs. 30,31). To the best of our knowledge, we show for the 
first time that RBBP7 also binds the tail of histone H3. Moreover, 
not only did RBBP7 coimmunoprecipitate with a histone H3 peptide 
from nuclear extracts but RBBP7 also coimmunoprecipitated with 
the purified glutathione S-transferase (GST)-RBBP7 fusion protein 
associated with the same histone H3 peptide in an in vitro binding 
assay (Fig. 2d), confirming that the association is direct. Notably, the 
symmetric dimethylation on arginine 2 and the trimethylation, but 
not the mono- or dimethylation, on lysine 4 prevented binding of 
RBBP7 to histone H3, suggesting that both residues belonged to the 
RBBP7 binding interface (Fig. 2d and data not shown). Nucleosomes 
symmetrically methylated on H3R2 were also methylated on H3K4, 
as demonstrated by a sequential chromatin immunoprecipitation 
(ChIP-reChIP) experiment (Supplementary Fig. 6), and occupied the 
–1 position relative to the TSS of active promoters. These promot-
ers were hyperacetylated and not methylated on H3K27, the major 
target site for the PRC2 repressor complex (Fig. 2e). These results 
are consistent with the exclusion from chromatin binding of multiple 
co-repressor complexes and directly link the presence of H3R2me2s 
with an open chromatin state.
H3R2me2s favors the binding of the coactivator WDR5
Consistent with the hypothesis that H3R2me2s might support euchro-
matin maintenance, in the second category of protein specifically 
binding to H3R2me2s, we identified the four core components of 
the human MLL, SET1a and SET1b complexes14,32: WDR5, ASH2L, 
RBBP5 and DPY30 (Fig. 3a). The MS spectra visualizing the strong-
est interactor, WDR5, is shown in Figure 3b. The others are shown 
in Supplementary Figure 5, and their relative enrichment values are 
reported in Supplementary Data 2. These four proteins are the only 
proteins that showed a high binding ratio to the H3R2me2s peptide, a 
weak binding to the H3 peptide, and were completely excluded by the 
asymmetric methylation of H3R2. We then investigated whether an 
H3R2me2s peptide would be a good substrate for the Lys4 SET methyl-
transferases. In an in vitro methylation assay, H3R2me2s greatly 
favored the methylation on H3K4, explaining the mechanistic basis 
for the colocalization of these two modifications at the same chroma-
tin sites. The in vitro reaction generated H3K4me1 and H3K4me2, 
whereas we failed to detect H3K4me3, in line with previous reports 
(Fig. 3c)32–36. To address the functional significance of the specific 
association of WDR5 with H3R2me2s, we validated this interaction 
by alternative methods. First, we carried out histone H3 peptide 
pull-down assays from nuclear extracts, followed by immunoblotting. 
As shown in Figure 3d, WDR5 preferentially precipitated with the 
H3R2me2s peptide. Although with lower affinity, we could also detect 
binding to the histone H3 unmodified peptide and to the H3K4me2/3 
peptides, whereas H3R2me2a completely blocked WDR5 binding, 
as previously reported15,37,38. Second, we measured the affinity of 
WDR5 toward differentially modified histone H3 peptides in order 
to assess the efficiency of direct binding. Real-time biointeraction 
shows that WDR5 binds H3R2me2s with an affinity that is one order 
of magnitude higher than the one shown for the unmodified his-
tone H3 peptide (Kd = 0.1 MM and 5.6 MM, respectively) (Fig. 3e and 
Supplementary Data 2). Lastly, we conducted genome-wide map-
ping of WDR5 in P493-6 cells and found that WDR5 was enriched 
on genomic locations marked by H3R2me2s, both at promoters and 
enhancer sites (Fig. 3f).
The WD40 domain is a newly identified methylarginine reader
To gain better insight into the preferential binding of H3R2me2s to 
WDR5, we next determined the crystallographic structure of the 
complex at 1.9Å resolution (Table 1). As previously reported37,39,40, 
WDR5 folded into a seven-blade B-propeller arranged around a 
narrow central channel where the side chain of Arg2 is accommodated 
(Fig. 4a,b). An omit map computed from the high-resolution data-
set reveals clear electron density for the two Arg2 methyl groups 
and illustrates how the water molecule network is reorganized to 
account for the increased hydrophobicity of the modified side chain 
(Supplementary Fig. 7 and Fig. 4c). The structure superposition 
shows that the overall binding mode of histone H3 to WDR5 is mostly 
unaffected by the symmetric Arg2 dimethylation and that the main 
differences are confined to the bottom of the inner cavity where the 
Arg2 side chain is inserted (Fig. 4c–e). Of the two water-mediated 
hydrogen bonds to the carbonyls of Ser175 and Ser218 in which the 
guanidinium moiety of the unmodified Arg2 is engaged, only the 
first one is maintained in the H3R2me2s structure, whereas the other 
is replaced by a hydrophobic interaction, mostly contributed by the 
side chain of Phe219, toward which the methylated Arg2 nitrogen 
projects. As observed for the other WDR5–H3 complexes37,39,40, 
the structural determinants of the histone recognition reside in the 
N-terminal Ala1, Arg2 and Thr3 residues, whereas the side chain of 
Lys4 points away from the surface. This could be important in the 
context of Lys4 methylation, or it could simply be a mutually exclusive 
situation for the MLL-SET bound conformation20. These results prove 
that WDR5, although binding weakly to the unmodified histone 
H3 tail, is indeed a specific reader of the H3R2me2s mark.
H3R2me2s recruits WDR5 in vivo upon cell-cycle exit
We investigated the role of the subset of genes enriched for 
H3R2me2s at their promoters. We first observed that these genes 
belong to fundamental pathways of transcription regulation and 
protein post-translational modification, including acetylation, 
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lysine demethylation and phosphorylation. 
A second category of genes that were highly 
enriched in our gene ontology analysis was related to vesicle-mediated 
transport (see Supplementary Fig. 8). We focused on those genes 
belonging to the category of transcriptional co-regulators and asked 
whether we could modulate H3R2me2s levels and correlate this 
modulation with the status of chromatin. We addressed this point 
in two cellular systems: the same P493-6 human B cells that we have 
described thus far and a human promyelocytic cell line, HL60.
The progression through the cell cycle of P493-B cells depends on the 
sustained expression of c-Myc41. Upon Myc depletion (Fig. 5a), cells 
went into G0–G1 phase, and target genes preferentially accumulated 
H3R2me2s (Fig. 5b and Supplementary Fig. 9). This event corre-
lated with increased acetylation and recruitment of Pol II (Fig. 5b), 
consistent with the exclusion of the NURD–Sin3a complex (Fig. 2c). 
Notably, when we checked for the levels of WDR5 in the same cells, 
we noticed a marked decrease of bulk WDR5 levels, consistent with 
the fact that WDR5 levels are regulated by Myc (Fig. 5a). We thus 
expected a reduction in WDR5 binding to chromatin and reduced 
H3K4me3 levels, which we did observe at most control sites (Fig. 5b, 
right panels). However, at H3R2me2s-enriched sites, we instead 
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Figure 5 WDR5 is recruited by H3R2me2s to chromatin. P493-6 cells 
were treated for 3 d with tetracycline. HL60 cells were differentiated for  
3 d with DMSO. (a) Levels of WDR5 in growing and tet-treated P493-6 cells 
(+tet). Western blotting (WB) was used to detect endogenous Myc, WDR5, 
actin, histone H3 and H3R2me2s levels in growing and arrested cells.  
(b) H3R2me2s levels normalized for total histone H3 at target and control 
sites under the two conditions: proliferating (blue bars) or quiescent 
(red bars) P493-6 cells. Similar ChIP experiments were conducted; the 
antibody is indicated on the side of each panel. The quantitative ChIP 
(qChIP) values are expressed as percent of input or normalized for total 
histone H3, in the case of histone modifications. (c) Expression levels of 
target and control genes. Values are represented as fold change between 
the two experimental conditions (proliferating or quiescent). (d) Levels 
of WDR5 in growing and differentiating HL60 cells. Western blotting was 
used to detect endogenous Myc, WDR5, actin, H3 and H3R2me2s levels. 
(e) H3R2me2s levels normalized for total histone H3 at target and control 
sites for the two conditions: proliferating cells (blue bars) or differentiated 
HL60 cells (red bars). Similar ChIP experiments were conducted; the 
antibody is indicated on the left side of each panel. The qChIP values are 
expressed as in b. (f) Expression levels of target and control genes. Values 




























WDR5–H3R2me2s WDR5–H3 unmodified Superposition 
Figure 4 Crystal structure of WDR5 bound to the  
N terminus of histone H3 symmetrically 
dimethylated on arginine 2. (a,b) Cartoon 
representation of WDR5 in complex with  
(a) R2me2s- and (b) unmodified (PDB 2H13  
(ref. 39)) histone H3 peptides. Histone H3 
peptides, in yellow ball-and-stick representation, 
bind the narrower top surface of the WDR5  
B-propeller and insert the Arg2 side chain into its 
central channel. (c,d) Enlarged view of the Arg2 
interaction network. The hydrophobic part of the 
arginyl side chain is stabilized by the phenylalanine 
clamp formed by Phe133 and Phe263 (purple 
sticks), while the guanidinium group participates 
in direct and water-mediated bonding to hydrogen 
(dashed lines). Two hydrogen bonds to structurally 
conserved water molecules anchor the unmodified 
Arg2 to the bottom of the WDR5 channel. The 
dimethylated side chain displaces one of the  
waters and protrudes toward the Phe219 aromatic 
ring to make tighter hydrophobic interactions.  
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affinity interaction between WDR5 and the symmetric dimethylated 
H3R2. For this reason, we propose that this interaction becomes 
extremely important in situations of reduced WDR5 nuclear molarity. 
We speculate that the increased affinity of WDR5 for H3R2me2s, in 
conditions of reduced nuclear concentration of WDR5, has a crucial 
role in maintaining the ‘on’ state for this set of genes, which are not 
transcriptionally downregulated but rather upregulated upon cell-
cycle exit (Fig. 5c).
H3R2me2s recruits WDR5 in vivo upon HL60 differentiation
We next explored the functional role of H3R2me2s in human pro-
myelocytic HL60 cells, which can be differentiated to granulocytes 
upon treatment with DMSO42. Upon differentiation, cells are forced 
out of the cell cycle, and concomitantly, Myc and WDR5 levels are 
reduced (Fig. 5d). We conducted genome-wide mapping of H3R2me2s 
in HL60 cells, in both undifferentiated and differentiated conditions. 
We noticed that, overall, H3R2me2s tended to accumulate at target 
sites (Fig. 5e), concomitantly with WDR5 recruitment and increased 
H3K4me3 methylation, which was similar to what we observed in 
P493-6 cells (Fig. 5b). Once again, we noticed that H3R2me2s-enriched 
promoters were kept in an open conformation, and their expression 
upon differentiation was either unaltered or increased (Fig. 5e,f).
PRMT5–WDR77 and PRMT7 methylate H3R2me2s
We sought to identify the enzyme catalyzing H3R2me2s. The human 
genome encodes two type II PRMTs that have been characterized6. 
When immunoprecipitated from transfected cells and incubated 
with recombinant histone H4, both PRMT5 and PRMT7 catalyzed 
the symmetric dimethylation of H4R3 (Fig. 6a). This experiment 
was repeated by immunopurifying PRMT5 and PRMT7 from cells, 
using both Flag and hemagglutinin (HA) antibodies. Although we 
were aware that PRMT5 could be a contaminant in Flag immunopre-
cipitates43, we did not actually detect it, and we observed a stronger 
methylation that was catalyzed by PRMT7 (Fig. 6b). When the 
experiment was conducted by immunoprecipitating with HA beads 
instead, we consistently observed a stronger methylation in the case 
of the PRMT5-catalyzed reaction (Supplementary Fig. 10a). Overall, 
we conclude that both enzymes are able to catalyze the symmetric 
dimethylation of H3R2.
We finally decided to knock down the levels of PRMT5 and 
PRMT7 (Fig. 6c) in cells, to observe the effects on H3R2me2s levels 
overall or at specific target sites. Upon reducing the levels of PRMT5 or 
PRMT7, we observed an overall reduction in H3R2me2s levels (Fig. 6d). 
Depletion of both PRMT5 and PRMT7 produced the strongest effect, 
and this also resulted in reduced H3K4me3 levels. The levels of hetero-
chromatic marks such as H3K9me3 and H3K27me3 remained stable, 
demonstrating specificity. At target sites, we also observed a reduction 
in H3R2me2s levels, which resulted in reduced WDR5 recruitment, 
H3K4me3 levels and histone H3 acetylation (Fig. 6e), and in transcrip-
tion downregulation (Fig. 6f). Similar results were also obtained by 
depleting WDR77 from cells (Supplementary Fig. 11).
DISCUSSION
Methylation of histones has been linked to both transcriptional activa-
tion and repression. Here we show for the first time that opposing sym-
metries of methylation of the same arginine side chain have opposite 
roles in either excluding or recruiting to chromatin the same coactivator: 
WDR5. Figure 6g shows a schematic representation of our findings.
H3R2me2s on the –1 nucleosome
We find the genomic location of this newly identified symmetric 
methylation on Arg2 of histone H3 extremely intriguing. First, 
Figure 6 PRMT7 and PRMT5–WDR77 
methylate H3R2me2s. (a,b) PRMT5 and PRMT7 
immunoprecipitates from transfected cells were 
incubated with recombinant histone H4 (a) or 
H3 (b) and SAM. H4R3me2s and H3R2me2s 
levels were visualized by western blotting (WB). 
(c) Cells were infected with short hairpin  
RNA (shRNA) viruses, targeting the indicated 
PRMTs. Two shRNA were used for each 
PRMT and the relative knockdown (KD) was 
quantified by RT-PCR. (d) Western blot analysis 
of the level of different histone modification 
(H3, H3R2me2s, H3K4me3, H3K9me3, 
H3K27me3) from total extract of HeLa cells. 
HeLa cells were infected with scramble, 
shPRMT5, shPRMT7 and double shPRMT5  
and PRMT7. (e) H3R2me2s levels at target  
and control sites in scramble control cells, or 
cells knocked down for PRMT5 or PRMT7.  
ChIP experiments were conducted with the 
antibody indicated on the left side of each 
panel. The qChIP values are expressed as 
percent of input or normalized for total histone 
H3, in the case of histone modifications.  
(f) Expression levels of target and control  
genes. Values are represented as fold change 
compared to scramble. (g) Schematic 
representation of the role of H3R2me2s.  
At promoters, it prevents heterochromatinization 
upon differentiation or cell-cycle exit, by recruiting WDR5, despite its reduced molarity in the nucleus, and by excluding co-repressor complexes such as 
PRC2, NURD and Sin3a, through impeding RBBP7 binding. PRMT6, by contrast, catalyzes the asymmetric dimethylation of H3R2, which leads to the 
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it is on the –1 nucleosome relative to the TSS, where it has an 
important role in preventing other nucleosomes from assembling 
in the surrounding region. Indeed, H3R2me2s will inhibit CAF1 
binding by impeding RBBP7 interactions with histone H3. This 
will function as a de facto fail-safe mechanism to prevent unwanted 
heterochromatinization. The impeding of RBBP7 interaction with 
histone H3 is a crucial mechanism to simultaneously exclude 
several co-repressor complexes, preventing H3K27 methylation by 
PRC2 and deacetylation by NURD and Sin3a. Our genome-wide 
mapping studies of H3R2me2s reveal the presence of this mark at 
specific euchromatic promoters, which are expressed in response 
to differentiation, cell-cycle exit or stress signals. We have pro-
vided evidence that PRMT7 and PRMT5–WDR77 can symmetri-
cally dimethylate this site both in vivo and in vitro. Nevertheless, 
further work will be required to assess how PRMT5 or PRMT7 do 
so in different cells and what regulates their respective shuttling 
from the cytoplasm to chromatin.
H3R2me2s at distal sites
Second, H3R2me2s localizes at sites distal from annotated promoters. 
To our knowledge, this is the first time evidence has been given for 
the targeted recruitment of WDR5, a crucial subunit of coactivator 
complexes, to specific euchromatic sites outside of promoter regions 
that are enriched for H3K4me1 and histone H3 and H4 acetylation. 
Our studies revealed that the WDR5 binding pocket binds to the 
H3R2me2s peptide with a Kd on the order of 0.1 MM. Work by other 
groups33–35 has recently shown that the same binding pocket of WDR5 
is used to interact with the SET domain of MLL1, with a comparable 
affinity33–35. Our data suggests that there is competitive binding of 
WDR5 to both H3R2me2s and the SET catalytic subunit in the com-
plex. This competition might serve a function in the diverse enzymatic 
activity of the MLL complex at different genomic sites. At distal sites, 
the WDR5–Ash2–Rbbp5–DPY30 subcomplex would be recruited to 
chromatin through the high affinity interaction between WDR5 and 
H3R2me2s. Recently, it has been proposed that this subcomplex has 
the capability to directly monomethylate H3K436,44, which would be 
perfectly consistent with our observed colocalization of H3R2me2s 
and H3K4me1 at all enhancer sites distant from TSSs (Fig. 1h). At pro-
moters, the situation might be slightly different, as the topology of the 
interactions among subunits of the WDR5–Ash2–Rbbp5–DPY30 sub-
complex could be rearranged by the direct binding of MLL or SET1a/b 
to WDR5, through the WIN (WDR5-interacting) motif, allowing the 
SET-containing enzyme to further trimethylate histone H3. It is note-
worthy that binding to H3R2me2s is a specific mechanism of WDR5 
recruitment to chromatin, but it is most likely not the only one. WDR5 
is indeed present at many other promoters, where it is recruited by 
alternative methods, and where, in the absence of H3R2me2s, it will 
most likely not directly interact with histone H3 (ref. 45).
An alternative explanation is that the function of H3R2me2s is linked 
to WDR5 recruitment, but not necessarily in the context of any particu-
lar SET domain–containing complex. Indeed, WDR5 is part of many 
other complexes13,46,47 and could serve as a scaffold that regulates chro-
matin recruitment dependently of the H3R2 methylation state.
WDR5 as a methylarginine reader
The crystal structure of WDR5, with a symmetric dimethylated 
H3R2me2s peptide, has finally helped us to gain mechanistic insight 
into the interaction between WDR5 and histone H3. The main dif-
ferences in the structures of WDR5 bound to unmodified histone H3 
or to H3R2me2s reside in the reorganization of the water-mediated 
interaction network at the bottom of the B-propeller pore in which the 
Arg2 side chain is inserted. Although the unmodified H3R2 side chain 
forms a hydrogen bond with two water molecules, mediating the inter-
action with the carbonyl group of Ser175 and Ser218, the dimethylated 
Arg2 forms a hydrogen bond with only one water molecule, creating 
a bridge to Ser175. Superposition of the methylated and unmodified 
Arg2 side chain (Fig. 4e) shows a marginal shift of the guanidinium 
group away from the water molecule in the direction of a hydrophobic 
pocket contributed by Phe219. Phe219 is thus one of the determinants 
of the high affinity interaction between WDR5 and H3R2me2s.
To conclude, H3R2 has emerged as a crucial amino acid residue, 
mediating protein-protein interactions between histones and various 
chromatin regulators. We have identified the symmetric dimethylation 
of this residue, which occurs at specific sites in the genome that corre-
late with euchromatic regions, and we have shown that this modifica-
tion has a very different role relative to the asymmetric dimethylation 
(H3R2me2a), revealing that subtle steric changes at this site can result 
in markedly different molecular and functional consequences for tran-
scriptional regulation. We propose that this newly described positive 
cross-talk between H3R2me2s, H3K4 methylation and histone H3 and 
H4 acetylation acts to preserve the euchromatic context at promoters 
or distal regulatory sites that need to be poised for activation upon 
cell-cycle exit or during differentiation.
METHODS
Methods and any associated references are available in the online 
version of the paper at http://www.nature.com/nsmb/.
Accession codes. Coordinates and structure factors have been depos-
ited in the Protein Data Bank (PDB) under accession code 4A7J.
Note: Supplementary information is available on the Nature Structural  Molecular 
Biology website.
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ONLINE METHODS
Antibodies. A full list of antibodies used is provided in Supplementary 
Methods.
Drosophila cultures and immunostaining of polytene chromosomes. Flies 
were reared on standard medium at 25 °C. Preparation and staining of polytene 
chromosomes were done as described48. Chromosomes were incubated with 
rabbit polyclonal anti-H3R2me2s or anti-H3R2me2a (PBS, 5% dry milk) for 
16 h at 4 °C, followed by incubation with fluorescein isothiocyanate (FITC)-
conjugated secondary antibody (Molecular Probes) for 2 h at 37 °C (1:200, 5% 
dry milk). Preparations were examined with confocal laser scanning microscopy 
(LSM 510; Zeiss).
Quantitative chromatin immunoprecipitation and quantitative PCR. qChiP 
was carried out as previously described15. See Supplementary Methods for 
details. PCR primer sequences are given in Supplementary Data 1.
Data processing. Sequencing output was analyzed using the Genome Analyzer 
Pipeline provided by Illumina. Sequence tags that aligned uniquely to the human 
genome build reference sequence HG18 with zero, one, or two mismatches, 
according to the ELAND alignment algorithm, were used for further analysis. 
For ChIP-seq binding site identification, classification, de novo motif discovery 
and gene ontology annotation, see Supplementary Methods.
Binding studies. Binding affinities were calculated using surface plasmon reso-
nance. See Supplementary Methods for details.
Mass spectrometry and data analysis (SILAC). After incubation with either 
H3R2me2a- or H3R2me2s-modified biotin peptides, we recovered the bound 
complexes by means of streptavidin-conjugated beads. Data from the two pull-
downs were then pooled according to the standard SILAC procedure25. Eluted pro-
tein complexes were separated by 1D SDS-PAGE and digested with trypsin, using 
published procedures49. Samples were analyzed on an Orbitrap or Orbitrap XL 
(Thermo Fisher) coupled to a Proxeon Easy-nLC. Survey full-scan MS spectra 
(m/z 300–1,400) were acquired with a resolution R = 60,000 at m/z 400, an 
automatic gain control target of 1 × 106 ions, and a maximum injection time of 
500 ms. The ten most intense peptide ions in each survey that were scanned 
with an ion intensity above 2,000 counts and a charge state q 2 were sequentially 
isolated to a target value of 1 × 104 and fragmented in the linear ion trap by 
collisionally induced dissociation and collisionally activated dissociation (CID/
CAD), using a normalized collision energy of 35%. A dynamic exclusion was 
applied, using a maximum exclusion list of 500 with one repeat count, and exclu-
sion duration of 30 s. Proteins were searched using Mascot version 2.2 (Matrix 
Science) against a concatenated target-decoy database, prepared by sequence 
reversing the human International Protein Index (IPI) sequences (version 3.52, 
73,928 sequences, http://www.ebi.ac.uk/) and adding common contaminants 
such as human keratins, porcine trypsin and proteases to give a total of 148,380 
sequences. Cysteine carbamidomethylation was searched as a fixed modification; 
N-acetylation and oxidized methionine were searched as variable modifications. 
Labeled arginine and lysine were specified as fixed or variable modifications, 
depending on prior knowledge about the parent ion. SILAC peptide and protein 
quantification was done automatically with MaxQuant version 1.0.13.13 (ref. 50), 
using default parameter settings. Maximum false discovery rates (FDR) were set 
to 0.01 for both protein and peptide.
Peptide pull-down and methylation assays. Peptide pulldowns and methylation 
assays were carried out as previously described15. See Supplementary Methods 
for details.
Knockdown experiments. HEK 293 T cells were transfected with pLKO vector 
(two different shRNA for each symmetric PRMT) together with VsVg and 
delta8.9 plasmids. Cells were incubated for 18 h, then fresh medium was added 
to the cells. After 24 h, the medium containing the viral particles was collected, 
filtered using a 0.22 Mm filter unit and added onto the target cells (HeLa), sup-
plemented with 10 Mg ml−1 of polybrene. The medium on 293T cells was then 
replaced, and the viral harvesting was repeated up to three times. Twenty-four 
hours after the last infection, the medium was replaced with fresh growth medium 
containing puromycin (1 Mg ml−1). Cells were selected over a 5-d period and 
harvested to be assayed. pSuper vector was used for transient transfection to 
knock down Wdr77 in cells, selected over a period of 3 d in puromycin. A pSuper 
targeting the luciferase sequence was used as a control.
Crystallization and crystal structure determination. To assemble the WDR5–
histone H3 complex, synthetic H3R2me2s peptide encompassing residues 1 to 
16 of histome H3 was incubated with purified WDR5 (residues 22–334)39 in a two-
fold molar excess for 1 h at 20 °C. Details of protein preparation are provided in 
Supplementary Methods. Crystallization experiments were conducted, using the 
sitting drop vapor diffusion technique, at 20 °C, mixing 100 nl of protein solution 
at 15 mg ml−1 with 100 nl of reservoir solution, using a Cartesian Honeybee liquid 
handler (Genomic Solutions). Tiny crystals grew in several conditions, typically in a 
reaction mixture containing 25%–30% PEG 3350, 50–100 mM ammonium sulphate, 
pH 7.5–8.5. For data collection, crystals grown in 30% PEG 3350, 0.1 M HEPES, pH 
7.5, and 60 mM ammonium sulphate were flash-cooled in liquid nitrogen without 
further cryoprotection. The data used for the structure solution were collected on 
the PX beamline ID14-1 at the ESRF. Data were indexed and scaled with HKL2000 
(ref. 51). Crystals belonged to the space group P21, and contained one copy of 
the WDR5–H3R2me2s complex per asymmetric unit. Molecular replacement was 
carried out with PHASER52, using the apo WDR5 as a search model (PDB 2H13). 
Model building of the histone H3 peptide was initiated with manual placement into 
the difference electron density, and then completed using iterative cycles of manual 
model building in Coot53 and restrained refinement in CNS54. The final model 
contains residues 32–298 of WDR5 and the first six residues of the histone H3 
peptide. Data collection and refinement statistics are shown in Table 1.
48. Phalke, S. et al. Retrotransposon silencing and telomere integrity in somatic cells 
of Drosophila depends on the cytosine-5 methyltransferase DNMT2. Nat. Genet. 41, 
696–702 (2009).
49. Shevchenko, A., Tomas, H., Havlis, J., Olsen, J.V. & Mann, M. In-gel digestion for 
mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1, 
2856–2860 (2006).
50. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized 
p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. 
Biotechnol. 26, 1367–1372 (2008).
51. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in 
oscillation mode. Methods Enzymol. 276, 307–326 (1997).
52. McCoy, A.J., Storoni, L.C. & Read, R.J. Simple algorithm for a maximum-likelihood 
SAD function. Acta Crystallogr. D Biol. Crystallogr. 60, 1220–1228 (2004).
53. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta 
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54. Brünger, A.T. et al. Crystallography and NMR system (CNS): a new software system 




























biochemical role of histone arginine methylation in 
transcriptional regulation
Methylated & unmethylated 
arginines as protein docking sites: 
adding another layer of complexity 
to the ‘histone code’
Post-translational modifications (PTMs) are 
essential for signal transduction. By altering 
the biophysical features of proteins, PTMs can 
regulate a diverse array of phenomena including 
protein subcellular localization, protein stability 
and protein–protein interactions. When a PTM 
occurs on histones, it directly modifies chroma-
tin structure and contributes to the organization 
of higher eukaryotic genomes into euchromatic 
and heterochromatic domains [1–6]. Euchromatic 
domains are important for regulating transcrip-
tion, by ensuring DNA accessibility, the assem-
bly of the transcription machinery and the bind-
ing of sequence-specific transcription factors. 
Conversely, heterochromatic domains maintain 
the large majority of the genome in a relatively 
silent and poorly accessible state. Enzymes such 
as serine/threonine and tyrosine kinases, lysine 
acetyltransferases, and lysine and arginine 
methyltransferases are able to phosphorylate 
acetylate and methylate histones, respectively. 
Understanding how these enzymes are regulated 
is of central importance for understanding how 
gene transcription and genomic integrity are 
regulated, and for elucidating the mechanisms 
controlling key physiological and pathologi-
cal events such as differentiation, development 
and cancer. 
A direct effect of PTMs on chromatin is the alter-
ation of its biophysical and biochemical character-
istics and the creation of a dynamic platform upon 
which the transcriptional machinery is recruited 
and assembled [7,8]. The histone code hypothesis 
suggests that histone PTMs can act as binding 
sites to be interpreted by chromatin readers and 
effector proteins [9]. Many nuclear proteins contain 
motifs such as the bromo domain, that selectively 
interact with acetylated histones [10]. The ‘Royal 
family’ domains, which are structurally similar to 
the prototype chromodomain and bind methyl-
ated residues, include the Tudor, Plant–Agenet, 
PWWP and MBT domains [11–13]. Recently, 
other domains have been identified as being able 
to recognize methylated arginines or lysines. One 
example is the large family of plant homeodomain 
(PHD) finger-domains, which are present in sev-
eral chromatin-associated proteins, and have been 
demonstrated to interact with methylated lysines 
and arginines on histone tails. Examples of PHD 
domain-containing proteins include the tumor 
suppressor inhibitor of growth 2 (ING2), which 
binds H3K4me3 [14], and Dnmt3a, which has an 
Post-translational modifications (PTMs) are commonly used to modify protein function. Modifications 
such as phosphorylation, acetylation and methylation can influence the conformation of the modified 
protein and its interaction with other proteins or DNA. In the case of histones, PTMs on specific residues 
can influence chromatin structure and function by modifying the biochemical properties of key amino 
acids. Histone methylation events, especially on arginine- and lysine-residues, are among the best-
characterized PTMs, and many of these modifications have been linked to downstream effects. The 
addition of a methyl group to either residue results in a slight increase in hydrophobicity, in the loss of a 
potential hydrogen-bond donor site and, in the alteration of the protein interaction surface. Thus far, a 
number of protein domains have been demonstrated to directly bind to methylated lysine residues. 
However, the biochemical mechanisms linking histone arginine methylation to downstream biological 
outputs remain poorly characterized. This review will focus on the role of histone arginine methylation in 
transcriptional regulation and on the crosstalk between arginine methylation and other PTMs. We will 
discuss the mechanisms by which differentially methylated arginines on histones modulate transcriptional 
outcomes and contribute to the complexity of the ‘histone code’.
KEYWORDS: arginine methylation  chromatin  DNA methylation  histone binding 
domain  histone code  histones post-translational modification  PRMT  protein 
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ATRX–DNMT3–DNMT3L (ADD) domain 
containing a PHD finger, and specifically binds 
to H4R3me2s [15]. One other example of a newly 
identified methyl-binding module is the ankyrin 
repeat of the H3K9 specific methyltransferase 
G9a, which selectively recognizes H3K9me1/2, 
further extending the repertoire of domains which 
are able to read differentially methylated lysines or 
arginines [16].
This review will focus on how arginine meth-
ylation specifically contributes to increase the 
complexity of the histone code. This is achieved 
in two main ways: 
 Methylated arginines can act as docking sites 
for chromatin-binding proteins on histone 
tails (FIGURE 1A & TABLE 1);
 Methylated arginines can act as exclusion 
marks, impeding the binding of proteins to 
histones (FIGURE 1B & TABLE 1).
 Methylated arginines as  
docking sites
The first described example of a binding module 
able to recognize methylated arginines was the 








































































































Figure 1. Methylated arginines on histone proteins. (A) Methylated arginines as docking sites for protein–histone interactions. 
Histone H3/H4: the PHD finger of DNMT3a directly binds H4R3me2s, while the PHD finger of RAG2 binds H3K4me3/H3R2me2s. The 
first five residues of histones H2A and H4 are identical, and H2A is also methylated at the R3 position. H4R3me2a and H3R17me2a are 
linked to downstream acetylation events and to transcriptional activation, but there is no evidence of direct binding of HAT complexes to 
these methylated residues (?). (B) Methylated arginines can impede protein–histone interactions. Histone H3: H3R2me2a blocks the 
binding of several proteins/domains to the histone H3 tail: the WD40 domain-containing protein WDR5, the PHD finger of ING2, of TAF3 
and of BPTF, the double chromodomain of CHD1 and the double Tudor domain of JMJD2A, are all excluded by this asymmetric 
dimethylated arginine. H3R8me2s blocks the binding of HP1 and the catalytic activity of G9a towards H3K9me1/2. H3R26me2a could 
potentially interfere with Polycomb (PRC1 and PRC2) binding and repressive functions (?). (C) Arginine/lysine methyl/methyl switches. 
Histone tails: several arginine/lysine regulatory switches can be identified on the four histones. Concurrent or alternate methylation 
events are likely to control binding of several ‘reader’ and ‘effector’ proteins to chromatin.  
?: Uncertainty or not proven yet; DNMT: DNA methyltransferase; HAT: Histone acetyltransferase; PHD: Plant homeodomain.
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protein (SMN). SMN serves as an assembly 
factor for small nuclear ribonucleoproteins 
(snRNPs), and is able to specifically recognize 
the Sm proteins SmD1 and SmD3 only when 
their C-terminal RG-rich domain is symmetri-
cally dimethylated [17]. Tudor domains are found 
in many organisms and have been implicated in 
allowing protein–protein interactions by direct 
recognition of methylated lysine and arginine 
residues [18–21]. They were initially identified as 
common protein motifs found in the Drosophila 
Tud proteins and in other proteins from a wide 
variety of organisms and different kingdoms, 
including fungi, plants and animals [11]. They 
are related to Plant–Agenet-, Chromo-, PWWP- 
and MBT-domains, and together they form 
the ‘Royal Family’ domains [11]. Several Tudor 
domain proteins have been demonstrated to 
interact with modified histones. In particular, 
53BP1, a protein involved in DNA repair, con-
tains a tandem Tudor domain that was origi-
nally proposed to bind histone H3 methylated 
on Lys79 during DNA damage response [19]. 
Later, this was demonstrated to be only one pos-
sible interaction between 53BP1 and histones, 
as both the yeast homolog, Crb2, and 53BP1 
itself, recognize a histone H4 peptide methyl-
ated on Lysine 20 (H4K20me2) [22,23]. Other 
examples of Tudor domain structures binding 
to methylated-peptides have demonstrated a 
great variability in their binding pockets and 
in the amino acids involved in the interactions, 
further increasing our understanding of how 
these domains recognize methylated residues. 
Specifically, Tudor domains can either fold into 
a single barrel-like structure composed of five 
E strands [24], or form an intertwined structure 
consisting of two Tudor domains [25,26]. In addi-
tion, the Tudor domains of JMJ2DA, a histone 
demethylase belonging to the Jumonji family of 
proteins [27], allow the binding of two differ-
ent methylated residues on histone H3 and H4, 
respectively, by simply changing the orientation 
of the targeted peptide in the binding pocket [28]. 
Finally, Tudor domains have also been impli-
cated in the recognition of both symmetrically 
and asymmetrically methylated arginines. The 
Tudor domain of the SMN protein is known 
to bind both symmetrically methylated argi-
nine [17,21], likely methylated by PRMT5 or 
PMRT7, and asymmetrically methylated argi-
nines methylated by PRMT4 [29]. To date, how-
ever, no Tudor domain has been demonstrated 
to directly recognize a methyl-arginine on his-
tones. Unfortunately, no in silico tools are able 
to predict whether a given Tudor domain will 
recognize a specific methyl arginine, and thus 
their binding specificity must be determined 
experimentally on a case-by-case basis. 
Recently, the first interaction of a protein 
domain with a methylated arginine on histone H4 
was described [15]. As will be discussed later in this 
review, the interaction of the DNA methyltrans-
ferase (DNMT) 3a ADD domain, containing a 
PHD finger, directly connects arginine methyla-
tion to DNA methylation, helping to explain how 
gene repression is initiated and maintained.
Further evidence that a methylated arginine 
can act as a potential docking site came from a 
report describing the crystal structure of RAG2, 
an essential protein in the variable diversity 
joining (VDJ) recombination process, bound 
to an H3 peptide trimethylated on lysine 4 
(H3K4me3). The concomitant presence of a 
symmetric dimethylated arginine at position 2 
(H3R2me2s) increased the affinity of RAG2 
for H3K4me3, at least in vitro [30]. Whether 
H3R2me2s actually exists in vivo, and whether 
it cooperates with H3K4 methylation to control 
VDJ recombination, however, still remains to be 
investigated [31].
 Methylated arginines as  
exclusion marks
A second, well-characterized mechanism by 
which PTMs influence protein–protein inter-
actions is by interfering with binding of other 
proteins to the histone tails. Structures of sev-
eral PHD fingers, Tudor, chromo and WD40 
domains have been recently co-crystallized with 
the tail of histone H3. In this context both H3R2 
and H3R8 form important hydrogen bonds 
with the PHD domains of several members of 
the ING family [14], BPTF [32], and TAF3 [33], 
with the chromodomain of HP1 [34,35], and 
the double chromodomain of CHD1 [36] and 
with the double Tudor-domain of JMJD2A [25]. 
Finally, in the case of the WD40 E propeller of 
WDR5, the unmethylated H3R2 makes essen-
tial contacts with the hydrophobic pocket of 
WDR5 and the asymmetric dimethylation of 
the same arginine disrupts this binding [37,38]. 
All of these interactions will be described in 
detail in later sections of this review where the 
effects of arginine dimethylation on each spe-
cific residue on histone H3, H2A and H4 will 
also be considered.
These mechanisms are not only relevant to 
histones, as the methylation of arginine next to 
a proline-rich motif has already been demon-
strated to block binding to SH3, but not to 
WW domains [39]. Similarly, CARM1-mediated 
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asymmetric dimethylation of the glucocorticoid 
receptor interacting protein (GRIP1)-binding 
domain of p300 regulates its association with 
the GRIP1 [40].
This leads us to speculate that, similar to what 
has been hypothesized by Fischle and colleagues 
for ‘methyl/phospho switches’ [41], proteins might 
encode for ‘arginine/lysine–methyl/methyl 
switches’ that are important for regulating and 
modulating the binding affinity of numerous 
chromatin-binding proteins (FIGURE 1A & 1B). 
Several such arginine/lysine pairs can be iden-
tified on histones. Whether both arginine and 
lysines can be methylated at these sites remains 
an open question (FIGURE 1C).
Biochemistry of protein  
arginine methylation
We will now describe the biochemistry of pro-
tein arginine methylation, and then review the 
known effects of specific methylation events at 
identified sites on histone H3 and H4.
In eukaryotes, from Saccharomyces cerevisiae 
to humans, arginine methylation is an abundant 
PTM [42], occurring on both histones and other 
nuclear and cytoplasmic proteins [43]. Arginine 
side chains have two terminal guanidino-groups 
(NH2), which are often involved in hydrogen 
bonding with protein interaction partners and by 
directly contacting thymine, adenine and gua-
nine bases and backbone phosphate groups on 
DNA and RNA [44]. The addition of one methyl 
group to either one of the guanidino-groups 
gives rise to monomethyl arginine (:-NG-
monomethylarginine; MMA), and this reaction 
can be performed by Type I, II and III PRMTs. 
Subsequently, MMA can be dimethylated either 
asymmetrically (:-NG,NG-dimethylarginine; 
ADMA) by Type I PRMTs or symmetrically 
(:-NG,N´G-dimethylarginine; SDMA) by 
Type II enzymes [43]. The direct effect of adding 
each methyl moiety to an arginine residue is that 
the shape, and as a consequence the protein sur-
face, changes, and the potential hydrogen bond 
donor is lost, while the amino acid gets bulkier 
and more hydrophobic (FIGURE 2A) [45,46].
Type I, II and III PRMTs make up a family 
of enzymes conserved from yeast to humans [47], 
and their exact number is still under investiga-
tion. In humans and mice, six genes are known 
to encode enzymes with Type I activity (PRMT1, 
PRMT2, PRMT3, PRMT4 [CARM1], PRMT6 
and PRMT8) and two genes encode proteins 
with Type II activity (PRMT5 and PRMT7). 
PRMT7 has also been inferred to have Type III 
activity, while a related protein on chromosome 4 
(PRMT9-[4q31]), also referred to as PRMT10, 
is predicted, based on sequence similarity, to also 
be a Type II enzyme (FIGURE 2B) [43,48]. All of these 
PRMTs contain the seven-E strand methyl-
transferase domain typical of class I methyl-
transferases [49], as well as the characteristic 
‘double E’ and ‘THWxQ’ sequence motifs [50]. 
FBXO11 and FBXO10 are two other proteins, 
which, while they show poor sequence similarity 
to other PRMTs, have been proposed to have 
PRMT Type II activity [48,51]. There is, however, 
little experimental evidence to support these pre-
dictions, and subsequent reports have described 
no specific PRMT activity for either the worm 
or human FBXO11 [52].
 Histone arginine methylation
So far only a few methylated arginines have 
been described on histones (FIGURE 2B) – asym-
metric and symmetric dimethylation on argi-
nine 3 of histone 4 (H4/H2AR3me2a catalyzed 
by PRMT1, and possibly by PRMT8, and 
H4/H2AR3me2s catalyzed by PRMT5, and 
possibly by PRMT7, respectively), H3R2me2a 
by PRMT6, H3R17me2a and H3R26me2a 
by PRMT4/CARM1 and H3R8me2s by 
PRMT5 [48]. PRMT2 might have weak Type I 
activity, targeting H4, but no specific mapping 
has been carried out to identify the methylated 
arginine(s) [53]. We will describe in detail the 
effect, in terms of transcriptional output, of 
site-specific methylation of different arginines 
on histones H3, H2A and H4. The crosstalk 
with other acetylation or methylation events 
on histones or with DNA methylation will also 
be addressed.
Arginine methylations linked to 
transcriptional activation: 
H4/H2AR3me2a, H3R17me2a & 
H3R26me2a
H4R3me2a & H2AR3me2a
Methylation of arginine at position 3 on the 
histone H4 tail was the first to be described [54] 
and it is of particular interest as H4R3 is the 
only site on which both an asymmetric and a 
symmetric modification can alternatively occur. 
This means that there are four possible methyla-
tion states for H4R3: H4R3me0, H4R3me1, 
H4R3me2a and H4R3me2s. Moreover, the 
extreme N-terminal tail of histone H4 is iden-
tical to that of histone H2A (FIGURE 1C), thus 
both histone tails can potentially be methylated 
simultaneously. H4/H2AR3 are asymmetri-
cally dimethylated by PRMT1, though there is a 
strong preference towards H4 over H2A [54], and 
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this has been described as an essential upstream 
event for other subsequent histone PTMs [55]. 
Its loss leads to the deacetylation of both H3 
and H4 and to an increase in H3K9me3 and 
H3K27me3 levels. In addition, H4R3me2a-
linked acetylation occurs preferentially on 
H4K5 and H4K12, which are specifically rec-
ognized and bound by TAFII250, the major 
subunit of the transcription complex TFIID, 
through its two tandem bromodomains [56]. 
Although asymmetric dimethylation of H4R3 
favors histone H4 acetylation, both in vitro and 
in cells, and thus correlates with gene activa-
tion, no direct mechanism has been uncovered 
yet [55]. One hypothesis is that H4R3me2a is 
directly recognized by a histone acetyltrans-
ferase (HAT), or by a subunit of one of the 
H4-specific HAT complexes [57]. However, 
there is no experimental data  supporting this 
prediction (FIGURE 1A).
The link between H4R3me2a and activation 
of gene expression has also been established in the 
case of an aberrant MLL1-EEN-Sam68-PRMT1 
complex driving leukemogenesis [58], where 
PRMT1 activity seems to cooperate with MLL1 
driven H3K4 methylation to activate target 
genes. There is no direct evidence regarding how 
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Figure 2. The arginine methylation cycle catalysed by protein arginine N-methyltransferases. (A) Arginine 
methylation/demethylation cycle. Type I, II and III PRMTs generate monomethylarginine (MMA) on one of the terminal guanidino 
nitrogen atoms. These two nitrogen atoms are equivalent. Next, Type I PRMTs are able to generate asymmetric dimethylarginine (ADMA) 
while Type II PRMTs generate symmetric dimethylarginine (SDMA). Type III PRMTs can only catalyze the first step to MMA. Two classes of 
enzymes have been described that are able to reverse the methylation reaction. PADI4 actually converts arginine and methylarginine to 
citrulline, while releasing either an imino or a methylimino group. There is no evidence yet for an enzyme catalyzing the remaining step 
of converting citrulline back to arginine. JMJD6, a member of the second class of enzymes, is part of the large Jumonji family of 
demethylases. The demethylase activity of this protein has thus far only been characterized in vitro and does not seem to discriminate 
between the demethylation of ADMA or SDMA back to arginine.  
(B) PRMT family members. The mammalian PRMTs consist of nine members, highly related and conserved in amino acid sequence and 
structure; two classes, PRMT Type I and Type II, differ slightly in their catalytic binding pocket, which allows MMA to be converted into 
ADMA or SDMA, respectively. All PRMTs contain the conserved methyltransferase signature motifs I, post I, II and III as well as the 
‘double E loop’ and ‘THW loop’ (in black or colored bars, the consensus sequence is indicated). PRMT2 (SH3 domain in purple), PRMT3 
(Zn Finger in yellow) and PRMT9-4q31 (tetratricopeptide repeat domains in green) contain additional protein domains that might 
contribute to substrate recognition or mediate protein–protein interactions. PRMTs are ordered based on their sequence similarity 
clustering. Right panel: enzymatic activity on histone substrates is indicated to the right of each PRMT. 
PMRT: Protein arginine N-methyltransferase.
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explanation is that PRMT1-driven H4R3me2a 
methylation antagonizes PRMT5-driven sym-
metric dimethylation of the same residue 
(H4R3me2s), which has been linked to deacet-
ylase activity [59,60]. In addition, the presence 
of H4R3me2s at repressed promoters strongly 
correlates with another histone modification 
on histone H3: H3R2me2a [4]. H3R2me2a 
blocks mixed lineage leukemia (MLL) bind-
ing and subsequent transcriptional activation 
(FIGURE 1B) [4,38,61]. A recent study links H4R3me2a 
to other acetylation events on both H3 and H4, 
and correlates the loss of H4R3me2a to a poor 
prognosis in breast carcinomas [62]. Loss of acety-
lation on H4K16 and methylation on H4K20, 
specifically on repetitive sequences, has already 
been demonstrated to be a hallmark of cancer 
[63]; however, whether loss of H4R3me2a dimeth-
ylation also occurs on repetitive sequences or on 
other genomic locations, needs to be investigated.
H3R17me2a
A few years after the identification of PRMT1 as 
the major Type I PRMT, CARM1, also known 
as PRMT4, was demonstrated to methylate his-
tone H3 at positions 17 (H3R17me2a) and 26 
(H3R26me2a) [64]. Soon after, the presence of 
H3R17 asymmetric dimethylation on promoters 
was linked to estrogen-receptor-regulated pS2 
gene activation [65] and to steroid-hormone-
dependent activation [66]. A total of 1 year later, 
arginine methylation by CARM1/PRMT4 was 
linked to lysine acetylation [67]. H3K18 and 
H3K23 acetylations by CBP precede and favor 
the high-affinity binding of CARM1/PRMT4 
to chromatin. H3R17 is subsequently methyl-
ated, and this is followed by enhanced gene tran-
scription. Once again, the ordered deposition of 
these modifications was suggested to cooperate 
in transcriptional activation, but many questions 
remain unanswered: which proteins act down-
stream of H3R17me2a? Are HATs or chroma-
tin remodeling complexes recruited by a direct 
docking mechanism on H3R17me2a? These 
are questions that will need to be answered in 
the near future (FIGURE 1A). Other reports have 
linked CARM1 to co-stimulatory functions. 
Torres-Padilla and colleagues have demon-
strated a role for PRMT4 in the regulation of 
cell fate and pluripotency [68]. Specifically, the 
degree of methylation of the arginine residues 
targeted by CARM1 is highest in those cells that 
are destined to contribute to the inner cell mass 
and the polar trophoectoderm. Conversely, the 
murine trophoectoderm is characterized by low 
arginine methylation on the H3 tail (H3R17 
and H3R26). This result suggests that epi-
genetic PTMs might be important in directing 
blastomeres to become part of the inner cell 
mass, increasing the transcriptional levels of 
genes responsible for the maintenance of pluri-
potency, such as Oct4, Sox2 and Nanog. Further 
work by the same group characterized the role 
of PRMT4 in mES cells by selectively depleting 
or overexpressing this enzyme. The results sug-
gest that PRMT4 is important in maintaining 
pluripotency, as cells lacking PRMT4 upregulate 
endodermal, mesodermal and trophectodermal-
specific genes, while cells overexpressing the 
enzyme have a delay in their differentiation upon 
RA treatment [69].
H3R26me2a
Much of what is known about H3R17me2a can be 
applied to H3R26me2a. Both arginines are meth-
ylated in vitro and in vivo by PRMT4, and have 
been correlated to gene activation. What remains 
to be explored is whether PRMT4, when present 
in macromolecular complexes within cells, such 
as the nucleosomal methylation activator com-
plex (NUMAC) [70], can preferentially methyl-
ate either H3R17 or H3R26. The prediction is 
that these two PTMs might play different roles, 
since the unmethylated arginines (H3R17me0 
and R26me0) potentially contact different H3 
histone binders and engage in different hydrogen 
bonds (FIGURE 1A & 1B).
H3R17me2a could either interfere or stimu-
late the binding of bromodomains, such as the 
one contained in PCAF, to the histone H3 tail. 
The PCAF bromodomain has indeed been dem-
onstrated to specifically bind to H3K14 when 
acetylated, and may contact the surrounding 
amino acids, including H3R17 [71]. Similarly, 
H3R26 is predicted to affect the binding of 
PC/CBX proteins [72] or of the mammalian 
PRC2 complex to H3K27me3 [73]. Whether 
H3R26 methylation plays a modulating role in 
Polycomb repressive functions still remains to 
be explored (FIGURE 1B). 
Repressive arginine methylations
H4/H2AR3me2s
The symmetric dimethylation of arginine 3 
on histone H4 can be catalyzed by at least two 
enzymes: PRMT5 and PRMT7 [74–76]. Unlike 
PRMT1, however, both PRMT5 and PRMT7 
catalyze the formation of SDMA (H4R3me2s). 
Initial reports associated the symmetric dimeth-
ylation at H4R3 with transcriptional repression, 
since PRMT5 was co-purified with a high-molec-
ular weight E2F4-containing complex termed 
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Cyclin E1 repressive complex. This complex, as 
the name suggests, represses Cyclin E1 transcrip-
tion, at least in part through the catalytic activity 
of PRMT5 [77]. Sif and colleagues later described 
PRMT5 as linked to hSWI/SNF-mediated 
repression [59,60]. The Brg1 chromatin remodeler, 
in association with mSin3A/histone deacetylase 
(HDAC)2 and PRMT5, binds to promoters of 
repressed genes, including genes regulated by 
the Myc–Max–Mad network (cad, nuc), and 
the tumor suppressors NM23 and ST7. These 
promoters are characterized by hypoacetylated 
H3 and H4 tails, which are preferentially methyl-
ated on H4R3me2s and H3R8me2s [59,60]. The 
importance of H4/H2AR3me2s in transcrip-
tional repression was later associated with can-
cer [78–80], but it was only recently that a direct 
mechanism linking the methylation on arginine 
H4/H2AR3me2s to a downstream event was 
described. Zhao and colleagues showed that 
H4R3me2s is a direct docking site for the DNA 
methyltransferase DNMT3A, which interacts 
with the methylated histone H4 tail through a 
PHD finger contained in the C-terminal ADD 
domain [15] (see BOX 1 for details on DNA methyla-
tion). PRMT5 is the main enzyme responsible 
for this methylation event, and a reduction in 
PRMT5 levels leads to diminished DNMT3A 
binding to chromatin, loss of DNA methylation 
and a subsequent increase in gene expression. 
Although the evidence is limited to a single model 
of gene regulation during cell differentiation (the 
E-globin locus), these data are key in expanding 
our knowledge on how arginine methylation can 
be directly linked to DNA methylation and gene 
silencing. In light of these results, two papers 
describing the link between arginine methyla-
tion and its role in germ cells differentiation and 
establishment of imprinting can be reinterpreted. 
Jelinic and colleagues linked the arginine meth-
ylation event on H4R3, driven by PRMT7, in 
combination with CTCFL, to DNA methylation 
at the Igf2/H19 imprinting control region [76]. 
The authors describe the arginine methylation 
event as being upstream of DNA methylation, 
since the expression of DNMT3a/b/L in the 
absence of PRMT7/CTCF in Xenopus oocytes 
does not lead to efficient methylation of the ana-
lyzed sequence. Interestingly, in the same assay, 
DNMT3a/b, in the absence of DNMT3L, did 
not yield a sufficient level of methylation. These 
data not only reinforce the importance of the 
DNMT3L noncatalytic subunit in establishing 
DNA methylation in germ cells, but suggest the 
existence of crosstalk between H4R3m2s and the 
unmethylated histone H3 tail. The PHD finger 
of DNMT3L has been demonstrated to selec-
tively bind histone H3 only in the absence of 
H3K4 methylation, and combination of the two 
tails (H3K4me0/H4R3me2s) could favor the tar-
geted methylation event at imprinted loci [81,82]. 
Regarding the hierarchical order between argi-
nine and DNA methylation, more work needs 
to be carried out to draw a conclusion. A recent 
paper shows that a lack of DNMT3L-dependent 
DNA methylation at imprinted loci leads to the 
loss of H4R3me2s, as well as other repressive his-
tone modifications [83]. The consensus, at pres-
ent, is that the symmetric methylation events on 
H4R3 and on DNA are interdependent, with the 
loss of one leading to the loss of the other. In a 
second paper, Ancelin and coworkers describe 
PRMT5 as a crucial partner of Blimp1, a tran-
scriptional repressor essential for primordial 
germ cell (PGC) specification [84]. The authors 
describe a relocalization of PRMT5/Blimp1 from 
the nucleus to the cytoplasm, with consequent 
loss of H4R3me2s and a de-repression of target 
genes, such as dhx38. These events coincide with 
the timing of imprint erasure and global genome 
demethylation in germ cells (E11.5). Whether 
a link between H4R3me2s demethylation 
and DNA demethylation is present, however, 
remains unclear.
H3R8me2s
The activity of PRMT5 on different substrates 
such as histone H3 and H4 is modulated by 
various cofactors. COPR5 is a nuclear protein, 
which binds to PRMT5, favoring its H4 spe-
cific activity (H4R3me2s) over its H3 activity 
(H3R8me2s) [85]. Whether there is a different 
cofactor directing methylation on H3R8 is still 
unknown. H3R8me2s, like H4R3me2s, has 
been associated with transcriptional repres-
sion [60]. Hypoacetylated histones are preferen-
tially methylated by PRMT5, and specifically, 
both H3K9ac and H3K14ac, block PRMT5 
mediated H3R8 methylation in vitro. This cross-
talk was also demonstrated in cell lines, where 
overexpression of PRMT5 leads to H3K9ac 
downmodulation at the ST7 and NM23 pro-
moters, concurrent with H3R8me2s upregula-
tion. This is consistent with the recruitment, 
by the PRMT5 complex, of HDAC activity, 
though, whether H3R8me2 plays a direct role 
in blocking acetylation by HATs still remains 
to be demonstrated [60]. 
Two other described interactions involve 
the H3K9 methyltransferase G9a and the 
H3K9me3 reader, HP1. In vitro evidence sug-
gests that H3R8me2s is capable of blocking 
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G9a-mediated H3K9 methylation [86]. In this 
context, the methylation of R8 might interfere 
with G9a functions such as establishment of 
imprinting and maintenance of euchromatic 
methylation at lysine 9, but direct in vivo evi-
dence is still missing [87]. HP1 has been crys-
tallized with a histone H3 peptide, and makes 
essential contacts with unmethylated H3R8. 
Mutation of the arginine to alanine impairs 
binding, and it is likely that dimethylation 
would have a very similar effect (FIGURE 1B) [34,35]. 
In these two latter examples, H3R8 methylation 
acts as a transcriptional activator rather than a 
repressor, blocking two well-described mecha-
nisms of transcriptional repression. H3R8me2s 
has also been associated with transcriptional 
activation, at least in the context of myogenic 
differentiation [88]. Whether this occurs in other 
contexts, however, needs to be explored.
H3R2me2a
The asymmetrical dimethylation on arginine 2 
of histone 3 (H3R2me2a), catalyzed by PRMT6, 
has been demonstrated to block the trimethyl-
ation on H3K4 [38]. Although the enzyme cata-
lyzing H3R2me2a in yeast has not yet been iden-
tified, a similar mechanism of mutual exclusion 
between H3R2me2a and H3K4me3 on chroma-
tin has also been described in S. cerevisiae [89]. 
In mammalian cells, H3R2me2a prevents the 
MLL-mediated trimethylation of H3K4 by 
blocking the binding of MLL/WDR5 to the 
histone H3 tail [37,38,61]. Conversely, H3K4me3 
impairs the asymmetrical methylation of H3R2, 
both in vitro and in vivo, on Myc targets and 
on genes of the HOXA cluster [38,61,90]. In yeast, 
the mechanism regulating the mutually exclu-
sive deposition of these two PTMs is different, 
as spp1, the homolog of Ash2L (by contrast to 
Box 1. DNA methylation.
  DNA methylation is a chemical modification that involves the post-synthetic addition of a methyl group on the 5th carbon of cytosine, 
typically in a cytosine–phosphate–guanine (CpG) dinucleotide context. There are two patterns of CpG distribution within the human 
and mouse genomes: a large proportion of CpGs are dispersed and generally methylated (<1 every 100 bps); a minor fraction of CpGs 
are instead clustered together and are termed CpG islands. Usually these islands are more than 500 bp in length, with a GC content 
greater than 55% and an observed CpG:expected CpG ratio of 0.65 [116]. CpG islands co-localize with the transcriptional start site 
of around 70% of genes [117], and their methylation status correlates with promoter activity [118]. DNA methyltransferases are the 
enzymes responsible for DNA methylation. In vertebrates, 3 families of DNA methyltransferases (MTases) comprising four members have 
been identified: DNMT1, DNMT2, DNMT3a and DNMT3b. In addition, DNMT3L has been identified as a cofactor of the DNMT3a and 
DNMT3b enzymes. They contain a C-terminal domain, of approximately 400–500 amino acids, which is characterized by the presence of 
10 conserved amino acid motifs shared between prokaryotic and eukaryotic DNA-(cytosine-C5)-MTases [119]. The catalytic core and co-
enzyme-binding site of MTases reside within this domain. In addition, DNMT1 and DNMT3 harbor large N-terminal regulatory regions, 
while DNMT2 is completely devoid of any N-terminal regulatory sequences [119,120]. The N-terminus of DNMT1 and DNMT3 acts as a 
platform for the binding of proteins involved in chromatin condensation, gene regulation and DNA replication.
– DNMT1 is the maintenance methylase and its main role is to preserve the epigenetic methylation pattern during DNA replication, 
ensuring the hemi-methylated strand gets fully re-methylated [121].
– DNMT3a and DNMT3b are ‘de novo’ methylases, and they target unmethylated or hemi-methylated substrates with equal efficacy. 
In vivo DNMT3a and DNMT3b are required for the setting up of DNA methylation at single-copy genes and repetitive sequences, 
respectively [122]. 
– DNMT3L is a regulatory subunit of DNMT3a and DNMT3b, and plays a fundamental role in establishing methylation at imprinting 
regions [83]. It does not possess enzymatic activity, but can interact with the unmethylated histone H3, contributing to stabilize the 
complex on chromatin [82].
– DNMT2 is the least characterized protein of the family, with very weak DNA methylation activity, but a robust RNA methylation 
activity [123,124]. Recently an in vivo function of DNMT2 in mediating DNA methylation in Drosophila embryos has been 
demonstrated [125].
  Different post-translational modifications on histones can cooperate with DNA methylation to modulate different gene-repression 
programs (reviewed in [122]). There is evidence for both the requirement of DNA methylation to establish repressive histone modifications 
and vice versa. 
– Methylated CpGs are recognized by methyl-CpG-binding domain (MBD)-containing proteins. There are five MBD-containing 
proteins in mammals: MBD1–4 and MeCP2. With the exception of MBD3 they all bind to 5meCpG [126], and help recruit repressor 
complexes containing histone deacetylases, histone methyltransferases and chromatin remodeling complexes [127]. Similarly, at least 
four proteins containing C2H2 zinc fingers have been demonstrated to recognize 5meCpGs: Kaiso, ZBTB4, ZBTB38 and UHRF1 [128]. 
Like MBDs, Kaiso, ZBTB4 and ZBTB38 are also able to recruit to chromatin several repressive complexes containing histone 
deacetylases (NCoR, mSin3a and SMRT) [129,130]. UHRF1 is unique, as its methyl DNA binding domain binds preferentially to 
hemi-methylated CpG sites [131]. Consistently, UHRF1 interacts with DNMT1, and is part of the complex responsible for maintenance 
of the CpG methylation status following DNA replication.
– Conversely, other studies unraveling the mechanism by which key pluripotency regulators, such as Oct4, are repressed during 
development, demonstrate that mutations or downregulation of histone methyltransferases can also lead to impaired DNA 
methylation [132,133].
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the WDR5 homolog), is excluded from bind-
ing to histone H3 when R2 is asymmetrically 
dimethylated, and this in turn prevents Set1 
methylation on H3K4.
These two marks (H3R2me2a and 
H3K4me3) have a mutually exclusive distribu-
tion on chromatin in both human and yeast 
cells [4,38,89]; while H3K4me3 is mainly pres-
ent within 2–3 kb around active transcription 
start sites, H3R2me2a is distributed outside of 
these domains and correlates with transcription-
ally inactive promoters [38,89]. The link between 
H3R2me2a and transcriptional repression is fur-
ther reinforced by a number of studies in which, 
at least in vitro, the asymmetric dimethylation of 
arginine 2 reduces, or completely abrogates, the 
binding of key components of the transcriptional 
machinery. This is the case for the PHD fingers of 
the TAF3 subunit of the TFIID complex [33], for 
the ING subunits within the HAT and HDAC 
complexes [14,30,57] and for the BPTF subunit of 
the NURF complex [32]. In each of these cases, 
the R2 side chain is buried within hydrophobic 
pockets, and the presence of a methyl moiety 
is likely to cause a clash with the surrounding 
amino acids that are part of the binding cage 
(FIGURE 1B). However, this is not the case for all 
PHD fingers. Two examples are the PHD fin-
gers of BHC80 and DNMT3L, which are not 
affected by H3R2me2a, and are instead excluded 
from interacting with the histone H3 tail in the 
presence of H3K4 trimethylation. The PHD fin-
ger of BHC80 makes contacts with H3K4me0 
and with H3R8 but not with H3R2, while the 
resolution of the DNMT3L crystals is too low to 
appreciate the structure of the bound H3R2 side 
chain (FIGURE 1B) [82,91]. 
Similar to PHD fingers, which bind to his-
tone H3, other domains such as the double 
chromodomain of CHD1, a chromatin remod-
eling protein [36], and the double Tudor domain 
of JMJD2A, a histone H3K9 demethylase [25], 
are also affected by the presence of the asym-
metric dimethylation on R2. JMJD2A binds 
to H3K4me3 and contributes to promote gene 
activation, as it has been observed for andro-
gen receptor responsive targets [92]. Whether 
H3R2me2a also plays a role in this context, 
needs to be proven.
 Citrullination &  
arginine demethylation
As discussed so far, arginine methylation can 
act in different ways in a signaling cascade 
that leads to either transcriptional activation 
or repression (FIGURE 1A & 1B). One of the key 
biochemical events in all signaling cascades is 
reversibility, and thus it is very important to dis-
cuss how arginine methylation can be removed, 
restoring the ground state of nonmethylated 
arginine. So far, four major mechanisms for the 
removal of methylated arginines from histones 
have been suggested.
Histone substitution
In this scenario, there is a rapid exchange of a 
methylated histone for a nonmethylated one. 
This can be coupled to transcriptional acti-
vation, since the -1 nucleosome (relative to 
the transcription start sites), is enriched for 
H3K4me3 and the histone variant H2A.Z [93], 
and can be preferentially evicted upon transcrip-
tional activation in human cells. Alternatively, 
histone chaperones can play a role in substituting 
H2A/H2B or H3/H4 dimers [94], but whether 
arginine methylation plays a role in facilitating 
any of these processes is not known.
Histone-tail cleavage
This mechanism has been recently proposed to be 
conserved in both higher and lower eukaryotes, 
and is mediated by specific serine endo peptidases 
such as mammalian cathepsyin L [95,96]. The con-
sensus in both model systems is that such ‘clip-
ping’ mechanisms occur preferentially on histone 
H3 after 21 amino acids, and that modifications 
associated with gene activation such as acetyla-
tion at position 23 or methylation at position 4 of 
histone H3 tend to impair this clipping process 
[95,96]. The biological meaning of these clipping 
events however remains unclear, as they seem to 
precede histone eviction and gene activation in 
yeast, specifically under nutrient deprivation or 
sporulation [96], while correlating with differenti-
ation in ES cells [95]. The net result of the clipping 
event is to eliminate the entire N-terminal tail of 
H3, containing, depending on the situations and 
the model system, arginine methylation at posi-
tion 2, 8 and 17. Whether arginine methylation 
plays a direct role in controlling histone clipping, 
remains to be explored, although in vitro meth-
ylation assays suggested that at least the asym-
metric dimethylation of H3R2 (H3R2me2a) is 
permissive for cleavage [96].
Conversion to citrulline
Conversion of arginine to citrulline occurs 
through an enzymatic reaction that releases 
imine or methylimine, and converts the amino 
acid into citrulline (FIGURE 2A) [97,98]. Cuthbert and 
colleagues first showed that peptidyl arginine 
deaminase (PADI)4, a nuclear member of the 
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PADI family, promiscuously deiminates argi-
nines on histone H3 (H3R2, H3R8, H3R17 and 
H3R26) and that deimination by PADI4 coun-
teracts arginine methylation by CARM1. The 
authors also concluded that dimethylation of 
arginines prevents deimination by PADI4 [98]. In 
a parallel paper, Wang and colleagues detected 
the release of methylamine from CARM1 or 
PRMT1 asymmetrically dimethylated argi-
nines [97] on both H3 and H4, suggesting that 
asymmetric dimethylation could be permis-
sive for the deimination reaction carried out by 
PADI4. High levels of citrullinated histones are 
detected on decondensed chromatin in both 
HL-60 granulocytes and blood neutrophils 
during the formation of neutrophil extracelluar 
traps (NETs). This seems to be a global effect, 
similar to, but distinct from, that observed for 
H4K16ac [99]. Citrullinated histones directly 
impair the compaction of in vitro assembled his-
tones, thus defining a biochemical mechanism 
associated with the presence of this unconven-
tional amino acid on histones [100]. A recent paper 
strengthens the link between PADI4-mediated 
citrullination and histone deacetylation, specifi-
cally studying the pS2 promoter, and the mutu-
ally exclusive presence of citrullinated H3 and 
methylated arginine 17 [101]. The cyclical appear-
ance of citrullination and arginine methylation 
on the estrogen-activated promoter suggests that 
citrullines have to be quickly converted into 
newly methylatable arginines [101]. Given that 
several papers have indeed questioned whether 
methylated arginines are a physiological sub-
strate for PADI4, as both MMA and ADMA are 
either poor substrates or completely refractory to 
de imination [102,103], the most likely explanation 
is that the unmethylated arginine ground-state 
is re-established either by histone substitution or 
by yet to be identified enzymes able to convert 
citrullines back to arginines (FIGURE 2A).
Direct histone demethylation
Demethylation by FAD-dependent monoamine 
oxydases such as LSD1 and members of the 
Jumonji family has been extensively studied in 
the past few years (see [27] for a recent review). 
So far, only one member of the Jumonji family, 
JMJD6, seems to possess an arginine demethyl-
ase activity [104]. This, however, has been recently 
challenged by Webby and coworkers, who claim 
that JMJD6 has a stronger lysine-hydroxylase 
activity than an arginine demethylase activ-
ity [105]. The authors link JMJD6 to the regula-
tion of gene expression via the post-translational 
hydroxylation of the splicing factor U2-small 
nuclear ribonucleoprotein auxiliary factor-65 
(U2AF65), which in turn affects the regulation 
of RNA splicing of a subset of genes [105]. Chang 
and colleagues had also previously reported a 
similar activity, but as they were enriching for the 
arginine monomethylated pepides in their mass 
spectrometric analysis, they might have overesti-
mated the demethylase function with respect to 
the hydroxylation function [104]. Moreover, the 
fact that JMJD6 shows no preference, in vitro, for 
either asymmetrically or symmetrically dimeth-
ylated substrates, poses a question regarding the 
specificity of this reaction. Further work on this 
enzyme is needed to assess which reaction is pref-
erentially catalyzed in vivo and whether cofactors 
can confer substrate specificity. 
Future perspective
A few areas in the PRMT field will need to 
be explored in the near future. These will be 
discussed in the following sections.
 In vivo functions of PRMTs
We have learned much about the biochemistry of 
PRMTs by studying their activity in vitro. Now 
we need to progress to studying the function of 
PRMTs in cells and animal systems. To do that 
we can take advantage of three main approaches: 
genomics, proteomics and drug discovery.
Genomics
Our knowledge of which genes are controlled by 
different PRMTs is very limited and is mainly 
based on single-gene analyses [38,55,61,69,76,80]. 
Chromatin immunoprecipitation (ChIP) is an 
essential technique for analyzing protein–DNA 
interactions in vivo, and when combined with 
technologies such as microarrays (ChIP-on-
chip) or deep sequencing (ChIP-PET and 
ChIP-Seq), it gives rise to powerful platforms for 
high-throughput genomic analysis. These ChIP-
based approaches allow genome-wide epigenetic 
studies and have already greatly advanced our 
understanding of the ‘epigenetic landscape’ in 
different systems. As an example, we now have 
a very clear picture of which genomic loci are 
occupied by different transcription factors in 
mouse embryonic stem cells [106] and whether 
they overlap with defined histone PTMs [107] 
or with DNA methylation [108]. Similarly, 
large-scale mapping studies of the genomic 
sites occupied by different PRMTs, in different 
cell lines or tissues, will give us a better under-
standing of the regulatory pathways controlled 
by these enzymes. Moreover, this information, 
together with the mapping of histone arginine 
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methylation in the same systems, will advance 
our understanding of how these PTMs control 
transcription. Further bio chemical validation 
will nevertheless be necessary to ultimately 
define the role of each methylated arginine on 
histones. Finally, with the generation of con-
ditional knockout animals lacking specific 
PRMTs, it will be possible to address the con-
sequences, in terms of global and promoter spe-
cific chromatin changes, of targeted deletions of 
PRMTs in a specific cell type and at a given time 
during development.
Proteomics
Structural determination of the endogenous 
complexes containing the different PRMTs will 
give us insight into how these enzymes target 
specific substrate arginines on different histones. 
So far, PRMTs have been studied as isolated pro-
teins, but evidence suggests that they act in large 
macromolecular complexes in vivo [109]. As an 
example, PRMT4 within the NUMAC is able to 
methylate nucleosomes, while the isolated pro-
tein preferentially methylates histones [70]. As for 
PRMT5, different interacting proteins are able 
to control its specificity. When complexed with 
COPR5, it preferentially methylates H4 over 
H3 [85], and this change in specificity, which 
can also redirect PRMT5 to methylate nonhis-
tone substrates, might also explain why PRMT5 
has been associated with both transcriptional 
repression and activation [88].
Drug discovery
Targeting arginine methyltransferase activity 
with a high degree of specificity will be instru-
mental in characterizing the role of PRMTs 
in vivo, and will hopefully be effective in treating 
malignancies such as certain subsets of lympho-
mas and hormone responsive tumors [80,110].
In the past, two categories of compounds have 
been used to block methyltransferase activity:
 Molecules that inhibit the activity of 
adenosyl homocysteine hydrolase, like ade-
nosine dialdehyde, resulting in the accumu-
lation of the methyl transferases natural 
inhibitor, adenosylhomocysteine;
 Analogs of S-adenosyl methyionine (SAM or 
AdoMet), like sinefungin, which compete 
with the cofactor to hamper methylation.
These classes of inhibitors are, however, highly 
aspecific, and cannot discriminate between 
arginine- and other kind of methyl transferases. 
Indeed, both arginine and lysine methyltransfer-
ases use SAM as a methyl donor. More recently, 
new small molecules, termed arginine methyl-
transferase inhibitors (AMIs) have been dem-
onstrated to more selectively target and block 
PRMT, as opposed to lysine methyl transe-
ferases activity [110]. AMI-1, one of the most 
effective compounds isolated by this screen, 
does not bind solely to the SAM pocket, but is, 
however, still not able to selectively inhibit the 
different PRMTs family members. Nonetheless, 
hormone dependent transcription can be nega-
tively affected by the presence of the drug [110]. 
The same authors also used AMI-5 chemical 
structure to further design a set of simplified 
analogs, obtaining compounds with higher 
potency, and in some cases higher specificity, 
to either PRMT1 or PRMT4/CARM1 [111]. A 
recent attempt to increase the specificity has 
been described by Osborne and colleagues who 
have developed a bisubstrate analog by combin-
ing a histone H4 peptide, a known substrate of 
PRMT1, with N-mustard, 5 -´(diaminobutyric 
acid)-N-iodoethyl-5´-deoxyadenosine ammo-
nium hydrochloride, to generate a PRMT1 
specific inhibitor [112]. 
Virtual screening and chemical docking stud-
ies [113–115] have also been attempted and the 
common conclusion from these very promising 
studies is that larger libraries and more refined 
docking tools will be necessary before these 
compounds will reach the desired specificity and 
potency to be used in vivo.
 Arginine methylation  
signaling cascade
This last point leads directly to one of the crucial 
challenges in the arginine methylation field; so 
far many methylation events on histones have 
been associated with either gene activation or 
repression. We must now attempt to understand 
the biochemical mechanism, and the causal role, 
behind this association, and to do this we need 
to gain a better understanding of the proteins 
that act both upstream and downstream of the 
arginine methylation events.
Upstream
If we think of arginine methylation as yet 
another way of transducing the signal in a 
cascade, then we need to find out how these 
enzymes are regulated in different tissues and 
during key physio logical and pathological events 
such as differentiation, development and cancer. 
Conditional knockout mice will be instrumental 
in this effort, as they will allow us to study the 
effects of loss of different PRMTs in a spatially 
and temporally restricted manner. 
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Executive summary
Arginine methylation is catalyzed by protein arginine methyltransferases
  There are two classes of protein arginine methyltransferases (PRMTs): Type I PRMTs promote the formation of asymmetrically 
dimethylarginine (:-NG,NG-dimethylarginine), Type II PRMTs catalyze the formation of symmetrically dimethylarginine (:-NG,N’G-
dimethylarginine). Both types, and a third type (Type III), are capable of forming :-NG-monomethylarginine.
Arginine methylation on histones
  Histones H3, H4 and H2A have been reported to be monomethylated (H3R2me1, H4R3me1), asymmetrically dimethylated  
(H4/H2AR3me2a, H3R2me2a, H3R17me2a and H3R26me2a), and symmetrically dimethylated (H4/H2AR3me2s and H3R8me2s). These 
can be divided into two groups, based on their role in transcription regulation:
– Activating arginine methylations: H4/H2AR3me2a, H3R17me2a and H3R26me2a.
– Repressive arginine methylations: H4/H2AR3me2s, H3R8me2S and H3R2me2a.
Methylated & unmethylated arginines can act in two major ways to increase the complexity of the ‘histone code’
  Methylated arginines can act as docking sites for other proteins on histone tails (examples include the plant homeodomain finger of 
DNMT3a binding to H4R3me2s and the plant homeodomain finger of RAG2 binding to H3K4me3/H3R2me2s).
  Methylated arginines can act as exclusion marks, impeding the binding of proteins to histones (examples include the WD40 domain 
containing protein WDR5, the PHD finger of ING2, of TAF3 and of BPTF, the double chromodomain of CHD1 and the double Tudor 
domain of JMJD2A, which are all excluded from binding to histone H3 when H3R2 is asymmetrically dimethylated [H3R2me2a]).
Research areas in the protein arginine N-methyltransferase field in the near future
  To explore the in vivo functions of PRMTs, using high-throughput genomics and proteomics techniques and by developing specific 
PRMT inhibitors.
  To characterize the signaling cascade both upstream and downstream of histone arginine methylation. Upstream events controlling 
enzymatic activity of PRMTs need to be elucidated, and we still need to uncover the full repertoire of downstream effectors, which are 
able to ‘read’ the methylated arginine and interpret them in terms of transcriptional output.
Downstream
It will be essential to identify new arginine bind-
ing modules in different proteins: so far only 
four proteins containing a Tudor domain (SMN, 
SPF30 and TDRD3) or a PHD finger (Dnmt3a) 
have been demonstrated to directly interact with 
dimethylated arginine residues. Additional stud-
ies are needed to obtain the full repertoire of 
interactors in each tissue. This is particularly 
important because not all PRMTs are ubiqui-
tously expressed, and in addition, different pro-
teins can recognize the same methylated residue 
in different contexts. Several high-throughput 
techniques will allow for the rapid screening of 
potential methyl–arginine interactors: see TABLE 2 
for details.
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A direct effect of post-translational modifications (PTMs) on nucleo-
somes is the formation of a dynamic plat-
form able to assemble the transcriptional 
machinery and to recruit chromatin 
modifiers. The histone code hypothesis 
suggests that histone PTMs can act as 
binding sites for chromatin readers and 
effector proteins, such as the bromo-
domains, that selectively interact with 
acetylated lysines, or the “Royal family” 
and the PHD finger domains, which are 
able to recognize methylated arginines 
and lysines. In this review we will dis-
cuss recent data describing the function 
of WD40 proteins as a new class of his-
tone readers, with particular emphasis 
on the ones able to recognize methylated 
arginine and lysine residues. We will 
discuss how WDR5, a classical seven-
bladed WD40 propeller, is able to bind 
with similar affinities both the catalytic 
subunit of the Trithorax-like complexes, 
and the histone H3 tail either unmodi-
fied or symmetrically dimethylated on 
arginine 2 (H3R2me2s). Furthermore, 
we will speculate on how these mutu-
ally exclusive interactions of WDR5 may 
play a role in mediating different degrees 
of H3K4 methylations at both promot-
ers and distal regulatory sites. Finally, 
we will summarize recent literature elu-
cidating how other WD40 proteins such 
as NURF55, EED and LRWD1 recog-
nize methylated histone tails, highlight-
ing similarities and differences among 
them.
On WD40 proteins
Propelling our knowledge of transcriptional control?
Valentina Migliori,1 Marina Mapelli2,* and Ernesto Guccione1,*


















































































WD40-Containing Proteins are 
Adaptor Proteins Mediating 
Protein-Protein Interactions
WD40 repeats (also known as WD 
repeats) are 40–60 amino acid motifs that 
preferentially end with a tryptophan and 
an aspartic acid (WD). They are highly 
conserved from bacteria to mammals, 
and are often found as part of multisub-
unit complexes, where they play a role in 
mediating protein-protein interactions. 
The first WD40 domain-containing pro-
tein was identified as part of the hetero-
trimeric G protein transducin complex.1 
The crystal structure of the β subunit 
of the complex showed the characteris-
tic seven blade β propeller fold, with a 
central cavity (Fig. 1A and B), and each 
blade comprising a four-stranded anti-
parallel β-sheet (Fig. 1C).2-4 It was later 
shown that β propeller can be assem-
bled with a number of repeats varying 
between 4 and 16 (SMART:SM00320; 
I N T E R P R O : I P R 0 0 1 6 8 0 ; 
PFAM:PF00400; PROSITE:PS00678).
As highlighted by the crystallographic 
structures determined to date, WD40 
domain proteins have several surfaces 
for the interaction with multiple bind-
ing partners, and it is no surprise that 
they are crucial for maintaining the 
integrity of the complexes that they are 
part of. They serve as interaction hubs 
and are associated with a wide variety 
of physiological pathways such as vesi-
cle biogenesis,5 cytokinesis,6 control of 
© 2012 Landes Bioscience.
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of WDR5 toward unmodified H3 ranging 
from 3.3 to 35 μM (KD). Moreover, despite 
an increased protein stability of WDR5 
bound to H3K4me2 over unmodified H3, 
as measured by differential static light 
scattering,24 none of the groups detected 
the increase in affinity toward K4 methyl-
ated peptides, that was initially reported.21 
Recently, it was shown that WDR5 binds 
H3 peptides symmetrically dimethylated 
on arginine (H3R2me2s) with a higher 
affinity, likely due to a reorganization of 
the water-mediated interaction network 
within the central channel. Specifically 
H3R2me2s is hydrogen-bonded to only 
one water molecule, as opposed to two 
waters bridging the interaction of WDR5 
with unmodified H3R2me.14 The crystal-
lographic structure of WDR5 in complex 
with H3R2me2s revealed a marginal shift 
of the methylated, hydrophobic guanidin-
ium group of H3R2 away from the single 
water molecule present in the direction of 
a hydrophobic pocket contributed by the 
Phe219 of WDR5 (Fig. 2A). Phe219 is 
thus an important determinant of the high 
affinity interaction between WDR5 and 
H3R2me2s. Following this line of reason-
ing, mutation of Phe219 into more hydro-
philic residues (WDR5-F219H) reduces 
the binding affinity between H3R2me2s 
and WDR5 from a KD of 0.1 μM to 
0.2–1.1 μM, without severely affecting 
the binding to the unmodified H3R2me0 
(KD of 5.6 ± 1.5μM to 7.0 ± 2.0μM) 
(Migliori and Guccione, unpublished).
methyltransferases (PRMTs) and sequen-
tially asymmetrically (by Type I PRMTs) 
or symmetrically (by Type II PRMTs) 
dimethylated.15 Only a few proteins have 
been shown to interact specifically with 
methylated arginines on histones. For 
example, TDRD3 is a transcriptional 
co-activator which directly interacts 
with H3R17me2a16 (where “a” stands 
for asymmetric), and the ADD domain 
of DNMT3A could possibly bind to 
H4R3me2s (where “s” refers to symmet-
ric), though this is still controversial.17,18
Recently, it has been shown that the 
methylation on H3R2 critically affects 
the binding of the transcriptional co-
activator protein WDR5, to histone H3. 
Specifically, the symmetric dimethylation 
leads to WDR5 recruitment,14 while the 
asymmetric dimethylation excludes its 
binding.13,19,20
Wysocka and coworkers showed that 
WDR5 could bind to unmodified his-
tone H3, and that the affinity was stron-
ger between WDR5 and a dimethylated 
H3K4 peptide (H3K4me2).21 Three later 
studies independently were able to deter-
mine the structure of WDR5, which folds 
as a classical seven-bladed β-propeller 
(Fig. 2A),22-24 bound to H3. Analysis of 
the structure revealed that Ala1, Arg2 and 
Thr3 of H3 are important for the specific-
ity of binding, and that the side chain of 
Arg2 inserts into the central channel of the 
β-propeller.22-24 Depending on the assay 
used, the three groups reported an affinity 
protein stability,7 RNA processing,8 con-
trol of replication9,10 and transcriptional 
regulation.11-14
In terms of transcriptional regulation, 
proteins containing WD-domains, such 
as EED, LRWD1, WDR77, RbBP4/7 and 
the homolog Drosophila NURF55, have 
been shown to mediate the localization 
of chromatin modifiers to specific sites on 
the genome by directly binding to histones 
and their methylated tails.
Here, we will summarize recent litera-
ture elucidating how WDR5, EED and 
NURF55 bind to histone tails, highlight-
ing similarities and differences between 
them.
WD40 Containing Proteins as 
Chromatin Readers
WDR5. Unlike phosphorylation or acety-
lation, methylation of histones does not 
change the overall charge of the modi-
fied amino acids, but it does render them 
bulkier and more hydrophobic. It is thus 
thought that methylation at specific sites, 
either on the histone globular domain or 
on the tails, can lead to either transcrip-
tional activation or repression, depending 
on downstream proteins recognizing the 
specific methylation event. Methylation 
can occur either on lysines, which can 
be mono-, di- or trimethylated by lysine 
methyltransferases (KMTs) or on argi-
nines, which can be monomethylated 
by class I, II and III protein arginine 
Figure 1. Topology of WD40 β propellers. (A and B) Ribbon diagrams of a seven-bladed WD40 β propeller viewed from the side and from the top. 
The blades are organized sequentially, and pack on each other counterclockwise around a central channel. The closure of the ring-like structure is 
achieved in blade 7 by the contribution of the β-strand 7d deriving from the N-terminal residues of the domain. (C) Each blade of the β propeller con-
sists of a β-sheet formed by four antiparallel β-strands, which are denoted a-b-c-d starting from the innermost strand to the most peripheral. Notably, 
the strand d of each blade corresponds to the N-terminal strand of the subsequent WD40 repeat.
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How is it possible to reconcile these 
biochemical data with the high degree of 
co-localization observed in vivo between 
H3R2me2s and methylated H3K414,30? 
The presence of H3K4me1 at distal 
regulatory sites has been long observed 
by several groups,31-33 but the mecha-
nism by which H3K4me1 is preferen-
tially catalyzed over H3K4me2/3 is still 
largely unknown. One possibility is the 
The topology of the WDR5:MLLWin inter-
action is reminiscent of what observed for 
WDR5:H3R2 (Fig. 2B).
Very importantly there seem to be a 
direct competition between H3 and the 
Win motif peptides in binding to WDR5, 
implying that the Win motif acts as dose 
dependent inhibitor of complex forma-
tion and catalytic activity toward H3K4 
methylation.29
Intriguingly, works by other groups25-27 
have shown that the binding pocket of 
WDR5, which interacts with H3R2me2s, 
can also interact with the SET domain 
of MLL1 with comparable affinity, via 
the so called Win (WDR5 interacting) 
motif.14,25-27 This association is not specific 
for MLL1, as initially thought, and it is 
indeed conserved among all SET domain 
members: MLL2–4, SET1A and SET1B.28 
Figure 2. Structural organization of WD40-domains in complex with histone tails and other ligands. (A) Structure of WDR5 (colored in light blue) in 
complex with the N-terminal fragment of histone H3 (in yellow balls-and-sticks) symmetrically di-methylated on Arg2 (PDB id 4A7J). The H3 peptide 
lines on the top surface of the β propeller inserting the Arg2 side chain into the central channel, in between two conserved Phe aromatic rings. At the 
bottom of the cavity, the interaction is further stabilized by hydrophobic interactions with Phe219 and a water-mediated hydrogen bond to Ser175. In 
this con"guration, the side chain of Lys4 points away from the propeller. (B) The MLL2 Win peptide encompassing Arg5065 (shown in pink) binds to 
WDR5 in much the same way as the histone H3 N-terminus, implying that the two ligands are mutually exclusive interactors of WDR5 (PDB id 3UVK). 
(C) Architecture of the EED WD40 propeller (displayed in green) in complex with histone H3 trimetyhylated on Lys27 (PDB id 3IIW). The methylated 
H3K27 side chain is docked on the propeller surface by hydrophobic interactions contributed by Phe97, Tyr148 and Tyr365. The presence on EED of 
bulky residues such as Tyr308 and Trp364 restricts the binding to histone peptides coding for small residues in position -2 from the methylated Lys. (D) 
Topology of NURF55 (colored in lilac) bound to histone H4 (PDB id 2XYI). The histone H4 peptide folds as a α-helix that "ts into a groove on the lateral 
surface of the propeller. The amphipathic character of the helix with positively charged residues on the left side and hydrophobic side chains on the 
opposite, matches the chemical environment of the propeller’s groove (left panel). (E) The PRC2 subunit Su(z)12 (shown in red) recognizes the same 
lateral groove of the NURF55 propeller occupied by histone H4 (PDB id2YB8). (F) Structure of NURF55 in complex to the N-terminus of histone H3 (PDB 
id 2YBA). The H3 peptide runs on the top of the propeller in an extended conformation, inserting the Arg2 side chain between Tyr185 and Phe325. This 
geometry is reminiscent of the complex with WDR5, although Arg2 does not go as deep into the central channel, and additional polar interactions 
contributed by Glu130NURF55, Glu183 NURF55 and Asn132 NURF55 anchor the Lys4H3 side chain on the propeller surface.
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at enhancer sites distant from TSSs14 (Fig. 
3B). These hypotheses are provocative, 
but it must be said that the mechanistic 
details of the WRAD mediated methyla-
tion are still largely missing and it is still 
unclear whether a dual catalytic site (one 
on MLL and the second on WRAD) is 
used toward an efficient tri-methylation 
of the substrates. Moreover, Takahashi 
and colleagues have recently shown that 
the reconstituted yeast WRAD complex 
does not have a substantial HMT activity. 
(WRAD) sub-complex could be recruited 
to chromatin via the high affinity inter-
action between WDR5 and H3R2me2s, 
in the absence of MLL/SET recruitment. 
Interestingly, this sub-complex has been 
proposed to have direct H3K4 monometh-
ylation activity, which is dependent on 
the ability of the ASH2L-SPRY domain 
to bind the cofactor S-adenosyl methio-
nine (SAM).35,36 The WRAD enzymatic 
activity would fit with the observed co-
localization of H3R2me2s and H3K4me1 
recruitment of histone demethylases that 
can demethylate H3K4me2/3 (KDMs)34 
or, alternatively, enzymes other than 
MLL could be involved in promoting 
H3K4 monomethylation (Fig. 3A). At 
those distal regulatory sites marked by 
H3R2me2s, the competitive binding of 
WDR5 to both H3R2me2s and the SET 
catalytic subunit of the Lys4-methylating 
complexes might have a regulatory func-
tion on the latter. The first possibility is 
that the WDR5/ASH2L/RBBP5/DPY30 
Figure 3. Regulation of the MLL/SET complexes at distal regulatory sites (Enhancers) and at Promoters. (A) H3K4 is e#ciently di- and tri-methylated 
(H3K4me2/3) in vivo by MLL/SET complexes. At distal regulatory sites H3K4me1 is more abundantly detected, either because of a constant demethyl-
ation by Jumonji-containing enzymes or by LSD1/2 (KDMs) or because alternative enzymes (SETx) directly monomethylate H3K4. (B) In the absence of 
the MLL/SET catalytic subunit, the WRAD complex could potentially monomethylate H3K4me1. Alternatively, the competition between WDR5, H3 and 
the Win Motif peptide on MLL/SET proteins could lead to reduced e#ciency in H3K4 tri-methylation and a consequent enhanced monomethylation 
at these sites. (C) Active promoters that are not enriched for H3R2me2s will recruit the MLL/SET complex to trimethylate H3K4 (H3K4me3). (D) When 
the -1 nucleosome is methylated on H3R2 (H3R2me2s) WDR5 will bind with high a#nity, most likely in the absence of the catalytic MLL/SET subunit. 
In order to be tri-methylated on H3K4, the histone tail will then translocate to the catalytic pocket of the MLL/SET (conformational change). (E) WDR5 
binding to H3 could be unrelated to the WRAD and MLL/SET complexes. WDR5 is part of the ATAC, the MOF and the CHD8 remodeler complex among 
possibly others.
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the binding of large or charged amino 
acids, specifically at position-2, that typi-
cally flank activation marks on histones. 
This could provide a molecular explana-
tion for the evidence that EED binds to 
H3K27me3 and H3K9me3 (ARKS), 
but not to H3K4me3 (RTKQ) (Fig. 2C) 
While EED has only been observed to 
bind H3K27me3 in vivo, in vitro it binds 
to most of the repressive marks, such as 
H3K9me3 or H4K20me3, with an affin-
ity that decreases with the degree of meth-
ylation (for example, H3K27me3 > me2 
> me1). This poor specificity observed in 
vitro could be explained by the topology 
of the interaction between EED and the 
H3K27 histone marks that occur only on 
the top surface of the β-propeller and not 
in the central channel (Fig. 2C). Instead, 
in the case of WDR5, the prominent fea-
ture of the association of the H3 tail with 
the β-propeller is the insertion of the Arg2 
side chain into the central cavity, where the 
presence of two phenylalanines favors the 
formation of a specific hydrophobic inter-
action with H3R2me2s14 (Fig. 2A). As a 
result, the interaction between WDR5 
and H3R2me2s appears to be extremely 
specific. In sharp contrast to EED that 
can bind several differentially methylated 
residues on histone H3 in vitro, WDR5 
has not been observed to interact with any 
other symmetrically di-methylated argi-
nines on histones (Migliori and Guccione, 
unpublished).
NURF55 and RbBP4/7. Besides 
EED, the PRC2 complex contains a sec-
ond WD40 protein termed NURF55 in 
Drosophila and RBBP4/7 in humans. 
This seven-blade β-propeller was origi-
nally identified as an interacting part-
ner of the Retinoblastoma protein.49 
Subsequently it was co-purified with the 
HAT1 acetyltransferase complex50 and 
several co-repressor complexes, including 
PRC2,51 NURD52 and CAF1.53 While 
NURF55 has been demonstrated to bind 
both H3 and H4,54,55 the precise mecha-
nism by which the binding of this multi-
functional chromatin reader is modulated 
by the crosstalk among histone modifica-
tions was only recently described.
The crystal structure of NURF55 
bound to histone H4 revealed that the 
binding occurs with the first helix of the 
histone fold, a region normally buried 
modification that would be predicted to 
destroy the binding, as observed in the 
case of H3R2me2a/me1 and WDR5.13,20,22 
More experiments are needed to clarify 
this point.
It is worth mentioning that the initial 
proposed model of WDR5 as the protein 
responsible to present the histone H3 tail 
to the MLL complex for methylation, 
is probably not accurate.21,40,41 On the 
contrary, it has been reported that the 
N-terminal of the histone tail has to be 
free to allow methylation by MLL,37,42 
while WDR5 plays a role in maintaining 
the integrity of the complex.
An alternate role for the observed bind-
ing of WDR5 to histone H3 has to finally 
be considered. WDR5 is part of several 
other complexes, for example the ATAC 
complex43 and the MOF complex,44 which 
possess acetyltransferase activity, and 
could in turn act to promote H3K4me3,45 
or the CHD8-containing chromatin 
remodeling complex,46 which could be 
similarly important to promote accessibil-
ity for further histone modifications (Fig. 
3E).
EED. The interplay between WDR5, 
H3 (either unmodified or symmetrically 
dimethylated on R2) and the other com-
ponents of the SET complexes is reminis-
cent of another important WD40 domain 
protein: EED. EED, together with EZH2 
and SU(z)12, form the PRC2 complex, 
a transcriptional co-repressor complex 
whose activity depends on its ability to 
trimethylate H3K27. While EZH2 is 
the catalytic subunit of the PRC2 com-
plex, EED binds directly to H3K27me3 
through its C-terminal domain, leading 
to the allosteric activation of the meth-
yltransferase activity of PRC2 and, as 
such, to the propagation of the repres-
sive mark.47,48 Similarly, H3R2me2s may 
favor H3K4 methylation by its interaction 
with WDR5 (Fig. 3D). This interaction 
displaces the Win motif from the WDR5 
binding cleft, and could cause an allo-
steric change in the complex, leading to 
its activation or favoring its processivity. 
The structure of EED in complex with 
H3K27me3 shows that the interaction 
occurs through a hydrophobic/aromatic 
cavity formed mainly by three residues: 
Phe97, Tyr148 and Tyr365. The peculiar-
ity of this cage is that it is able to prevent 
Indeed, when they use the WRAD com-
plex, less than 1% of H3K4me1 and no 
H3K4me2–3 were detected in their 
methylation assays, much less than what 
observed with the wt Set1/COMPASS or 
MLL/COMPASS-like complexes.37 These 
discrepancies could be due to the different 
protocols used to purify the complex sub-
units or the quality of the substrate, thus 
we reckon additional experiments will be 
necessary to clarify the issue.
A second role for the presence of 
H3R2me2s at distal regulatory sites could 
be to favor the dissociation of the MLL/
SET complex itself from the WRAD, by 
directly competing for the Win motif. 
This would lead to a preferential mono- 
over trimethylation of H3K4 (H3K4me1 
> H3K4me3) (Fig. 3B).
At promoters H3K4me3 is typically 
enriched over H3K4me138,39 (Fig. 3C). 
It is possible that at the subset of pro-
moters marked by both H3K4me3 and 
H3R2me2s, the topology of the inter-
actions among subunits of the WDR5/
Ash2/Rbbp5/DPY30 sub complex is rear-
ranged by the direct binding of the SET 
catalytic subunit to WDR5, via the Win 
motif. If so, the WRAD complex could be 
recruited first by the high affinity interac-
tion with H3R2me2s, and then undergo a 
conformational change leading to assem-
bly of the full complex that trimethyl-
ates histone H3 (Fig. 3D). Detailed time 
course studies will have to be performed 
in order to clarify whether this is the case.
Interestingly, a recent study on 
H3R2me2s both in yeast and eukaryotic 
cells reports a much higher degree of over-
lap between H3R2me2s and H3K4me3 at 
promoters. By taking advantage of yeast 
genetics, the authors further prove that 
the interdependency between H3R2me2s 
and H3K4me3 is mutual, since the argi-
nine methylation mark is not present in a 
SET1 mutant background.30
Although no formal prove has been 
provided to date, it is possible that the 
Win motif of the MLL proteins can also 
be symmetrically methylated on the argi-
nine required for the binding to WDR5, 
and that this methylation could enable 
MLL to better compete with H3R2me2s 
for binding to WDR5. Alternatively, 
the Win motif could possibly be mono- 
or asymmetrically dimethylated, a 
© 2012 Landes Bioscience.
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However, the authors fail to explain the 
mechanisms by which the WD40 motifs 
simultaneously interact with H3K9me3, 
ORC and other possible co-repressors to 
stabilize heterochromatin in cis.62 This 
will be an interesting aspect to address 
with both biochemical and structural biol-
ogy studies.
WD40 Domains  
as Flexible Scaffolds  
for Intracellular Interactions
A recent report by Wang and colleagues 
identified HOTTIP, a long non-coding 
RNA transcribed from the 5' of the HOXA 
locus, as a direct interactor of WDR5. In 
vivo, HOTTIP has been shown to coor-
dinate the activation of several HOXA 
genes and its binding to WDR5 targets 
the MLL complex activity to all genes in 
the HOXA cluster.63
WDR5 is also the first member of the 
Trithorax complex to be shown to directly 
interact with Oct4 and to regulate self-
renewal in mouse embryonic stem cells.64 
The authors observed a strong correla-
tion between WDR5 and Oct4 binding 
to chromatin on a genome-wide scale. 
Moreover, they proved that WDR5 is 
required in the initial phase of somatic cell 
reprogramming to iPS cells and propose 
a model in which Oct4 first binds and 
promotes WDR5 expression in somatic 
cells, then interacts with WDR5 and con-
fers DNA specificity to the WDR5/MLL 
complex. This re-establishes H3K4me3 
on self-renewal genes such as Nanog or 
Pou5f1, promoting subsequent strong 
binding of Oct4 to these promoters and 
directing a robust transcriptional activa-
tion of the pluripotency network.64
To conclude, WD40-containing pro-
teins are versatile proteins, which can 
simultaneously mediate interactions 
between histones, protein- and RNA-
partners, thus integrating complex signal-
ing pathways and ultimately controlling 
gene transcription.
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residue does not impair binding.56 This is 
in line with more recent data showing that 
the opposite symmetricity (H3R2me2s) 
has a negative effect on this interaction.14
WDR77. The cofactor WDR77, also 
called Mep50, is another WD40 protein, 
which directly interacts with histones. 
WDR77 binds specifically to histone 
H2A, most likely favoring the specific 
methylation of H2AR3 by PRMT5.58 
The exact surface of interaction and how 
WDR77 stimulates this methylation 
event is however, still unknown. Solving 
the crystal structure of PRMT5/WDR77 
in combination with H2A will prove 
extremely interesting and provide further 
understanding into the role of this WD40 
protein in aiding PRMT5 activity.
It is also important to note that 
PRMT5 methylates histones both in the 
nucleus and in the cytoplasm. Specifically 
the symmetrical dimethyation of H2AR3 
seems to occur in the cytoplasm, contribut-
ing to the repression of pro-differentiation 
genes in embryonic stem cells.59 Whether 
this holds true for the other histone meth-
ylation events catalyzed by PRMT5, such 
as H3R2me2s or H3R8me2s, remains to 
be addressed.
LRWD1. In two recent proteomic 
screens, LRWD1, another WD40 
repeat-containing protein, was identi-
fied to interact with repressive trimethyl 
marks (H3K9me3, H3K27me3 and 
H4K20me3) and with the ORC com-
plex.60,61 Further studies have shown 
that LRWD1 stabilizes ORC binding to 
chromatin, specifically heterochromatin.9 
While the ability of LRWD1 to bind het-
erochromatin was accurately described by 
multiple groups, none addressed whether 
this interaction occurred directly or indi-
rectly. A more recent study proved that 
LRWD1 is recruited to pericentric het-
erochromatin by its direct binding to 
H3K9me3. The localization of the WD40 
protein is not altered in cells lacking 
H4K20me3 (Suv420h1h2-/-), while it is 
compromised in cells lacking H3K9me3 
(Suv39h1h2-/-). Functionally, this inter-
action helps to maintain heterochromatin 
silencing, as Lrwd1 knockdown results in 
failure to silence the major satellite repeats. 
in the nucleosome structure (Fig. 2D).25 
Consistently, mutations that disrupted 
such interactions led specifically to the loss 
of HAT1 acetyltransferase activity, which 
is directed toward newly synthetized and 
non-nucleosomal H4. Unlike the binding 
between WDR5 and histone H3, which 
occurs deep in the central cavity of the 
WD40 propeller, NURF55 interacts with 
H4 on the side surface of the protein. The 
binding surface is hydrophobic on one 
side, and negatively charged on the other, 
thus perfectly matching the H4-helix, 
which has alternating hydrophobic and 
positively-charged amino acids (Fig. 2D). 
The extensive hydrogen bond network 
that stabilizes the binding is unique to the 
surface of this β-propeller, and is absent 
in WDR5 and other members of the fam-
ily. RBBP4/7 is also part of the NURF 
complex, and it remains to be addressed 
whether the interaction surface on H4 is 
made accessible during the remodeling 
process by the ISWI-containing ATP-
dependent chromatin-remodeling com-
plex. By determining the crystallographic 
structure of NURF55 bound to H3, a more 
recent publication reconciled the binding 
data with the direct activity of NURF55-
containing complexes on chromatin.56 The 
authors show that in the context of the 
PRC2 complex, NURF55 is able to bind 
to both Su(z)12, which binds in the same 
binding pocket as the H4 peptide (Fig. 
2E), and to H3, which instead binds on 
the top-flat surface of the β-propeller (Fig. 
2F). Unlike WDR5, the arginine at posi-
tion 2 does not interact with residues deep 
in the central cavity, but is nonetheless 
very important in recognizing NURF55, 
together with H3K4 whose side chain is 
docked on the propeller surface by polar 
interactions with negatively charged resi-
dues of NURF55. Consistently, methyla-
tion on H3K4 impairs NURF55/Su(z)12 
binding.56,57 More specifically, H3K4me3 
methylation on nucleosomes reduces the 
catalytic turnover of PRC2, resulting in 
an overall reduction in H3K27 meth-
ylation. Interestingly, despite an involve-
ment of H3R2 in binding to the surface 
of NURF, the presence of the asymmet-
ric dimethylation (H3R2me2a) of this 
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